{
    "testId": 389955020,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 57,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 34,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 1,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 3600,
    "averageTimeSpentInSeconds": 90,
    "otherAverageTimeSpentInSeconds": 78,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 2725,
            "questionIndex": 2725,
            "questionText": "<p>A 35-year-old man is evaluated due to poor exercise tolerance and muscle weakness.&nbsp; He has no past medical history.&nbsp; Blood pressure is 175-185 mm Hg systolic and 105-115 mm Hg diastolic on repeat measurements, and pulse is 78-95/min.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Sodium</td><td style=\"vertical-align:middle;\">146 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Potassium</td><td style=\"vertical-align:middle;\">2.4 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Glucose</td><td style=\"vertical-align:middle;\">95 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">0.7 mg/dL</td></tr></tbody></table><p>CT scan of the abdomen reveals a 3-cm mass in the left adrenal gland.&nbsp; Which of the following additional findings would be expected in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"2606\" src=\"https://www.uworld.com/media/L24133.jpg\" ></p><p>This patient has significant <strong>hypertension</strong> at a relatively young age, which raises suspicion for secondary causes of hypertension.&nbsp; In particular, his <strong>hypokalemia</strong> associated with a 3-cm <strong>adrenal mass</strong> is highly suggestive of <strong>primary hyperaldosteronism</strong> (Conn syndrome).&nbsp; Conn syndrome is characterized by the excessive, unregulated secretion of aldosterone, usually due to adrenal adenoma or bilateral adrenal hyperplasia.</p><p>Aldosterone stimulates renal reabsorption of sodium, leading to expanded blood volume and hypertension.&nbsp; However, hypernatremia is generally mild due to increased renal blood flow and secretion of natriuretic factors (ie, aldosterone escape).&nbsp; The hypertension causes a compensatory drop in renin production <strong>(Choice E)</strong>; <strong>low plasma renin activity</strong> (PRA) with an elevated serum aldosterone level confirms the diagnosis of Conn syndrome.</p><p>In addition, aldosterone causes wasting of potassium, leading to hypokalemia, which can cause muscle weakness and decreased exercise tolerance.&nbsp; Aldosterone also stimulates nephrons to secrete hydrogen ions into the urine, resulting in increased reabsorption of bicarbonate, elevated serum bicarbonate levels <strong>(Choices A and D)</strong>, and <strong>metabolic alkalosis</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Secondary hyperaldosteronism is characterized by elevated aldosterone with elevated PRA and metabolic alkalosis.&nbsp; Typical endogenous causes include renovascular hypertension and renin-secreting tumor.&nbsp; However, this patient&#39;s 3-cm adrenal mass makes renovascular hypertension less likely, and a renin-secreting tumor would typically be found in the kidneys, not the adrenal glands.</p><p><strong>Educational objective:</strong><br>Primary hyperaldosteronism (Conn syndrome) causes hypertension, hypokalemia, and metabolic alkalosis.&nbsp; The diagnosis is confirmed by low plasma renin activity with an elevated serum aldosterone level.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 10292,
            "topic": "Hyperaldosteronism",
            "titleId": 10292,
            "title": "Hyperaldosteronism",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:500px\">\n\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tHigh\n\t\t\t</td>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tHigh\n\t\t\t</td>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 1,
                    "correctTaken": 1799,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:500px\">\n\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tHigh\n\t\t\t</td>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tHigh\n\t\t\t</td>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tHigh\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 2,
                    "correctTaken": 1314,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:500px\">\n\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tHigh\n\t\t\t</td>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tHigh\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 3,
                    "correctTaken": 9135,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:500px\">\n\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tHigh\n\t\t\t</td>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 4,
                    "correctTaken": 3599,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:500px\">\n\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tHigh\n\t\t\t</td>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t\t<td style=\"width:33%; vertical-align:middle;\">\n\t\t\t\tHigh\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 5,
                    "correctTaken": 204,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "694,760,true,-1,1*1249,1450,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "199",
                    "mediaDataId": 0,
                    "title": "Secondary hypertension",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27535640",
                    "mediaDataId": 0,
                    "title": "Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27535640",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 75,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 16051,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:500px\"><tbody style=\"text-align:center\"><tr><td style=\"width:33%; vertical-align:middle;\"><strong>Plasma renin activity</strong></td><td style=\"width:33%; vertical-align:middle;\"><strong>Serum aldosterone</strong></td><td style=\"width:33%; vertical-align:middle;\"><strong>Serum bicarbonate</strong></td></tr></tbody></table>",
            "standards": null,
            "totalTimeSpentReview": 488,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 8880,
            "questionIndex": 8897,
            "questionText": "<p>A 55-year-old man comes to the office for follow-up of hypertension.&nbsp; The diagnosis was made 3 months ago after the patient experienced a transient ischemic attack.&nbsp; He has occasional headaches and general fatigue but otherwise feels well.&nbsp; Current medications include aspirin, lisinopril, and low-dose chlorthalidone.&nbsp; Blood pressure is 157/95 mm Hg and pulse is 69/min.&nbsp; BMI is 26 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Cardiac auscultation reveals an S4 heart sound.&nbsp; There are no carotid or abdominal bruits on examination.&nbsp; Pulses are 2+ in all extremities.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Potassium</td><td style=\"vertical-align:middle;\">3.1 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">0.9 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Plasma renin activity</td><td style=\"vertical-align:middle;\">low</td></tr></tbody></table><p>Which of the following best explains this patient&#39;s laboratory findings?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T90673\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"5\"><p align=\"center\"><strong>Adrenocortical causes of hypertension</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Plasma aldosterone</strong></p></td><td><p align=\"center\"><strong>Plasma renin activity</strong></p></td><td><p align=\"center\"><strong>Aldosterone/<br>renin ratio</strong></p></td><td><p align=\"center\"><strong>Clinical examples</strong></p></td></tr><tr><td><p align=\"center\"><strong>Primary hyperaldosteronism</strong></p></td><td><p align=\"center\">&#8593;</p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">&#8593;</p></td><td><ul><li>Bilateral adrenal hyperplasia</li><li>Adrenal adenoma</li></ul></td></tr><tr><td><p align=\"center\"><strong>Secondary hyperaldosteronism</strong></p></td><td><p align=\"center\">&#8593;</p></td><td><p align=\"center\">&#8593;</p></td><td><p align=\"center\">&#8596;</p></td><td><ul><li>Renovascular HTN</li><li>Malignant HTN</li><li>Renin-secreting tumor</li></ul></td></tr><tr><td><p align=\"center\"><strong>Nonaldosterone mediated</strong></p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">&#8596;</p></td><td><ul><li>Cushing syndrome</li><li>Exogenous mineralocorticoids (eg, fludrocortisone)</li><li>Deoxycorticosterone excess*</li></ul></td></tr><tr><td colspan=\"5\"><p>*Includes deoxycorticosterone-producing adrenal tumors (rare) &amp; relatively uncommon forms of<br>congenital adrenal hyperplasia (eg, 11&#42933;-hydroxylase deficiency).</p><p><strong>HTN</strong> = hypertension.</p></td></tr></tbody></table></div><p>This patient with low plasma renin likely has secondary hypertension due to <strong>primary hyperaldosteronism</strong>, which is typically caused by an adrenal adenoma or bilateral adrenal hyperplasia.&nbsp; Primary hyperaldosteronism is characterized by <strong>autonomous aldosterone</strong> secretion that leads to increased intravascular volume and <strong>hypertension</strong>.&nbsp; Hypertension can cause headaches if severe and left ventricular hypertrophy (eg, S4 heart sound) if prolonged.</p><p>The elevated serum aldosterone causes&nbsp;<strong>suppressed plasma renin activity</strong> (PRA) due to feedback inhibition of the renin-angiotensin-aldosterone system.&nbsp; Electrolyte abnormalities such as <strong>hypokalemia</strong> and metabolic alkalosis are often present due to aldosterone-mediated <a href=\"2802\">K<font size=\"2\"><sup>+</sup></font> and H<font size=\"2\"><sup>+</sup></font> secretion</a>, respectively.&nbsp; The addition of a thiazide diuretic (eg, chlorthalidone) for treatment of hypertension can substantially worsen these electrolyte abnormalities (as in this patient).</p><p>Despite increased Na<font size=\"2\"><sup>+</sup></font> reabsorption, extravascular volume overload (eg, peripheral edema) is rarely seen due to <a href=\"2606\">aldosterone escape</a>.</p><p><strong>(Choice A)</strong>&nbsp; Thiazides (eg, chlorthalidone) inhibit the Na<font size=\"2\"><sup>+</sup></font>-Cl<font size=\"2\"><sup>&#8722;</sup></font> cotransporter in the distal convoluted tubule, which results in natriuresis and potassium wasting.&nbsp; Although thiazide use explains this patient&#39;s hypokalemia (which can cause fatigue), by itself it would be expected to cause a rise in PRA due to reduced intravascular volume and decreased Na<font size=\"2\"><sup>+</sup></font> delivery to the macula densa (which <a href=\"59904\">stimulates renin release</a>).</p><p><strong>(Choice B)</strong>&nbsp; ACE inhibitors (eg, lisinopril) decrease conversion of angiotensin I to angiotensin II, which results in a compensatory rise in PRA in addition to reduced glomerular filtration rate due to efferent arteriole vasodilation.&nbsp; A mild rise in serum creatinine and an increase in serum potassium are often seen.</p><p><strong>(Choice C)</strong>&nbsp; Malignant hypertension is characterized by markedly elevated blood pressure with end-organ damage to the eye (eg, retinal hemorrhages, papilledema), CNS (eg, hemorrhage, encephalopathy), and kidneys (eg, nephrosclerosis).&nbsp; Kidney involvement results in creatinine elevation (normal in this patient) and dysregulated renin release that leads to a paradoxically high PRA.</p><p><strong>(Choice E)</strong>&nbsp; Renovascular hypertension is characterized by decreased renal perfusion (most often due to unilateral renal artery stenosis) that results in an inappropriately high PRA that leads to hypertension.&nbsp; An abdominal bruit is typically auscultated.</p><p><strong>Educational objective:</strong><br>Primary hyperaldosteronism results in hypertension and predisposes to electrolyte abnormalities (ie, hypokalemia, metabolic alkalosis).&nbsp; Low plasma renin activity is expected.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 10292,
            "topic": "Hyperaldosteronism",
            "titleId": 10292,
            "title": "Hyperaldosteronism",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chlorthalidone adverse effect",
                    "choiceNumber": 1,
                    "correctTaken": 2503,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lisinopril adverse effect",
                    "choiceNumber": 2,
                    "correctTaken": 1023,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Malignant hypertension",
                    "choiceNumber": 3,
                    "correctTaken": 250,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary hyperaldosteronism",
                    "choiceNumber": 4,
                    "correctTaken": 9302,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renovascular hypertension",
                    "choiceNumber": 5,
                    "correctTaken": 618,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "284,297,true,-1,1*350,445,true,-1,1*447,601,true,-1,1*1827,2083,true,-1,1*2637,2783,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "199",
                    "mediaDataId": 0,
                    "title": "Secondary hypertension",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22806599",
                    "mediaDataId": 0,
                    "title": "Primary aldosteronism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22806599",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 98,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 13696,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 969,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 4678,
            "questionIndex": 4678,
            "questionText": "<p>A 34-year-old woman, gravida 1 para 1, comes to the office for postpartum follow-up.&nbsp; She had a vaginal delivery 6 weeks ago that was complicated by severe postpartum bleeding requiring aggressive volume resuscitation and transfusion of 5 units of packed red blood cells.&nbsp; Since the delivery, the patient has been very fatigued with poor appetite.&nbsp; She is &#x22;very concerned&#x22; about having little energy to bond with her child; her family has been helping with the baby.&nbsp; The patient has been formula feeding her infant due to lack of milk production.&nbsp; Her prepregnancy weight was 63.5 kg (140 lb), weight at delivery was 82.5 kg (182 lb), and current weight is 56.2 kg (124 lb).&nbsp; Blood pressure is 90/69 mm Hg and pulse is 88/min.&nbsp; Examination shows a well-healed perineal laceration scar.&nbsp; Which of the following is the most likely cause of this patient&#39;s current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31499\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Sheehan syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Obstetric hemorrhage complicated by hypotension</li><li>Postpartum pituitary infarction</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Lactation failure (&darr; prolactin)</li><li>Amenorrhea, hot flashes, vaginal atrophy (&darr; FSH, LH)</li><li>Fatigue, bradycardia (&darr; TSH)</li><li>Anorexia, weight loss, hypotension (&darr; ACTH)</li><li>Decreased lean body mass (&darr; growth hormone)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s <strong>massive postpartum hemorrhage</strong> with subsequent lactation failure, hypotension, and weight loss are concerning for <strong>Sheehan syndrome</strong> (<strong>ischemic necrosis</strong> of the pituitary gland).&nbsp; During pregnancy, the pituitary gland is physiologically enlarged and vulnerable to ischemia from hemorrhagic shock.&nbsp; This potentially life-threatening complication is characterized by anterior pituitary dysfunction; deficiencies in multiple hormone systems (ie, panhypopituitarism) are common.</p><p>Sheehan syndrome typically presents after delivery with <strong>failure of postpartum lactation</strong> due to prolactin deficiency and lactotroph cell necrosis.&nbsp; <strong>Secondary adrenal insufficiency</strong> (eg, persistent hypotension, weight loss, lethargy) is also a common complication due to impaired ACTH secretion.&nbsp; Amenorrhea (hypogonadotropic hypogonadism) and <strong>central hypothyroidism</strong> may also occur.&nbsp; Management involves replacing the deficient hormones, but there is no effective treatment to restore lactation.</p><p><strong>(Choices A and C)</strong>&nbsp; Lactation failure is a risk factor for adjustment disorder with depressed mood (&#x22;postpartum blues&#x22;) and postpartum depression.&nbsp; Although fatigue and poor appetite are common symptoms of mood disorders, hypotension and significant weight loss suggest an underlying medical disorder.</p><p><strong>(Choice D)</strong>&nbsp; Postpartum thyroiditis is characterized by autoimmune inflammation and destruction of the thyroid within a year of delivery.&nbsp; It causes transient hyperthyroid symptoms (eg, weight loss, palpitations, tremor) followed by a self-limited hypothyroid state.&nbsp; However, it is not associated with hypotension or lactation failure.</p><p><strong>(Choice E)</strong>&nbsp; Primary adrenal insufficiency manifests with similar symptoms such as fatigue, hypotension, and weight loss.&nbsp; However, most patients with primary adrenal insufficiency have hyperpigmentation (due to increased melanocyte-stimulating hormone) but not lactation failure.</p><p><strong>(Choice F)</strong>&nbsp; Pituitary apoplexy generally refers to spontaneous hemorrhage into the pituitary gland and occurs most commonly in patients with a pituitary adenoma.&nbsp; Typical symptoms include acute headache, visual field defects, and decreased visual acuity.&nbsp; Symptomatic deficiencies of pituitary hormones are less common.</p><p><strong>Educational objective:</strong><br>Sheehan syndrome (postpartum ischemic necrosis of the anterior pituitary) is a potentially life-threatening complication of massive postpartum hemorrhage.&nbsp; It typically presents with lactation failure (prolactin deficiency) as well as hypotension and anorexia (secondary adrenal insufficiency).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2767,
            "topic": "Hypopituitarism",
            "titleId": 2767,
            "title": "Hypopituitarism",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with depressed mood",
                    "choiceNumber": 1,
                    "correctTaken": 188,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pituitary ischemic necrosis",
                    "choiceNumber": 2,
                    "correctTaken": 13424,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postpartum depression",
                    "choiceNumber": 3,
                    "correctTaken": 1235,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postpartum thyroid inflammation",
                    "choiceNumber": 4,
                    "correctTaken": 392,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary adrenal insufficiency",
                    "choiceNumber": 5,
                    "correctTaken": 279,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Spontaneous pituitary hemorrhage",
                    "choiceNumber": 6,
                    "correctTaken": 1321,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "940,988,true,-1,1*1226,1337,true,-1,1*2106,2254,true,-1,1*2266,2574,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "495",
                    "mediaDataId": 0,
                    "title": "Sheehan syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23245206",
                    "mediaDataId": 0,
                    "title": "Sheehan&#39;s syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23245206",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16785150",
                    "mediaDataId": 0,
                    "title": "Characteristic features of 20 patients with Sheehan&#39;s syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16785150",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 73,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 16839,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 702,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 4216,
            "questionIndex": 4216,
            "questionText": "<p>A 28-year-old woman is hospitalized following a motor vehicle accident.&nbsp; She was returning home following a wine-tasting event when she veered off the road and rolled her car.&nbsp; Initial evaluation in the emergency department found severe hypotension, a hip fracture, multiple rib fractures, and evidence of blunt abdominal trauma.&nbsp; The patient underwent emergent laparotomy, which revealed a liver laceration and extensive hemoperitoneum.&nbsp; Her condition was stabilized with surgical intervention, fluid resuscitation, and blood transfusions.&nbsp; In the early postoperative period soon after extubation, the patient developed numbness in the fingertips and around her lips.&nbsp; She also developed forceful flexion of the wrist with abduction of the thumb while her nurse was measuring her blood pressure.&nbsp; Temperature is 37.4 C (99.3 F), blood pressure is 120/68 mm Hg, pulse is 80/min, and respirations are 12/min.&nbsp; Neurologic examination shows hyperactive reflexes diffusely with 5/5 muscle strength in all extremities.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t35910\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Acute hypocalcemia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Causes</strong></p></td><td><ul><li><strong>Neck surgery </strong>(parathyroidectomy)</li><li>Pancreatitis</li><li>Sepsis</li><li>Tumor lysis syndrome</li><li>Acute alkalosis</li><li><strong>Chelation</strong>: blood (citrate) transfusion, EDTA, foscarnet</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Muscle cramps</li><li>Chvostek &amp; Trousseau signs</li><li>Paresthesias</li><li>Hyperreflexia/tetany</li><li>Seizures</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>IV calcium gluconate/chloride</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>EDTA</strong> = ethylenediaminetetraacetic acid; <strong>IV</strong> = intravenous.</p></td></tr></tbody></table></div></p><p>This patient has paresthesias, <a href=\"2008\">carpal spasm (Trousseau sign)</a>, and hyperreflexia.&nbsp; In the setting of high-volume transfusion, these neurologic features are most likely due to <strong>hypocalcemia</strong>.&nbsp; Other potential features of severe hypocalcemia include tetany, laryngospasm, seizures, encephalopathy, and heart failure.&nbsp; Patients with chronic hypocalcemia may have only mild symptoms, but patients with acute hypocalcemia will have more severe manifestations at the same calcium concentration.</p><p><strong>Citrate</strong> in <strong>transfused blood</strong> binds <strong>ionized calcium</strong>, which is the biologically active fraction (total calcium levels will not be significantly affected).&nbsp; Hypocalcemia is uncommon following blood transfusion in patients with normal liver function as citrate is rapidly metabolized by the liver; however, this patient likely has hepatic dysfunction due to the liver laceration as well as ischemic liver injury due to hypotension.&nbsp; Other infused substances that can chelate calcium in the blood include lactate, foscarnet, and sodium ethylenediaminetetraacetic acid (EDTA).</p><p><strong>(Choice A)</strong>&nbsp; Alcohol withdrawal is most pronounced 12-48 hours following the last drink.&nbsp; Clinical features may include hyperreflexia, tremor, diaphoresis, and gastrointestinal upset, but carpal spasm and paresthesias are more consistent with hypocalcemia.</p><p><strong>(Choice B)</strong>&nbsp; Hyperventilation due to anxiety can cause acute respiratory alkalosis, increasing the binding of calcium to albumin and reducing ionized calcium concentrations.&nbsp; However, this patient&#39;s respiratory rate is only 12/min.</p><p><strong>(Choice C)</strong>&nbsp; Fat embolism can occur following pelvic or long bone fractures.&nbsp; Manifestations of fat embolism include respiratory insufficiency, hypoxemia, altered mental state, and petechial rash.</p><p><strong>(Choice D)</strong>&nbsp; Hypomagnesemia (not hypermagnesemia) can present similarly to hypocalcemia.&nbsp; Severe hypermagnesemia causes hyporeflexia, paralysis, apnea, and cardiac arrest.&nbsp; Rarely, very severe hypermagnesemia can cause hypocalcemia by inhibiting parathyroid hormone release, but this would typically be seen with infusions of magnesium, such as in the treatment of severe preeclampsia and eclampsia.</p><p><strong>Educational objective:</strong><br>High-volume blood transfusion can cause symptomatic hypocalcemia due to chelation of ionized calcium by citrate in transfused blood.&nbsp; Patients with impaired hepatic function are at increased risk due to decreased clearance of citrate by the liver.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2731,
            "topic": "Hypocalcemia",
            "titleId": 2731,
            "title": "Hypocalcemia",
            "topicAttributeId": 330638,
            "topicAttribute": "Normal structure and function of endocrine glands",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alcohol withdrawal",
                    "choiceNumber": 1,
                    "correctTaken": 500,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anxiety",
                    "choiceNumber": 2,
                    "correctTaken": 162,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fat embolism",
                    "choiceNumber": 3,
                    "correctTaken": 772,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypermagnesemia",
                    "choiceNumber": 4,
                    "correctTaken": 1980,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypocalcemia",
                    "choiceNumber": 5,
                    "correctTaken": 40753,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "103,109,true,-1,1*147,201,true,-1,1*275,289,true,-1,1*656,888,true,-1,1*1317,1459,true,-1,1*2232,2314,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "468",
                    "mediaDataId": 0,
                    "title": "Calcium disorders",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22613418",
                    "mediaDataId": 0,
                    "title": "Effects of liver function on ionized hypocalcaemia following rapid blood transfusion",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22613418",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 106,
            "othersAvgTimeSpent": 53,
            "notes": null,
            "peopleTaken": 44167,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 92,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 913,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 4420,
            "questionIndex": 4420,
            "questionText": "<p>A 42-year-old woman comes to the emergency department due to 2 syncopal episodes in the last 3 days.&nbsp; The patient was well until approximately a month ago when she began to feel increasingly fatigued and weak.&nbsp; For the past 2 weeks, she has had anorexia, nausea, and abdominal pain.&nbsp; The patient&#39;s medical history is unremarkable, and she takes no medications.&nbsp; She drinks wine only on social occasions, and does not use tobacco or illicit drugs.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 86/52 mm Hg, pulse is 90/min, and respirations are 18/min.&nbsp; Cardiopulmonary examination is normal.&nbsp; The abdomen is mildly tender with otherwise normal findings.&nbsp; The skin shows hyperpigmentation in the palmar creases.&nbsp; Which of the following additional findings is most likely present in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t53662\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Primary adrenal insufficiency</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Autoimmune adrenalitis (most common)</li><li>Infection (eg, tuberculosis)</li><li>Metastatic infiltration</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Fatigue, weakness, anorexia/weight loss</li><li>Nausea, vomiting, abdominal pain</li><li>Salt craving, postural hypotension</li><li>Hyperpigmentation</li><li>Acute adrenal crisis: confusion, hypotension/shock</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Hyponatremia, hyperkalemia, eosinophilia</li><li>Low morning cortisol, high ACTH</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Glucocorticoids (eg, hydrocortisone, prednisone)</li><li>Mineralocorticoids (eg, fludrocortisone)</li></ul></td></tr></tbody></table></div><p>This patient has typical features of <strong>primary adrenal insufficiency</strong> (PAI), also known as Addison disease.&nbsp; The initial symptoms of PAI often are nonspecific and can include <strong>fatigue</strong>, malaise, weakness, and <strong>weight loss</strong>.&nbsp; <strong>Gastrointestinal symptoms</strong> (eg, nausea, abdominal pain, diarrhea) occur in up to 90% of patients.&nbsp; Aldosterone deficiency causes <strong>volume depletion</strong> and cortisol deficiency causes loss of vascular tone; these changes can manifest as hypotension, postural dizziness, or syncope.&nbsp; Skin signs can include generalized or patchy <strong>hyperpigmentation</strong> (due to cosecretion of melanocyte-stimulating hormone with ACTH) and sometimes vitiligo (due to autoimmune destruction of melanocytes).</p><p>The secretion of antidiuretic hormone (ADH) is increased in PAI; this results from both nonosmotic stimulus for ADH release in the setting of hypovolemia and reduced inhibition of ADH in the setting of reduced cortisol.&nbsp; With increased ADH secretion there is increased water retention that leads to <strong>hyponatremia</strong>, the most common electrolyte abnormality in PAI.&nbsp; Aldosterone deficiency also leads to renal potassium retention; therefore,&nbsp;<strong>hyperkalemia</strong> is usually present as well.</p><p><strong>(Choice A)</strong>&nbsp; Hypoglycemia is a potential complication of cortisol deficiency in PAI, and can be triggered by fasting, infection, or alcohol consumption.&nbsp; Hyperglycemia is not seen in the absence of preexisting type 1 diabetes mellitus.</p><p><strong>(Choice C)</strong>&nbsp;&nbsp;Hyponatremia,&nbsp;rather than hypernatremia, is the most common electrolyte abnormality in PAI and is due to increased ADH secretion.</p><p><strong>(Choice D)</strong>&nbsp; PAI can cause mild hypercalcemia due to increased release of calcium from the bones, increased proximal tubular calcium absorption, and volume contraction.&nbsp; PAI with concurrent hypoparathyroidism leading to hypocalcemia can be seen in the polyglandular autoimmune syndrome type 1 but is extremely rare.</p><p><strong>(Choice E) </strong> In addition to potassium retention, aldosterone deficiency also stimulates renal retention of hydrogen and chloride ions, leading to a mild hyperchloremic metabolic acidosis.</p><p><strong>Educational objective:</strong><br>Chronic primary adrenal insufficiency presents with weight loss, fatigue, and gastrointestinal symptoms.&nbsp; Volume depletion and reduced vascular tone can cause hypotension and syncope.&nbsp; Most patients have hyponatremia due to renal sodium loss and increased secretion of antidiuretic hormone.&nbsp; Hyperkalemia is also common due to renal potassium retention in the setting of aldosterone deficiency.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23445,
            "topic": "Adrenal insufficiency",
            "titleId": 23445,
            "title": "Adrenal insufficiency",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Hyperglycemia",
                    "choiceNumber": 1,
                    "correctTaken": 2927,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hyperkalemia",
                    "choiceNumber": 2,
                    "correctTaken": 11630,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypernatremia",
                    "choiceNumber": 3,
                    "correctTaken": 1262,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypocalcemia",
                    "choiceNumber": 4,
                    "correctTaken": 913,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypochloremia",
                    "choiceNumber": 5,
                    "correctTaken": 951,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "250,264,true,-1,1*402,446,true,-1,1*914,964,true,-1,1*1085,1238,true,-1,1*1396,1458,true,-1,1*1804,1868,true,-1,1*2105,2408,true,-1,1*2560,2595,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "491",
                    "mediaDataId": 0,
                    "title": "Adrenal insufficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26760044",
                    "mediaDataId": 0,
                    "title": "Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26760044",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 44,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 17683,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 745,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 16060,
            "questionIndex": 17502,
            "questionText": "<p>A 26-year-old woman, gravida 0 para 0, comes to the office with her husband due to infertility.&nbsp; The patient has been unable to conceive despite regular unprotected intercourse for the last 12 months.&nbsp; Her last menstrual period was 4 months ago.&nbsp; Medications include citalopram for major depressive disorder and levothyroxine for hypothyroidism.&nbsp; The patient does not use tobacco, alcohol, or recreational drugs.&nbsp; BMI is 34 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination, including pelvic examination and visual field testing, is normal.&nbsp; Laboratory evaluation shows serum prolactin of 110 ng/mL.&nbsp; Serum TSH is 3.4 &micro;U/mL and serum creatinine is 0.9 mg/dL.&nbsp; Pregnancy test is negative.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T84054\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hyperprolactinemia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical manifestations</strong></p></td><td><ul><li>Premenopausal women: oligomenorrhea/amenorrhea, infertility, galactorrhea</li><li>Postmenopausal women: mass effect symptoms (eg, headache, visual field defects) if due to large adenoma</li><li>Men: hypogonadism (decreased libido, erectile dysfunction), mass effect symptoms</li></ul></td></tr><tr><td><p align=\"center\"><strong>Causes</strong></p></td><td><ul><li>Physiologic (eg, pregnancy, breastfeeding)</li><li>Chest wall injury (eg, burns, herpes zoster)</li><li>Prolactinoma</li><li>Infiltrative pituitary/hypothalamic disorders (eg, malignancy, sarcoidosis)</li><li>Medications (eg, antipsychotics, metoclopramide)</li><li>Hypothyroidism</li><li>Chronic kidney disease</li></ul></td></tr><tr><td><p align=\"center\"><strong>Evaluation</strong></p></td><td><ul><li>Serum prolactin</li><li>MRI of pituitary (if cause not known)</li></ul></td></tr></tbody></table></div><p>This patient with infertility (ie, failure to conceive after 12 months of unprotected intercourse) and oligomenorrhea (eg, last menstrual period 4 months ago) most likely has <strong>anovulatory infertility</strong>.&nbsp; Anovulation can occur due to primary ovarian dysfunction (eg, primary ovarian insufficiency, polycystic ovary syndrome) or secondary to an <strong>underlying hormonal disorder</strong> (eg, hypothyroidism, hyperprolactinemia).&nbsp; Therefore, the initial evaluation of anovulatory infertility includes <strong>TSH and prolactin levels</strong>.</p><p>This patient has <strong>hyperprolactinemia</strong> (normal: &lt;20 ng/mL).&nbsp; High prolactin levels suppress hypothalamic GnRH secretion, leading to decreased LH and estradiol secretion.&nbsp; The resultant hypogonadism presents clinically with <strong>oligomenorrhea/amenorrhea</strong> and anovulatory infertility, as seen in this patient.</p><p>The degree of hyperprolactinemia often correlates with the underlying cause:</p><ul><li><p>Very high prolactin levels (eg, &#8805;200 ng/mL) usually indicate a prolactin-secreting pituitary macroadenoma (ie, prolactinoma or lactotroph adenoma).</p></li><li><p>Moderate hyperprolactinemia can be due to hypothyroidism or renal insufficiency, which are less likely in this patient with normal TSH and creatinine levels.</p></li><li><p><strong>Mild to moderate elevations</strong> (&lt;200 ng/mL), as seen in this patient, can occur due to disruption of inhibitory dopamine pathways by medications (ie, antipsychotics [eg, haloperidol] but not usually selective serotonin reuptake inhibitors [eg, citalopram]).&nbsp; They may also occur due to <strong>small prolactinomas</strong> (microadenomas) that may not present with classic mass symptoms (eg, headache, bitemporal hemianopsia) <strong>(Choice D)</strong>.</p></li></ul><p>Prolactinomas are the <strong>most common</strong> cause of hyperprolactinemia <strong>in women of reproductive age</strong>.&nbsp; Therefore, the most appropriate next step in evaluation of this patient is <strong>MRI of the head</strong>.</p><p><strong>(Choices A and E)</strong>&nbsp; Polycystic ovary syndrome (PCOS) can also present with obesity, oligomenorrhea, and anovulatory infertility.&nbsp; Weight loss is the first-line recommendation for improving fertility rates; metformin is not typically recommended due to minimal improvement in ovulatory function and fertility rates.&nbsp; This patient has hyperprolactinemia and no signs of hyperandrogenism (eg, hirsutism), making a prolactinoma more likely than PCOS.</p><p><strong>(Choice B)</strong>&nbsp; A <a href=\"21821\">progesterone withdrawal test</a> is used to evaluate estrogen activity in patients with secondary amenorrhea.&nbsp; This patient has hyperprolactinemia, which causes low estrogen (ie, hypogonadism) due to negative feedback on the hypothalamic-pituitary-ovarian axis.&nbsp; Therefore, this test has no utility in this patient.</p><p><strong>Educational objective:</strong><br>The most common pathologic cause of hyperprolactinemia in women of reproductive age is a pituitary adenoma (prolactinoma); diagnosis is with MRI of the head.&nbsp; Women with hyperprolactinemia can have secondary amenorrhea and anovulatory infertility because high prolactin levels suppress GnRH, LH, and estrogen secretion.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11896,
            "topic": "Hyperprolactinemia",
            "titleId": 11896,
            "title": "Hyperprolactinemia",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Add metformin therapy",
                    "choiceNumber": 1,
                    "correctTaken": 11,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Order progesterone withdrawal test",
                    "choiceNumber": 2,
                    "correctTaken": 156,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform MRI of the head",
                    "choiceNumber": 3,
                    "correctTaken": 1762,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Stop citalopram and remeasure prolactin level in 3 months",
                    "choiceNumber": 4,
                    "correctTaken": 329,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend weight loss and remeasure prolactin level in 3 months",
                    "choiceNumber": 5,
                    "correctTaken": 191,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "147,250,true,-1,1*869,1174,true,-1,1*1193,1231,true,-1,1*2593,2777,true,-1,1*2964,3236,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "734",
                    "mediaDataId": 0,
                    "title": "Hyperprolactinemia, including prolactinoma",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26124750",
                    "mediaDataId": 0,
                    "title": "Progress in the diagnosis and classification of pituitary adenomas.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26124750",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24010395",
                    "mediaDataId": 0,
                    "title": "Pituitary adenomas: an overview.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24010395",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 55,
            "othersAvgTimeSpent": 84,
            "notes": null,
            "peopleTaken": 2449,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1358,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 26920,
            "questionIndex": 114841,
            "questionText": "<p><u><strong>Patient Information</strong></u><br><strong>Age:</strong> 33 years<br><strong>Gender:</strong> F, self-identified<br><strong>Race/Ethnicity:</strong> unspecified<br><strong>Site of Care:</strong> office</p><p><u><strong>History</strong></u><br><strong>Reason for Visit/Chief Concern:</strong> fatigue and lethargy<br><strong>History of Present Illness:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>5 months postpartum</li><li>she has been able to manage daily tasks but continues to struggle with low energy levels throughout the day and does not feel completely rested on awakening</li><li>reports some loss of interest in things she used to enjoy prior to becoming a mother</li><li>has a diminished appetite</li><li>was unable to breastfeed because she had difficulty establishing her milk supply</li><li>has decreased desire for sexual activity due to moderate dyspareunia</li></ul><p><strong>Past Medical History:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>no chronic medical conditions</li></ul><p><strong>Medications:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>prenatal vitamin</li><li>iron supplementation</li></ul><p><strong>Obstetric History:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>gravida 1 para 1</li><li>term spontaneous vaginal delivery complicated by delayed postpartum hemorrhage of 2 L; dilation and curettage performed to control bleeding and remove retained products of conception; 2 units of packed red blood cells transfused</li><li>has not resumed menses postpartum</li></ul><p><strong>Allergies:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>no known drug allergies</li></ul><p><strong>Family history:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>mother with major depressive disorder</li></ul><p><u><strong>Physical Examination</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:100%;\"><tbody><tr><td style=\"text-align: center;\"><strong>Temperature</strong></td><td style=\"text-align: center;\"><strong>Pulse</strong></td><td style=\"text-align: center;\"><strong>Resp</strong></td><td style=\"text-align: center;\"><strong>BP</strong></td><td style=\"text-align: center;\"><strong>O</strong><font size=\"2\"><sub><strong>2</strong></sub></font>&nbsp;<strong>Sat</strong></td><td style=\"text-align: center;\"><strong>Ht</strong></td><td style=\"text-align: center;\"><strong>Wt</strong></td><td style=\"text-align: center;\"><strong>BMI</strong></td></tr><tr><td style=\"text-align: center; vertical-align:top;\">36.1 C<br>(97 F)</td><td style=\"text-align: center; vertical-align:top; \">58/min</td><td style=\"text-align: center;\">&mdash;</td><td style=\"text-align: center; vertical-align:top; \">90/58<br>mm Hg</td><td style=\"text-align: center; vertical-align:top; \">98%<br>on RA</td><td style=\"text-align: center;\">&mdash;</td><td style=\"text-align: center; vertical-align:top; \">68 kg (150 lb);<br>4.5 kg (10 lb) less than&nbsp;<br>prepregnancy wt</td><td style=\"text-align: center;\">&mdash;</td></tr></tbody></table><ul style=\"margin-left: -1.2em; \"><li>Appearance: patient appears fatigued and disheveled</li><li>HEENT and neck: no palpable cervical masses</li><li>Cardiac: regular rhythm, normal S1 and S2</li><li>Abdominal: soft, nontender with no palpable masses</li><li>Pelvic: thinning hair along the mons pubis, vulvovaginal atrophy, and a small uterus</li></ul><p><u><strong>Question</strong></u>:&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T103383\" style=\"overflow-x:auto;\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Sheehan syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Obstetric hemorrhage complicated by hypotension</li><li>Postpartum anterior pituitary infarction</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>features</strong></p></td><td><ul><li>Spectrum of disease based on severity of pituitary infarction (immediate adrenal crisis &#8594; years after delivery)</li><li>Lactation failure (&#8595; prolactin)</li><li>Amenorrhea, hot flashes, vaginal atrophy (&#8595; FSH, LH)</li><li>Fatigue, bradycardia (&#8595; TSH)</li><li>Anorexia, weight loss, hypotension (&#8595; ACTH)</li><li>&#8595; Lean body mass (&#8595; GH)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Cortisol level (most important)</li><li>Thyroxine level</li><li>FSH level</li><li>Prolactin level</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Corticosteroids</li><li>Estrogen-progestin replacement therapy</li></ul></td></tr></tbody></table></div><p>This patient with fatigue, lactation failure, and amenorrhea most likely has <strong>pituitary insufficiency</strong> resulting from a pituitary infarction.&nbsp; The pituitary gland is enlarged during pregnancy; however, because its blood supply does not increase proportionally and perfusion is by a low-pressure venous portal system, the anterior pituitary is particularly susceptible to hypotension-related ischemia; in contrast, the posterior pituitary gland has direct arterial supply and is not as susceptible.&nbsp; Therefore, the classic presentation of postpartum pituitary infarction (ie, <strong>Sheehan syndrome</strong>) occurs after a <strong>massive postpartum hemorrhage</strong>.</p><p>The constellation of symptoms in Sheehan syndrome occurs due to <strong>deficiencies</strong> in the following <strong>anterior pituitary gland hormones</strong>:</p><ul><li><p>ACTH, which causes decreased cortisol levels, resulting in fatigue, <strong>hypotension</strong>, anorexia, loss of secondary body hair (ie, secondary adrenal insufficiency)</p></li><li><p>Prolactin, which causes <strong>lactation failure</strong></p></li><li><p>FSH and LH, which cause decreased estrogen production, resulting in <strong>amenorrhea</strong>, vulvovaginal atrophy (eg, dyspareunia), and decreased libido (ie, hypogonadotropic hypogonadism)</p></li><li><p>TSH, which causes decreased T3 and T4, resulting in fatigue and <strong>bradycardia</strong> (ie, central hypothyroidism)</p></li><li><p>Growth hormone, which decreases lean body mass in adults</p></li></ul><p>The diagnosis is typically with hormone levels, particularly a serum cortisol level because this test has the most diagnostic accuracy and cortisol deficiency is the most life-threatening complication.&nbsp; Treatment involves hormone replacement.</p><p><strong>(Choice B)</strong>&nbsp; Postpartum depression (major depressive disorder with peripartum onset) often presents within 4-6 weeks of delivery and can persist for months.&nbsp; Although major depression symptoms can include changes in energy levels, appetite, and weight, this patient&#39;s additional symptoms (eg, hypotension, lactation failure) are not caused by postpartum depression alone.</p><p><strong>(Choice C)</strong>&nbsp; Postpartum thyroiditis can present with a diffusely enlarged thyroid gland and classic symptoms of hyperthyroidism (eg, weight loss) followed by hypothyroidism (eg, fatigue, bradycardia).&nbsp; However, isolated thyroid dysfunction does not cause hypotension or lactation failure; in fact, hypothyroidism can cause galactorrhea.</p><p><strong>(Choice D)</strong>&nbsp; Although this patient has signs of adrenal insufficiency (eg, fatigue, hypotension), her other symptoms (eg, vulvovaginal atrophy, amenorrhea, lactation failure) suggest a secondary, central cause (ie, pituitary insufficiency).</p><p><strong>(Choice E)</strong>&nbsp; Primary ovarian insufficiency (POI) is hypergonadotropic hypogonadism that occurs in women age &lt;40; it causes amenorrhea, hot flashes, vulvovaginal atrophy, and changes to sexual function.&nbsp; However, POI does not cause hypotension or lactation failure.</p><p><strong>Educational objective:</strong><br>Sheehan syndrome (ie, pituitary infarction) is a complication of massive postpartum hemorrhage that classically presents with lactation failure (prolactin deficiency), persistent hypotension (ACTH deficiency), and amenorrhea (gonadotropin deficiency).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2767,
            "topic": "Hypopituitarism",
            "titleId": 2767,
            "title": "Hypopituitarism",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Pituitary insufficiency",
                    "choiceNumber": 1,
                    "correctTaken": 4630,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postpartum depression",
                    "choiceNumber": 2,
                    "correctTaken": 141,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postpartum thyroiditis",
                    "choiceNumber": 3,
                    "correctTaken": 162,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary adrenal insufficiency",
                    "choiceNumber": 4,
                    "correctTaken": 90,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary ovarian insufficiency",
                    "choiceNumber": 5,
                    "correctTaken": 30,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "231,278,true,-1,1*471,502,true,-1,1*571,609,true,-1,1*749,1007,true,-1,1*1467,1496,true,-1,1*1919,2121,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "495",
                    "mediaDataId": 0,
                    "title": "Sheehan syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28615049",
                    "mediaDataId": 0,
                    "title": "A case of acute Sheehan&#39;s syndrome and literature review: a rare but life-threatening complication of postpartum hemorrhage.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28615049",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23245206",
                    "mediaDataId": 0,
                    "title": "Sheehan&#39;s syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23245206",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 93,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 5053,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 92,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 864,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 8901,
            "questionIndex": 8918,
            "questionText": "<p>A 36-year-old man comes to the office with a 6-month history of fatigue, mild headache, and decreased libido.&nbsp; His past medical history is notable for type 2 diabetes and bipolar disorder.&nbsp; His medications include metformin and risperidone.&nbsp; The patient smokes a pack of cigarettes a day and drinks 2 or 3 cans of beer daily.&nbsp; Blood pressure is 126/73 mm Hg and pulse is 86/min.&nbsp; His BMI is 31 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows decreased testicular volume but is otherwise normal.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"500\"><tbody><tr><td>LH</td><td>0.5 mIU/mL</td></tr><tr><td>Testosterone, total</td><td>100 ng/dL (normal: 240-950 ng/dL)</td></tr><tr><td>TSH</td><td>0.05 &#956;U/mL</td></tr><tr><td>Thyroxine (T<font size=\"2\"><sub>4</sub></font>), free</td><td>0.45 ng/dL (normal: 0.9-1.7 ng/dL)</td></tr><tr><td>Prolactin</td><td>35 ng/mL</td></tr></tbody></table></blockquote><p>Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31603\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:.1in;\"><strong>Common causes of hypogonadism in men</strong></p></td></tr><tr><td><p align=\"center\"><strong>Primary</strong></p><p align=\"center\"><strong>(testicular)</strong></p></td><td><ul><li>Congenital (eg, Klinefelter syndrome, cryptorchidism)</li><li>Drugs (eg, alkylating agents, ketoconazole)</li><li>Orchitis (eg, mumps), trauma, torsion</li><li>Chronic kidney disease</li></ul></td></tr><tr><td><p align=\"center\"><strong>Secondary</strong></p><p align=\"center\"><strong>(pituitary/hypothalamic)</strong></p></td><td><ul><li><strong>Gonadotroph damage</strong>: Tumor, cranial trauma, infiltrative diseases (eg, hemochromatosis), apoplexy</li><li><strong>Gonadotropin suppression</strong>: Exogenous androgens, hyperprolactinemia, diabetes mellitus, morbid obesity</li></ul></td></tr><tr><td><p align=\"center\"><strong>Combined</strong></p><p align=\"center\"><strong>(primary &amp; secondary)</strong></p></td><td><ul><li>Hypercortisolism</li><li>Cirrhosis</li></ul></td></tr></tbody></table></div><p>This patient has <strong>hypopituitarism</strong> featuring central hypogonadism (low LH and testosterone) and central hypothyroidism (low TSH and thyroxine) along with mildly elevated prolactin.&nbsp; This is strongly suggestive of a <strong>nonfunctioning pituitary adenoma</strong>, which usually arises from the gonadotropin-secreting cells (<strong>gonadotrophs</strong>) in the pituitary gland.&nbsp; Normal gonadotrophs secrete LH and FSH (which are dimeric hormones consisting of a common &#945;-subunit and a different &#946;-subunit), but the dysfunctional cells in most gonadotroph adenomas secrete primarily the common <strong>&#945;-subunit</strong>.</p><p>The clinical symptoms of &#945;-subunit overproduction are usually minimal (&#x22;nonfunctioning&#x22; adenoma), and the diagnosis is not usually apparent until the adenoma is large enough to cause features of <strong>mass effect</strong> on local tissues (eg, headache, visual field defects, disruption of the surrounding pituitary function).&nbsp; Production of most <strong>pituitary hormones</strong> (eg, TSH, LH) will be <strong>decreased</strong> due to compression of the neighboring normal pituitary cells.&nbsp; By contrast, <strong>prolactin</strong> levels are often <strong>mildly to moderately elevated</strong> due to anatomic disruption of the dopaminergic neural pathways that normally suppress prolactin secretion.&nbsp; (A more significant elevation of prolactin [eg, &gt;200 ng/mL] would suggest a prolactin-secreting adenoma (prolactinoma) rather than a nonfunctioning adenoma.)</p><p><strong>(Choice A)</strong>&nbsp; Excessive alcohol intake can cause hypogonadism by suppressing LH release by the pituitary or by directly inhibiting testosterone production in the testes.&nbsp; However, pituitary TSH production is usually unaffected by alcohol, and this patient&#39;s moderate intake is unlikely to have significant endocrine effects.</p><p><strong>(Choice B)</strong>&nbsp; Klinefelter syndrome (47,XXY) is a chromosomal disorder associated with hypogonadism, small testes, and decreased virilization.&nbsp; The hypothalamic-pituitary axis is usually intact, however, and LH is increased.&nbsp; This patient&#39;s late onset of symptoms makes a chromosomal abnormality unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Chronic autoimmune thyroiditis (Hashimoto thyroiditis) is characterized by immune-mediated destruction of thyroid follicles and is the most common cause of hypothyroidism in the general population.&nbsp; Patients will have low free T<font size=\"2\"><sub>4</sub></font> and elevated TSH.</p><p><strong>(Choice D)</strong>&nbsp; Many commonly used antipsychotic medications (eg, risperidone) can cause hyperprolactinemia due to blockade of the normal dopamine-dependent regulation of prolactin secretion.&nbsp; However, TSH&nbsp;is usually unaffected.</p><p><strong>Educational objective:</strong><br>Hypopituitarism with a mild to moderate increase in prolactin suggests a nonfunctioning (gonadotroph) adenoma.&nbsp; Patients may develop symptomatic hypogonadism or hypothyroidism but are frequently asymptomatic until the adenoma becomes very large and causes a mass effect on surrounding tissues.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2767,
            "topic": "Hypopituitarism",
            "titleId": 2767,
            "title": "Hypopituitarism",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alcohol-related testicular atrophy",
                    "choiceNumber": 1,
                    "correctTaken": 847,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chromosomal abnormality",
                    "choiceNumber": 2,
                    "correctTaken": 294,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chronic autoimmune thyroiditis",
                    "choiceNumber": 3,
                    "correctTaken": 1164,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication side effect",
                    "choiceNumber": 4,
                    "correctTaken": 30218,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pituitary adenoma",
                    "choiceNumber": 5,
                    "correctTaken": 38626,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "750,883,true,-1,1*966,1009,true,-1,1*1568,1732,true,-1,1*1733,1888,true,-1,1*1902,2057,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "616",
                    "mediaDataId": 0,
                    "title": "Pituitary tumors",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24010395",
                    "mediaDataId": 0,
                    "title": "Pituitary adenomas: an overview.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24010395",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 96,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 71149,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2515,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 4082,
            "questionIndex": 4082,
            "questionText": "<p>A 55-year-old homeless man comes to the emergency department with muscle cramps and perioral numbness.&nbsp; The patient appears malnourished and says that he has consumed a lot of alcohol recently.&nbsp; His past medical history is significant for chronic-recurrent abdominal pain for which he was advised to quit drinking alcohol.&nbsp; His temperature is 36.7 C (98 F), blood pressure is 110/65 mm Hg, pulse is 80/min, and respirations are 18/min.&nbsp; Examination shows a regular heart rate and clear lung fields.&nbsp; The abdomen is soft without significant tenderness.&nbsp; There are normoactive bowel sounds.&nbsp; Laboratory studies are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"350\"><tbody><tr><td>Hemoglobin</td><td>7.2 g/dL</td></tr><tr><td>Hematocrit</td><td>26%</td></tr><tr><td>Mean corpuscular volume</td><td>104 fL</td></tr><tr><td>Platelets</td><td>80,000/&micro;L</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td>Sodium</td><td>136 mEq/L</td></tr><tr><td>Potassium</td><td>3.1 mEq/L</td></tr><tr><td>Chloride</td><td>90 mEq/L</td></tr><tr><td>Calcium</td><td>6.0 mg/dL</td></tr><tr><td>Magnesium, serum</td><td>0.8 mg/dL</td></tr><tr><td>Phosphorus, inorganic, serum</td><td>2.0 mg/dL</td></tr><tr><td>Albumin</td><td>3.4 g/dL</td></tr></tbody></table></blockquote><p>Which of the following is the most probable cause of the hypocalcemia observed in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img id=\"7195\"  src=\"https://www.uworld.com/media/L18773.jpg\" draggable=\"false\" ></p><p>This patient has symptomatic hypocalcemia associated with significant hypomagnesemia and hypophosphatemia.&nbsp; Hypomagnesemia is very common in hospitalized alcoholics and can cause hypocalcemia by inducing resistance to parathyroid hormone (PTH) as well as by decreasing PTH secretion.&nbsp; The cause of hypomagnesemia in alcoholics is multifactorial, and may include urinary losses, malnutrition, acute pancreatitis, and diarrhea.&nbsp; This patient has additional features of <strong>malnutrition/malabsorption</strong> including anemia and mild hypoalbuminemia.</p><p>Hypocalcemia due to hypomagnesemia is typically refractory to treatment with calcium unless magnesium is replaced as well.&nbsp; Although PTH levels increase rapidly after magnesium replacement, hypocalcemia takes longer to improve because PTH resistance persists despite improvement in magnesium levels.&nbsp; Despite PTH deficiency, phosphorus levels are normal or low in magnesium deficiency; this is possibly due to intracellular phosphorus depletion.</p><p><strong>(Choice A)</strong>&nbsp; Extracellular deposition of calcium can lead to hypocalcemia.&nbsp; This may occur in patients with hyperphosphatemia, osteoblastic bone metastasis, and acute pancreatitis.&nbsp; This patient has chronic abdominal pain but no specific features of acute pancreatitis.</p><p><strong>(Choice B)</strong>&nbsp; About 50% of circulating calcium is protein bound, predominantly to albumin.&nbsp; Consequently, serum total calcium varies with albumin concentration.&nbsp; Interpretation of serum calcium levels requires correcting for the serum albumin level (serum calcium concentration falls by 0.8 mg/dL for every 1 gm/L decrease in albumin).&nbsp; This patient&#39;s serum calcium is low even after correcting for the mild hypoalbuminemia.</p><p><strong>(Choice D)</strong>&nbsp; Hypophosphatemia generally coexists with hypomagnesemia in alcoholic patients.&nbsp; Decreased gastrointestinal absorption and increased renal loss of phosphate are causes of hypophosphatemia in alcoholism.&nbsp; Hypophosphatemia itself does not cause hypocalcemia.</p><p><strong>(Choice E)</strong>&nbsp; Resistance to PTH (pseudohypoparathyroidism) may result in hypocalcemia with high PTH and high phosphate levels.&nbsp; This condition is very rare and is usually associated with characteristic facial features (ie, Albright hereditary osteodystrophy).</p><p><strong>Educational objective:</strong><br>Hypomagnesemia is an important cause of hypocalcemia, particularly in alcoholics.&nbsp; Hypomagnesemia causes decreased release of parathyroid hormone (PTH) and PTH resistance.&nbsp; Hypoparathyroidism induced by low magnesium is not associated with elevated phosphorus levels (as seen with other causes of hypoparathyroidism).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2731,
            "topic": "Hypocalcemia",
            "titleId": 2731,
            "title": "Hypocalcemia",
            "topicAttributeId": 330638,
            "topicAttribute": "Normal structure and function of endocrine glands",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Extracellular calcium deposition",
                    "choiceNumber": 1,
                    "correctTaken": 91,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypoalbuminemia",
                    "choiceNumber": 2,
                    "correctTaken": 176,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypomagnesemia",
                    "choiceNumber": 3,
                    "correctTaken": 978,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypophosphatemia",
                    "choiceNumber": 4,
                    "correctTaken": 169,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Resistance to parathyroid hormone",
                    "choiceNumber": 5,
                    "correctTaken": 69,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "139,314,true,-1,1*691,867,true,-1,1*962,1014,true,-1,1*1027,1063,true,-1,1*1121,1194,true,-1,1*1531,1618,true,-1,1*1986,2031,true,-1,1*2195,2232,true,-1,1*2429,2573,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "468",
                    "mediaDataId": 0,
                    "title": "Calcium disorders",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "8777856",
                    "mediaDataId": 0,
                    "title": "Hypocalcaemia and chronic alcohol intoxication: transient  hypoparathyroidism secondary to magnesium deficiency",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/8777856",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 104,
            "othersAvgTimeSpent": 103,
            "notes": null,
            "peopleTaken": 1483,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1844,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 3729,
            "questionIndex": 3729,
            "questionText": "<p><u><strong>Patient Information</strong></u><br><strong>Age:</strong> 25 years<br><strong>Gender:</strong> F, self-identified<br><strong>Race/Ethnicity:</strong> unspecified<br><strong>Site of Care:</strong> emergency department</p><p><u><strong>History</strong></u><br><strong>Reason for Visit/Chief Concern:</strong> &#x22;I am urinating a lot.&#x22;<br><strong>History of Present Illness:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>increased daytime urinary frequency and nocturia for past 4 weeks</li><li>no fever, dysuria, hematuria, abdominal pain</li></ul><p><strong>Past Medical History:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>bipolar disorder diagnosed at age 22, currently stable with pharmacotherapy</li></ul><p><strong>Medications:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>lithium</li><li>quetiapine</li></ul><p><strong>Allergies:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>none</li></ul><p><strong>Family History:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>hypothyroidism in sister and mother</li></ul><p><strong>Social History:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>no tobacco, alcohol, or recreational drug use</li></ul><p><u><strong>Physical Examination</strong></u></p><div class=\"equation-scroll\"><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"forceleft\" style=\"width:600px;\"><tbody><tr><td style=\"width:12%; text-align:center;\"><strong>Temp</strong></td><td style=\"width:12%; text-align:center;\"><strong>Pulse</strong></td><td style=\"width:12%; text-align:center;\"><strong>Resp</strong></td><td style=\"width:12%; text-align:center;\"><strong>BP</strong></td><td style=\"width:12%; text-align:center;\"><strong>O</strong><font size=\"2\"><sub><strong>2</strong></sub></font>&nbsp;<strong>Sat</strong></td><td style=\"width:12%; text-align:center;\"><strong>Ht</strong></td><td style=\"width:12%; text-align:center;\"><strong>Wt</strong></td><td style=\"width:12%; text-align:center;\"><strong>BMI</strong></td></tr><tr><td style=\"width:12%; text-align:center;\">36.9 C<br>(98.4 F)</td><td style=\"width:12%; text-align:center;\">75/min</td><td style=\"width:12%; text-align:center;\">12/min</td><td style=\"width:12%; text-align:center;\">124/70<br>mm Hg</td><td style=\"width:12%; text-align:center;\">99%<br>on RA</td><td style=\"width:12%; text-align:center;\">&ndash;</td><td style=\"width:12%; text-align:center;\">&ndash;</td><td style=\"width:12%; text-align:center;\">24 kg/m<font size=\"2\"><sup>2</sup></font></td></tr></tbody></table></div>&nbsp;<ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>Appearance: awake and alert; comfortable</li><li>Pulmonary: clear lungs</li><li>Cardiac: regular rhythm; normal S<font size=\"2\"><sub>1</sub></font> and S<font size=\"2\"><sub>2</sub></font></li><li>Abdominal: soft and nontender, no costovertebral angle tenderness</li><li>Neurologic: no abnormalities; fully oriented</li></ul><p><u><strong>Diagnostic Studies</strong></u><br>Urine output: 4.5 L/24 hours</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:600px;\"><tbody><tr><td style=\"width:25%; text-align:center;\"></td><td style=\"width:25%; text-align:center;\"><strong>At admission</strong></td><td style=\"width:25%; text-align:center;\"><strong>After 6 hr of water restriction</strong></td><td style=\"width:25%; text-align:center;\"><strong>After desmopressin administration</strong></td></tr><tr><td style=\"width:25%; text-align:center;\">Serum sodium</td><td style=\"width:25%; text-align:center;\">144 mEq/L</td><td style=\"width:25%; text-align:center;\">152 mEq/L</td><td style=\"width:25%; text-align:center;\">&ndash;</td></tr><tr><td style=\"width:25%; text-align:center;\">Serum osmolality</td><td style=\"width:25%; text-align:center;\">300 mOsm/kg</td><td style=\"width:25%; text-align:center;\">315 mOsm/kg</td><td style=\"width:25%; text-align:center;\">296 mOsm/kg</td></tr><tr><td style=\"width:25%; text-align:center;\">Urine osmolality</td><td style=\"width:25%; text-align:center;\">126 mOsm/kg</td><td style=\"width:25%; text-align:center;\">132 mOsm/kg</td><td style=\"width:25%; text-align:center;\">395 mOsm/kg</td></tr></tbody></table><p><u><strong>Question:</strong></u> Which of the following is the most appropriate treatment?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"75453\" src=\"https://www.uworld.com/media/highresdefault/L107390.png\"  ></p><p>This patient with <strong>polyuria</strong> (urinary output &gt;3 L/24 hr) has a disorder of <strong>arginine vasopressin</strong> (AVP), also known as antidiuretic hormone.&nbsp; Normally, elevated plasma osmolality (ie, &gt;295 mOsm/kg) triggers the release of AVP, which <a href=\"45725\">increases water reabsorption at the collecting ducts</a> and results in concentrated urine.&nbsp; In this patient, <strong>water deprivation</strong> has resulted in elevated plasma osmolality, but her urine remains <strong>inappropriately dilute</strong> (urine osmolality &lt;300 mOsm/kg), confirming an AVP disorder.&nbsp; (In contrast, primary polydipsia would lead to urine osmolality &gt;600 mOsm/kg with water deprivation, reflecting intact urine concentrating ability.)</p><p>When an AVP disorder is confirmed, <strong>desmopressin</strong> (AVP analogue) is subsequently administered to distinguish between central <strong>AVP deficiency</strong> (AVP-D), formerly known as central diabetes insipidus, and renal <strong>AVP resistance</strong> (AVP-R), formerly known as nephrogenic diabetes insipidus.&nbsp; A significant increase in urine osmolality (eg, &gt;300 mOsm/kg) following desmopressin administration, as seen in this patient, indicates responsiveness to AVP, therefore&nbsp;<strong>confirming AVP-D</strong>&nbsp;(vs AVP-R).</p><p>AVP-D management&nbsp;includes continuation of <strong>desmopressin</strong> and&nbsp;secondary testing (eg, MRI of the brain) to identify underlying causes (eg, tumor, autoimmune hypophysitis).</p><p><strong>(Choices A and D)</strong>&nbsp; Amiloride is a potassium-sparing diuretic that blocks <a href=\"6700\">sodium channels in the collecting duct</a> and prevents sodium reabsorption, whereas thiazide diuretics (eg, hydrochlorothiazide) act at the distal convoluted tubule.&nbsp; These agents can be used as adjunct treatments in AVP disorders because they induce mild hypovolemia and greater reabsorption of water in the proximal tubule, lowering net water excretion.&nbsp; However, desmopressin directly addresses the deficiency of endogenous AVP and is preferred as the initial treatment of AVP-D.</p><p><strong>(Choice B)</strong>&nbsp; Demeclocycline reduces renal responsiveness to AVP by inhibiting the AVP-mediated aquaporin insertion in the collecting tubule; it is used for treating syndrome of inappropriate antidiuretic hormone.&nbsp; It would likely worsen symptoms in an AVP disorder.</p><p><strong>(Choice E)</strong>&nbsp; Lithium is a common cause of AVP-R; however, this effect usually occurs after many years of use.&nbsp; This patient&#39;s rapid increase in urine osmolality following the administration of desmopressin is inconsistent with AVP-R, and lithium discontinuation is not required.</p><p><strong>(Choice F)</strong>&nbsp; Continued water restriction in a patient with AVP-D can cause severe hypernatremia and is not advised.</p><p><strong>Educational objective:</strong><br>Arginine vasopressin (AVP) is secreted in response to rising plasma osmolality and stimulates renal water reabsorption (ie, concentrating urine).&nbsp; AVP deficiency is diagnosed when urine is inappropriately dilute despite elevated plasma osmolality and urine concentration rapidly rises (&gt;300 mOsm/kg) following desmopressin administration.&nbsp; Treatment requires continuation of desmopressin.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 18034,
            "topic": "Diabetes insipidus",
            "titleId": 18034,
            "title": "Diabetes insipidus",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amiloride",
                    "choiceNumber": 1,
                    "correctTaken": 234,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Demeclocycline",
                    "choiceNumber": 2,
                    "correctTaken": 116,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Desmopressin",
                    "choiceNumber": 3,
                    "correctTaken": 2736,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydrochlorothiazide",
                    "choiceNumber": 4,
                    "correctTaken": 193,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lithium discontinuation",
                    "choiceNumber": 5,
                    "correctTaken": 1750,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Water restriction",
                    "choiceNumber": 6,
                    "correctTaken": 245,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "548,684,true,-1,1*1161,1328,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "494",
                    "mediaDataId": 0,
                    "title": "Arginine vasopressin deficiency and resistance (diabetes insipidus)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32169331",
                    "mediaDataId": 0,
                    "title": "Management of central diabetes insipidus.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32169331",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 80,
            "othersAvgTimeSpent": 99,
            "notes": null,
            "peopleTaken": 5274,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 798,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 16059,
            "questionIndex": 17501,
            "questionText": "<p>A 32-year-old woman comes to the office due to 7 months of irregular periods and 3 months of amenorrhea.&nbsp; Her only preexisting medical condition is hypothyroidism treated with levothyroxine.&nbsp; The patient lives with her husband and 4-year-old son.&nbsp; Her husband uses condoms for contraception.&nbsp; Family history is significant for breast cancer in her mother.&nbsp; Examination shows mild vaginal dryness.&nbsp; The remainder of the physical examination, including visual fields, is normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"padding-left: 2em;\">Creatinine</td><td style=\"vertical-align:middle;\">1.1 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Endocrine</td></tr><tr><td style=\"padding-left: 2em;\">Prolactin, serum</td><td style=\"vertical-align:middle;\">100 ng/mL (normal: &lt;20)</td></tr><tr><td style=\"padding-left: 2em;\">Thyroid function tests</td></tr><tr><td style=\"padding-left: 3em;\">TSH</td><td style=\"vertical-align:middle;\">1.2 &micro;U/mL</td></tr><tr><td style=\"vertical-align:middle;\"></td></tr></tbody></table><p>A pregnancy test is negative.&nbsp; MRI reveals a 7 mm pituitary microadenoma.&nbsp; The most important reason for treating this patient now is to prevent which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"54364\" src=\"https://www.uworld.com/media/highresdefault/L83702.jpg\"  ></p><p>This patient has hyperprolactinemia, likely due to a prolactin-secreting pituitary adenoma <strong>(prolactinoma)</strong>.&nbsp; Prolactin suppresses production of GnRH in the hypothalamus, leading to decreased release of FSH and LH, manifesting as <strong>central hypogonadism</strong>.&nbsp; In premenopausal women, this typically presents with anovulation, oligo/amenorrhea, and infertility.</p><p>The resultant estrogen deficiency can cause vasomotor symptoms (eg, hot flashes), vaginal dryness and atrophy, and dyspareunia.&nbsp; Because estrogen maintains bone mass in premenopausal women, prolonged estrogen deficiency can lead to <strong>osteoporosis</strong> and an increased risk for fragility fractures.</p><p>Therefore, all patients with hyperprolactinemia causing hypogonadal symptoms warrant <a href=\"4351\">treatment</a>.&nbsp; Other indications for treatment&nbsp;include <strong>galactorrhea</strong> and, in those with larger adenomas, <strong>mass effect symptoms</strong> (eg, headache, visual field defects).&nbsp; Initial treatment usually includes <strong>dopamine agonists</strong> (eg, cabergoline, bromocriptine), which suppress prolactin production; transsphenoidal surgery is considered for patients who do not respond adequately to dopamine agonists.</p><p><strong>(Choices B and C)</strong>&nbsp; Chronic unopposed estrogen exposure (eg, due to obesity, chronic anovulation) can increase the risk for endometrial hyperplasia and cancer.&nbsp; Hyperestrogenism may also increase the risk for other estrogen-sensitive cancers (eg, breast).&nbsp; However, the oligo/amenorrhea associated with hyperprolactinemia is characterized by low, not high, estrogen levels.</p><p><strong>(Choice D)</strong>&nbsp; Treatment of hyperprolactinemia with dopamine agonists can restore fertility in most patients.&nbsp; Although menstruation may not normalize for a few months after initiation of treatment, prolonged treatment is effective in most cases.</p><p><strong>(Choice E)</strong>&nbsp; Macroadenomas (ie, &gt;1 cm) may undergo a rapid increase in size, leading to mass effect symptoms.&nbsp; However, rapid enlargement is quite rare (&#8804;5%) in microadenomas, which often remain stable in size for several years; rapid enlargement of these may suggest a malignant lesion.</p><p><strong>Educational objective:</strong><br>Prolactin suppresses production of GnRH in the hypothalamus, leading to decreased release of FSH and LH and central hypogonadism.&nbsp; In premenopausal women, this presents with anovulation, oligo/amenorrhea, and infertility.&nbsp; The resultant estrogen deficiency can lead to osteoporosis.&nbsp; Therefore, all patients with hyperprolactinemia and hypogonadal symptoms warrant treatment (eg, dopamine agonists).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11896,
            "topic": "Hyperprolactinemia",
            "titleId": 11896,
            "title": "Hyperprolactinemia",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bone loss",
                    "choiceNumber": 1,
                    "correctTaken": 4830,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Breast cancer",
                    "choiceNumber": 2,
                    "correctTaken": 645,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial cancer",
                    "choiceNumber": 3,
                    "correctTaken": 839,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Permanent infertility",
                    "choiceNumber": 4,
                    "correctTaken": 2421,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rapid increase in adenoma size",
                    "choiceNumber": 5,
                    "correctTaken": 3109,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "513,674,true,-1,1*921,1147,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "734",
                    "mediaDataId": 0,
                    "title": "Hyperprolactinemia, including prolactinoma",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 108,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 11844,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 41,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1643,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 3634,
            "questionIndex": 3634,
            "questionText": "<p>A 45-year-old man comes to the emergency department due to a 4-week history of progressively worsening shortness of breath.&nbsp; The patient has no history of cardiopulmonary disease, although his wife, who accompanies him, states that he snores heavily at night.&nbsp; In addition, over the last 6 months his hands and feet have become enlarged; he is unable to take off his wedding ring and his shoes no longer fit.&nbsp; The patient has no significant medical history and takes no medications.&nbsp; He does not use tobacco or alcohol.&nbsp; On examination, he has coarse facial features with prominent frontal bones and jaw and crowding of the pharyngeal space.&nbsp; The extremities show enlarged, swollen hands and feet.&nbsp; There are fine crackles at the lung bases.&nbsp; Which of the following is most likely to be found on echocardiogram?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31111\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:.1in;\"><strong>Clinical features of acromegaly</strong></p></td></tr><tr><td style=\"width: 18%;\"><p align=\"center\"><strong>Local tumor effect</strong></p></td><td style=\"width: 82%;\"><p>Headache, visual field defects, cranial nerve defects</p></td></tr><tr><td><p align=\"center\"><strong>Musculoskeletal</strong></p></td><td><p>Gigantism, frontal bossing, malocclusion of jaw, macrognathia, arthritis, carpal tunnel syndrome, enlargement of hands/feet</p></td></tr><tr><td><p align=\"center\"><strong>Skin</strong></p></td><td><p>Skin thickening, hyperhidrosis (odor), skin tags</p></td></tr><tr><td><p align=\"center\"><strong>Cardiovascular</strong></p></td><td><p>Cardiomyopathy, hypertension, heart failure</p></td></tr><tr><td><p align=\"center\"><strong>Respiratory</strong></p></td><td><p>Sleep apnea</p></td></tr><tr><td><p align=\"center\"><strong>Gastrointestinal</strong></p></td><td><p>Colon polyps/cancer, diverticulosis</p></td></tr><tr><td><p align=\"center\"><strong>Endocrine</strong></p></td><td><p>Galactorrhea, hypogonadism, diabetes mellitus, hypertriglyceridemia</p></td></tr><tr><td><p align=\"center\"><strong>Additional features</strong></p></td><td><p>Enlarged tongue, thyroid, salivary glands, liver, spleen, kidney, prostate</p></td></tr></tbody></table></div><p>This patient has characteristic manifestations of <strong>acromegaly</strong>, including coarsening of facial features, pharyngeal crowding, and enlargement of hands and feet.&nbsp; Acromegaly is caused by excessive secretion of growth hormone, usually from a pituitary somatotroph adenoma.&nbsp; Growth hormone increases hepatic production of insulin-like growth factor-1 (IGF-1), which causes excessive growth of bone and soft tissues, leading to the clinical manifestations of the disease.</p><p>In the heart, acromegaly causes <strong>concentric myocardial hypertrophy</strong> leading to diastolic dysfunction; eventually this may also lead to left ventricular dilation and systolic dysfunction with global hypokinesis.&nbsp; The cardiomyopathy is worsened by concurrent hypertension, obstructive sleep apnea (likely present in this patient), and valvular heart disease, which are common in acromegaly.&nbsp; Complications include <strong>heart failure</strong> (eg, dyspnea, crackles at bases) and <strong>arrhythmias</strong>.&nbsp; Cardiovascular disease is the leading cause of death in patients with acromegaly, but normalization of growth hormone levels following successful treatment markedly reduces cardiovascular mortality.</p><p><strong>(Choice A)</strong>&nbsp; Left ventricular aneurysm is not a common complication of acromegalic cardiomyopathy.&nbsp; It usually occurs as a result of Q-wave myocardial infarction in the territory of the left anterior descending artery; less common causes include hypertrophic cardiomyopathy and Chagas disease.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"3310\">Hypertrophic cardiomyopathy</a>, a congenital cardiomyopathy that should be distinguished from myocardial hypertrophy caused by other cardiovascular diseases (eg, hypertensive, valvular, ischemic), is characterized by asymmetric thickening of the interventricular septum, leading to left ventricular outflow tract obstruction, diastolic dysfunction, and mitral regurgitation.&nbsp; It would not explain the features of acromegaly seen in this patient.</p><p><strong>(Choice D)</strong>&nbsp; Flail mitral valve leaflet is caused by rupture of the chordae tendineae (due to mitral valve prolapse, endocarditis, or myxomatous degeneration) or by rupture of the papillary muscles in acute myocardial infarction.&nbsp; Acute mitral regurgitation due to a flail leaflet is characterized by severe pulmonary edema and hypotension with a hyperdynamic precordium.</p><p><strong>(Choice E)</strong>&nbsp; A mild-to-moderate pericardial effusion may not by itself produce any specific symptoms or signs unless cardiac tamponade occurs.&nbsp; Signs of tamponade include tachycardia, elevated jugular pressure, pulsus paradoxus, and edema.</p><p><strong>Educational objective:</strong><br>Acromegaly causes concentric myocardial hypertrophy and diastolic dysfunction; this may eventually lead to left ventricular dilation and global hypokinesis.&nbsp; This cardiomyopathy is often worsened by concurrent hypertension, obstructive sleep apnea, and valvular heart disease.&nbsp; Complications include heart failure and arrhythmias.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2661,
            "topic": "Acromegaly",
            "titleId": 2661,
            "title": "Acromegaly",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Apical left ventricular aneurysm",
                    "choiceNumber": 1,
                    "correctTaken": 291,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Asymmetric thickening of the interventricular septum",
                    "choiceNumber": 2,
                    "correctTaken": 2172,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Concentric left ventricular hypertrophy",
                    "choiceNumber": 3,
                    "correctTaken": 11905,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Flail posterior mitral valve leaflet",
                    "choiceNumber": 4,
                    "correctTaken": 1308,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Moderate pericardial effusion",
                    "choiceNumber": 5,
                    "correctTaken": 357,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "489,501,true,-1,1*563,637,true,-1,1*797,906,true,-1,1*1118,1311,true,-1,1*1917,1938,true,-1,1*1994,2070,true,-1,1*2537,2895,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "753",
                    "mediaDataId": 0,
                    "title": "Growth hormone disorders: Excess (gigantism, acromegaly) and deficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23226648",
                    "mediaDataId": 0,
                    "title": "Congestive heart failure in acromegaly: a review of 6 cases.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23226648",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 95,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 16033,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2414,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 4323,
            "questionIndex": 4323,
            "questionText": "<p>A 49-year-old man comes to the office due to a 3-month history of fatigue.&nbsp; He also reports diffuse joint pain, finger swelling, and difficulty gripping objects with his right hand.&nbsp; The patient has poorly controlled hypertension despite compliance with medications, a low-salt diet, and regular exercise.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 146/98 mm Hg, pulse is 90/min, and respirations are 14/min.&nbsp; On examination, facial features appear coarse and differ significantly from those on his driver&#39;s license photograph taken 3 years ago.&nbsp; The palms are sweaty and have a doughy feel.&nbsp; The skin is oily.&nbsp; Multiple skin tags are noted, particularly on the neck.&nbsp; Tapping the ventral aspect of the right wrist produces shooting pain on the lateral side of the right hand.&nbsp; Which of the following is the best next step in evaluating this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"5590\" src=\"https://www.uworld.com/media/L7631.jpg\" ></p><p>This patient&#39;s presentation (ie, coarse facial features, arthralgias, uncontrolled hypertension, enlargement of the digits, <a href=\"4417\">carpal tunnel syndrome</a>) is consistent with <a href=\"5404\">acromegaly</a>.&nbsp; This condition is caused by excessive <strong>growth hormone (GH)</strong> secretion, usually due to a pituitary <strong>somatotroph adenoma</strong>.&nbsp; Other common features include jaw malocclusion, hyperhidrosis, cardiomyopathy, macroglossia, and pituitary mass effect symptoms (eg, headache, visual field defects).</p><p>GH stimulates hepatic <a href=\"3944\">insulin-like growth factor-1 (IGF-1)</a> secretion, which mediates most of the clinical manifestations of acromegaly.&nbsp; IGF-1 levels in patients with acromegaly are consistently elevated throughout the day and are useful as an initial test, in contrast to GH, which fluctuates widely and has low sensitivity and specificity <strong>(Choice A)</strong>.</p><p>Treatment can alleviate many of the physiologic effects (eg, hyperglycemia) of acromegaly, although skeletal and joint abnormalities are largely irreversible.&nbsp; Initial treatment for most patients includes <strong>transsphenoidal resection</strong> of the pituitary adenoma.&nbsp; For patients with residual or unresectable tumors, medical therapy is indicated; options include <strong>somatostatin analogues</strong> (eg, octreotide) or <strong>growth hormone receptor antagonists</strong> (eg, pegvisomant).</p><p><strong>(Choice B)</strong>&nbsp; In normal individuals, administration of glucose rapidly suppresses GH secretion, whereas in patients with acromegaly, GH is not suppressed and may paradoxically increase.&nbsp; Measurement of GH in an oral glucose suppression test can confirm the diagnosis of acromegaly; this test is especially useful in patients with equivocal IGF-1 levels but is not recommended as the initial diagnostic test.</p><p><strong>(Choice D)</strong>&nbsp; Once acromegaly is confirmed, patients should undergo MRI of the head to identify a pituitary mass.&nbsp; However, incidental pituitary lesions are common in normal patients and can be misleading.&nbsp; As a general rule in endocrinology, imaging is performed after the biochemical diagnosis of a disorder is made.</p><p><strong>(Choice E)</strong>&nbsp; Thyrotropin-releasing hormone administration suppresses GH secretion in normal individuals but stimulates secretion in many patients with acromegaly.&nbsp; However, this test has poor sensitivity and is not routinely performed.</p><p><strong>Educational objective:</strong><br>Acromegaly is caused by excessive secretion of growth hormone (GH), usually due to a pituitary somatotroph adenoma.&nbsp; Insulin-like growth factor-1 mediates most of the effects of GH and is the preferred initial test in suspected acromegaly.&nbsp; GH is not as sensitive or specific due to wide fluctuations in circulating levels.&nbsp; Initial treatment for most patients includes transsphenoidal resection of the pituitary adenoma.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2661,
            "topic": "Acromegaly",
            "titleId": 2661,
            "title": "Acromegaly",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Fasting growth hormone level",
                    "choiceNumber": 1,
                    "correctTaken": 1438,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Growth hormone level following an oral glucose load",
                    "choiceNumber": 2,
                    "correctTaken": 1653,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insulin-like growth factor-1 level",
                    "choiceNumber": 3,
                    "correctTaken": 11440,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the pituitary gland",
                    "choiceNumber": 4,
                    "correctTaken": 1057,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyrotropin-releasing hormone stimulation test",
                    "choiceNumber": 5,
                    "correctTaken": 352,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "849,1006,true,-1,1*1008,1301,true,-1,1*1912,2024,true,-1,1*2036,2187,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "753",
                    "mediaDataId": 0,
                    "title": "Growth hormone disorders: Excess (gigantism, acromegaly) and deficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25356808",
                    "mediaDataId": 0,
                    "title": "Acromegaly: an Endocrine Society clinical practice guideline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25356808",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 112,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 15940,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1178,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 4077,
            "questionIndex": 4077,
            "questionText": "<p>A 45-year-old woman is brought to the emergency department due to left groin and abdominal pain accompanied by nausea and vomiting.&nbsp; The patient has a history of systemic lupus erythematosus, hypertension, and glucocorticoid-induced hyperglycemia.&nbsp; Abdominal examination shows central obesity; skin striae; and a nonreducible, tender mass in the left groin.&nbsp; CT scan of the abdomen reveals a left femoral hernia containing a bowel segment and dilated small bowel loops.&nbsp; The patient undergoes urgent exploratory laparotomy for resection of the obstructed bowel loop and repair of the hernia.&nbsp; There are no intraoperative complications, but she abruptly develops hypotension in the postoperative recovery unit.&nbsp; Blood pressure remains &lt;90/60 mm Hg despite intravenous fluid boluses.&nbsp; Which of the following is the best immediate step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40246\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Acute adrenal insufficiency (adrenal crisis)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Adrenal hemorrhage or infarction</li><li>Illness/injury/surgery in patient with chronic AI</li><li>Pituitary apoplexy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Hypotension &amp; shock</li><li>Nausea, vomiting, abdominal pain</li><li>Fever, generalized weakness</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Hydrocortisone or dexamethasone</li><li>Rapid intravenous volume repletion</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>AI</strong> = adrenal insufficiency.</p></td></tr></tbody></table></div><p>Several aspects of this patient&#39;s presentation suggest that her refractory, acute-onset hypotension following surgery is due to <strong>adrenal crisis</strong>.&nbsp; Adrenal crisis can develop in the setting of an acute stressor (eg, illness, surgery) in patients with adrenal insufficiency (AI) (eg, chronic primary AI, secondary AI).&nbsp; This patient&#39;s history of systemic lupus erythematous (which often requires prednisone therapy for flares) and evidence of hypercortisolism (eg, central obesity, purple striae, glucocorticoid-induced hyperglycemia) suggest <strong>chronic glucocorticoid therapy</strong>.&nbsp; Patients on chronic glucocorticoid therapy can develop hypothalamic-pituitary-adrenal axis suppression and <strong>secondary AI</strong>.&nbsp; Because their pituitary gland is unable to increase ACTH secretion when needed (eg, <strong>acute stressor</strong>), these patients are at high risk of <strong>acute AI</strong> (adrenal crisis).</p><p>Adrenal crisis primarily presents with <strong>hypotension</strong> and <strong>shock</strong>; hypoglycemia is also usually present.&nbsp; Adrenal crisis due to secondary AI may present less dramatically than that due to primary AI because only cortisol is deficient and angiotensin II-mediated <a href=\"27888\">aldosterone production</a> remains intact (primary AI involves loss of both cortisol and aldosterone).&nbsp; However, cortisol does play an important role in maintaining vascular tone, and isolated cortisol deficiency can lead to hemodynamic collapse.</p><p>The hypotension in adrenal crisis is often <strong>refractory</strong> to initial volume resuscitation, and treatment requires intravenous <strong>hydrocortisone</strong> or <strong>dexamethasone</strong> in addition to aggressive volume repletion.</p><p><strong>(Choices A, B, and C)</strong>&nbsp; CT scan of the abdomen can help diagnose postoperative intraabdominal hemorrhage leading to hemorrhagic shock, dobutamine infusion can be used to treat cardiogenic shock, and intramuscular epinephrine is used to treat anaphylactic shock.&nbsp; However, this patient&#39;s history of chronic glucocorticoid use and evidence of iatrogenic hypercortisolism make adrenal crisis due to secondary AI more likely.</p><p><strong>(Choice D)</strong>&nbsp; Intravenous colloid solutions (eg, albumin) are used in the treatment of hepatorenal syndrome and spontaneous bacterial peritonitis; however, crystalloid solutions (eg, normal saline, Ringer lactate) are preferred for volume resuscitation.</p><p><strong>Educational objective:</strong><br>Patients on chronic glucocorticoid therapy often have secondary adrenal insufficiency and can develop adrenal crisis when exposed to an acute stressor (eg, surgery, illness, trauma).&nbsp; Adrenal crisis primarily presents with hypotension and shock that is refractory to initial volume resuscitation.&nbsp; Treatment requires intravenous hydrocortisone or dexamethasone in addition to aggressive volume repletion.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23445,
            "topic": "Adrenal insufficiency",
            "titleId": 23445,
            "title": "Adrenal insufficiency",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "CT scan of the abdomen",
                    "choiceNumber": 1,
                    "correctTaken": 1371,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dobutamine infusion",
                    "choiceNumber": 2,
                    "correctTaken": 1510,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intramuscular epinephrine",
                    "choiceNumber": 3,
                    "correctTaken": 2364,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous colloid solutions",
                    "choiceNumber": 4,
                    "correctTaken": 866,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous hydrocortisone",
                    "choiceNumber": 5,
                    "correctTaken": 7228,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "117,166,true,-1,1*167,185,true,-1,1*327,361,true,-1,1*962,1246,true,-1,1*1372,1600,true,-1,1*1747,1943,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "491",
                    "mediaDataId": 0,
                    "title": "Adrenal insufficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26363354",
                    "mediaDataId": 0,
                    "title": "Adrenal crisis: still a deadly event in the 21st century.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26363354",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 49,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 13339,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 892,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 15720,
            "questionIndex": 17156,
            "questionText": "<p>A 32-year-old woman comes to the office due to feeling down for the past several months.&nbsp; The patient has had persistent tiredness, lack of motivation, memory impairment, and loss of libido.&nbsp; She also has had anorexia but reports an unusual craving for foods like salty pretzels or potato chips.&nbsp; Menses occur at regular intervals.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs and works as a fashion designer.&nbsp; Blood pressure is 110/62 mm Hg and pulse is 88/min.&nbsp; BMI is 19.8 kg/m<font size=\"2\"><sup>2</sup></font> with weight of 54 kg (119 lb), which is 15 kg (33 lb) lower than her previous weight.&nbsp; The lungs are clear on auscultation and heart sounds are normal.&nbsp; The abdomen is soft and nontender with no organomegaly.&nbsp; There is decreased axillary and pubic hair.&nbsp; Mental status examination reveals a restricted affect.&nbsp; She has no suicidal ideation.&nbsp; Which of the following is most likely to establish the diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>In the evaluation of depression, medical causes of depressed mood should always be considered.&nbsp; Although this patient&#39;s fatigue, anorexia, memory impairment, lack of motivation, and loss of libido can be attributed to <strong>major depressive disorder</strong> (MDD), salt craving and reduced body hair are suggestive of <strong>primary adrenal insufficiency</strong> (PAI) (also known as Addison disease).&nbsp; PAI usually results from autoimmune destruction of the bilateral <a href=\"27888\">adrenal cortex</a> and presents with the following:</p><ul><li><strong>Mineralocorticoid deficiency</strong> causes renal salt wasting, with hypotension, weight loss, hyponatremia, hyperkalemia, and dietary <strong>salt craving</strong>.</li><li><strong>Glucocorticoid deficiency</strong> leads to fatigue, anorexia, and many <strong>psychiatric manifestations</strong> of adrenal insufficiency (eg, irritability, depressed mood).&nbsp; It also contributes to hypotension.</li><li><strong>Androgen deficiency</strong> leads to loss of libido and suppression of secondary sexual characteristics (eg, <strong>reduced</strong> pubic <strong>hair</strong>).&nbsp; These effects are typically only seen in women because androgen production still occurs in the testes of men.</li></ul><p>In patients with suspected AI, salt craving and hyperpigmentation are specific for PAI and help differentiate it from secondary AI.&nbsp; The diagnosis of PAI is made by <strong>stimulation testing</strong> with <strong>cosyntropin</strong>, a synthetic form of ACTH.&nbsp; Low production of cortisol following cosyntropin administration is diagnostic of PAI.</p><p><strong>(Choice B)</strong>&nbsp; CT scan of the chest, abdomen, and pelvis can help identify malignancy.&nbsp; Small cell lung cancer and Hodgkin lymphoma can rarely cause paraneoplastic limbic encephalitis, which manifests with mood changes and memory loss.&nbsp; However, this would not account for dietary salt craving and reduced secondary sexual characteristics.</p><p><strong>(Choice C)</strong>&nbsp; A detailed nutritional history may help diagnose anorexia nervosa, which is commonly associated with MDD.&nbsp; However, anorexia nervosa usually requires BMI &lt;18.5 kg/m<font size=\"2\"><sup>2</sup></font>&nbsp;and is commonly accompanied by amenorrhea; in addition, salt craving makes PAI more likely.</p><p><strong>(Choice D)</strong>&nbsp; Acute HIV infection can present with fatigue and weight loss; however, hepatomegaly and/or splenomegaly is often present as well.&nbsp; In addition, it would not explain salt craving and reduced secondary sexual characteristics.</p><p><strong>(Choice E)</strong>&nbsp; Symptomatic improvement with antidepressant therapy may help confirm suspected MDD; however, this patient&#39;s symptoms are more consistent with depressed mood secondary to an underlying medical condition.&nbsp; Once a diagnosis of PAI is confirmed, treatment with corticosteroid replacement therapy is most appropriate.</p><p><strong>Educational objective:</strong><br>In patients with depressed mood, an underlying medical condition should be considered and may be suggested by findings that are unexplained by psychiatric illness alone.&nbsp; Primary adrenal insufficiency presents with clinical manifestations of deficiency of mineralocorticoids (eg, dietary salt craving), glucocorticoids (eg, fatigue, depressed mood), and androgens (eg, reduced secondary sexual characteristics in women).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23445,
            "topic": "Adrenal insufficiency",
            "titleId": 23445,
            "title": "Adrenal insufficiency",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cosyntropin stimulation testing",
                    "choiceNumber": 1,
                    "correctTaken": 9611,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the chest, abdomen, and pelvis",
                    "choiceNumber": 2,
                    "correctTaken": 2097,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Detailed nutritional history",
                    "choiceNumber": 3,
                    "correctTaken": 8529,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "HIV antigen and antibody testing",
                    "choiceNumber": 4,
                    "correctTaken": 174,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trial of antidepressant therapy",
                    "choiceNumber": 5,
                    "correctTaken": 1867,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "968,1078,true,-1,1*1079,1211,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "491",
                    "mediaDataId": 0,
                    "title": "Adrenal insufficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 109,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 22278,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 43,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1347,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 3231,
            "questionIndex": 3231,
            "questionText": "<p>A 45-year-old man comes to the office for follow-up after a recent emergency department visit for abdominal pain.&nbsp; His blood pressure was elevated, and abdominal ultrasonography revealed an incidental right adrenal mass.&nbsp; The patient had no prior abnormal findings, and the pain resolved with analgesics.&nbsp; Today he has no symptoms except mild headache, which he attributes to stress at work.&nbsp; The patient does not take any medications and does not use tobacco, alcohol, or recreational drugs.&nbsp; Blood pressure is 160/94 mm Hg.&nbsp; Serum potassium is 3.0 mEq/L, and sodium is 145 mEq/L.&nbsp; Additional work-up shows a plasma aldosterone/plasma renin activity ratio of 45 (normal: &lt;20).&nbsp; He declines surgery for removal of the adrenal mass.&nbsp; Which of the following is the most appropriate therapy for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T90672\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Primary hyperaldosteronism (Conn syndrome)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Bilateral adrenal hyperplasia (~60%) or unilateral adenoma</li><li>Difficult-to-control hypertension</li><li>Hypokalemia &amp; metabolic alkalosis*</li><li>No extravascular volume overload (aldosterone escape)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Elevated plasma aldosterone &amp; low plasma renin (ratio &gt;20)</li><li>Absence of aldosterone suppression with oral saline load</li><li>CT scan of adrenal glands to determine bilateral hyperplasia vs adenoma</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Bilateral adrenal hyperplasia: MRA (eg, spironolactone)</li><li>Unilateral adenoma: surgical resection preferred</li></ul></td></tr><tr><td colspan=\"2\"><p>*In some patients, the characteristic electrolyte abnormalities are apparent only after a thiazide<br>is initiated for blood pressure management.</p><p><strong>MRA</strong> = mineralocorticoid receptor antagonist.</p></td></tr></tbody></table></div><p>This patient has hypertension and hypokalemia and a normal physical examination.&nbsp; This clinical presentation suggests <strong>primary hyperaldosteronism</strong>, which involves unregulated aldosterone secretion leading to excessive renal reabsorption of Na<font size=\"2\"><sup>+</sup></font> and secretion of K<font size=\"2\"><sup>+</sup></font>/H<font size=\"2\"><sup>+</sup></font>.&nbsp; <strong>Hypertension</strong> can develop as a result (and cause headaches if severe), as well as <strong>hypokalemia</strong> with metabolic alkalosis.&nbsp; Despite increased Na<font size=\"2\"><sup>+</sup></font> reabsorption, extravascular volume overload is rarely seen because of <a href=\"2606\">aldosterone escape</a>: increased intravascular volume results in an increase in pressure natriuresis and atrial natriuretic peptide release, which limit net Na<font size=\"2\"><sup>+</sup></font> and water retention.&nbsp; <strong>Serum Na<font size=\"2\"><sup><strong>+</strong></sup></font></strong> typically remains within the <strong>high end of normal range</strong> because of antidiuretic hormone release that is triggered by the temporary increase in serum osmolality.</p><p>Additional laboratory findings include a <strong>high plasma aldosterone concentration</strong> (PAC) (&gt;15 ng/dL) accompanied by <strong>low plasma renin activity</strong> (PRA), which results in a <strong>high PAC/PRA ratio</strong> (&gt;20).&nbsp; An oral NaCl load, which inhibits renin release, can be administered to confirm the diagnosis:&nbsp; Normally, inhibition of renin release suppresses aldosterone secretion; in contrast, patients with primary hyperaldosteronism have renin-independent aldosterone secretion.&nbsp; Common etiologies of primary hyperaldosteronism include bilateral adrenal hyperplasia and <strong>adrenal adenoma</strong>, which can be distinguished by CT scan of the abdomen and adrenal venous sampling.</p><p>Surgery is preferred for an adrenal adenoma, whereas medical treatment with a mineralocorticoid receptor antagonist (MRA) is indicated for bilateral adrenal hyperplasia.&nbsp; In patients with an adrenal adenoma who <strong>decline surgery</strong> or are poor surgical candidates, an MRA should be prescribed.&nbsp; Spironolactone is most commonly used, although <strong>eplerenone</strong> is less likely to cause adverse endocrine effects (eg, gynecomastia, decreased libido).</p><p><strong>(Choices A, B, and F)</strong>&nbsp; Calcium channel blockers (eg, amlodipine), thiazide diuretics (eg, chlorthalidone), and ACE inhibitors (eg, ramipril) are first-line antihypertensive medications that can be used in combination with an MRA in primary hyperaldosteronism.&nbsp; However, these medications do not reduce the activity of <a href=\"59886\">autonomously secreted aldosterone</a> and should not be used without an MRA.&nbsp; Furthermore, thiazides can worsen hypokalemia in patients with primary hyperaldosteronism if not used with an MRA.</p><p><strong>(Choices C and E)</strong>&nbsp; Clonidine and hydralazine are second-line antihypertensive medications that are typically used in patients whose conditions do not respond adequately to multiple first-line medications.</p><p><strong>Educational objective:</strong><br>In primary hyperaldosteronism, autonomous aldosterone secretion results in an elevated plasma aldosterone/renin ratio.&nbsp; Hypokalemia is often present, and serum Na<font size=\"2\"><sup>+</sup></font> is typically in the high end of normal range.&nbsp; Patients with an adrenal adenoma who are not surgical candidates and those who decline surgery are treated with a mineralocorticoid receptor antagonist (eg, spironolactone, eplerenone).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 10292,
            "topic": "Hyperaldosteronism",
            "titleId": 10292,
            "title": "Hyperaldosteronism",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amlodipine",
                    "choiceNumber": 1,
                    "correctTaken": 232,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chlorthalidone",
                    "choiceNumber": 2,
                    "correctTaken": 402,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Clonidine",
                    "choiceNumber": 3,
                    "correctTaken": 657,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Eplerenone",
                    "choiceNumber": 4,
                    "correctTaken": 12449,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydralazine",
                    "choiceNumber": 5,
                    "correctTaken": 354,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ramipril",
                    "choiceNumber": 6,
                    "correctTaken": 1864,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "91,149,true,-1,1*251,272,true,-1,1*328,341,true,-1,1*342,398,true,-1,1*481,585,true,-1,1*587,728,true,-1,1*1973,2059,true,-1,1*2062,2250,true,-1,1*2541,2686,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "199",
                    "mediaDataId": 0,
                    "title": "Secondary hypertension",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16932426",
                    "mediaDataId": 0,
                    "title": "Primary aldosteronism: diagnostic and treatment strategies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16932426",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 115,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 15958,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1666,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 16575,
            "questionIndex": 18019,
            "questionText": "<p>A 44-year-old woman comes to the office due to excessive thirst and urination.&nbsp; She has to get up several times during the night to urinate.&nbsp; Two months ago, she was diagnosed with type 2 diabetes mellitus, which she manages with diet and exercise.&nbsp; Blood pressure is 134/78 mm Hg and pulse is 88/min.&nbsp; BMI is 32 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The remainder of the physical examination is normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Sodium</td><td>147 mEq/L</td></tr><tr><td>Potassium</td><td>4 mEq/L</td></tr><tr><td>Chloride</td><td>106 mEq/L</td></tr><tr><td>Bicarbonate</td><td>26 mEq/L</td></tr><tr><td>Blood urea nitrogen</td><td>26 mg/dL</td></tr><tr><td>Glucose</td><td>112 mg/dL</td></tr><tr><td>Creatinine</td><td>1.1 mg/dL</td></tr><tr><td>Calcium</td><td>9.8 mg/dL</td></tr><tr><td>Serum osmolality</td><td>305 mOsm/kg H<font size=\"2\"><sub>2</sub></font>O</td></tr><tr><td>Urine osmolality</td><td>180 mOsm/kg H<font size=\"2\"><sub>2</sub></font>O</td></tr><tr><td>Urine specific gravity</td><td>1.001</td></tr></tbody></table><p>Which of the following is the most likely cause for this patient&#39;s excessive thirst and urination?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T37350\"><table class=\"table-default-style table-header-footer-style\" style=\"width:88%\"><tbody><tr><td colspan=\"4\"><p align=\"center\"><strong>Causes of polyuria &amp; dilute urine</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Primary polydipsia</strong></p></td><td><p align=\"center\"><strong>Central DI</strong></p></td><td><p align=\"center\"><strong>Nephrogenic DI</strong></p></td></tr><tr><td><p align=\"center\"><strong>Cause</strong></p></td><td><ul><li>ADH independent (excessive water intake)</li></ul></td><td><ul><li>ADH deficiency (CNS pathology)</li></ul></td><td><ul><li>ADH resistance (renal disease)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Antipsychotics (dry mouth)</li><li>Psychiatric conditions</li></ul></td><td><ul><li>Idiopathic</li><li>Trauma</li><li>Pituitary surgery</li><li>Ischemic encephalopathy</li></ul></td><td><ul><li>Chronic lithium use</li><li>Hypercalcemia</li><li>Hereditary (<em>AVPR2</em> &amp; aquaporin 2 mutations)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Results<br>of water<br>deprivation</strong></p></td><td><ul><li>High urine osmolality</li></ul></td><td><ul><li>Low urine osmolality</li></ul></td><td><ul><li>Low urine osmolality</li></ul></td></tr><tr><td><p align=\"center\"><strong>Response to<br>desmopressin</strong></p></td><td><ul><li>No change</li></ul></td><td><ul><li>Increased urine osmolality</li></ul></td><td><ul><li>No change</li></ul></td></tr><tr><td colspan=\"4\"><p><strong>ADH</strong> = antidiuretic hormone; <strong><em>AVPR2</em></strong> = vasopressor V2; <strong>DI</strong> = diabetes insipidus.</p></td></tr></tbody></table></div><p>This patient with high serum osmolality and urine studies showing low osmolality and specific gravity likely has <strong>diabetes insipidus (DI)</strong>.&nbsp; DI can be caused by either deficient antidiuretic hormone (ADH) production (central DI) or renal ADH resistance (nephrogenic DI).&nbsp; Both central and nephrogenic DI are characterized by impaired water reabsorption and concentration of urine, resulting in <strong>high serum osmolality</strong> and <strong>polyuria</strong> with <strong>dilute urine</strong>.</p><p>In this patient:</p><ul><li>Polyuria (eg, &gt;3 L urine/24 hours) is suggested by frequent urination and nocturia.</li><li><strong>Mild hypernatremia</strong> is present; this common finding in DI reflects ongoing water losses and maintains a stimulus for compensatory <strong>polydipsia</strong> (in patients with intact thirst reflex).</li><li><strong>Low urine osmolality</strong> (&lt;300 mOsm/kg H<font size=\"2\"><sub>2</sub></font>O) and <strong>low urine specific gravity</strong> (&lt;1.006) in the setting of high serum osmolality (&gt;250 mOsm/kg H<font size=\"2\"><sub>2</sub></font>O) reflect inappropriately dilute urine.</li></ul><p>Polyuria with high serum osmolality can also be seen in diabetes mellitus (DM) complicated by marked hyperglycemia (eg, diabetic ketoacidosis).&nbsp; However, DM causes osmotic diuresis (eg, glucosuria) with a high urinary solute concentration.&nbsp; Therefore, urine specific gravity and urine osmolality (eg, typically &gt;600 mOsm/kg H<font size=\"2\"><sub>2</sub></font>O) are high in DM.&nbsp; This patient&#39;s low urine osmolality, low specific gravity, and only mildly elevated glucose levels make DI a much more likely cause of her urinary symptoms <strong>(Choice C)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; The syndrome of inappropriate ADH production (SIADH) is characterized by excessive ADH production.&nbsp; This causes concentrated urine; polyuria is not seen, and patients typically have hyponatremia.</p><p><strong>(Choice D)</strong>&nbsp; Hypothyroidism can cause hypotonic hyponatremia resulting from decreased free water excretion.&nbsp; It is not associated with the hypernatremia and persistently dilute urine seen in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Impaired thirst perception can cause primary polydipsia (seen in psychiatric conditions or CNS lesions), resulting in excessive water intake and dilute urine.&nbsp; However, patients have low serum osmolality and sodium (hyponatremia).&nbsp; This patient has hyperosmolality and hypernatremia with dilute urine; therefore, her polydipsia reflects an appropriate thirst reflex for replacing ongoing water losses.</p><p><strong>Educational objective:</strong><br>Urine osmolality and specific gravity can be used to narrow the cause of suspected polyuria.&nbsp; Low urine osmolality and low urine specific gravity (eg, &lt;1.006) suggest dilute urine, as seen in diabetes insipidus.&nbsp; High urine osmolality and high urine specific gravity suggest osmotic diuresis from conditions such as diabetes mellitus.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 18034,
            "topic": "Diabetes insipidus",
            "titleId": 18034,
            "title": "Diabetes insipidus",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Diabetes insipidus",
                    "choiceNumber": 1,
                    "correctTaken": 12014,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Excess antidiuretic hormone production",
                    "choiceNumber": 2,
                    "correctTaken": 863,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hyperglycemia",
                    "choiceNumber": 3,
                    "correctTaken": 2037,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothyroidism",
                    "choiceNumber": 4,
                    "correctTaken": 55,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Impaired thirst perception",
                    "choiceNumber": 5,
                    "correctTaken": 946,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "3018,3259,true,-1,1*1120,1153,true,-1,1*1385,1560,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "494",
                    "mediaDataId": 0,
                    "title": "Arginine vasopressin deficiency and resistance (diabetes insipidus)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30819684",
                    "mediaDataId": 0,
                    "title": "Diabetes insipidus.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30819684",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 78,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 15915,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 515,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 4306,
            "questionIndex": 4306,
            "questionText": "<p>A 38-year-old woman comes to the office with a 3-week history of weight loss, nausea, abdominal pain, and postural dizziness.&nbsp; She traveled to Thailand 6 months ago and has felt fatigued since then.&nbsp; Medical history is notable for moderate persistent asthma treated with an inhaled beta-2 agonist and inhaled corticosteroid.&nbsp; Over the last 2 years, the patient has had several asthma exacerbations requiring oral prednisone.&nbsp; She also has hypothyroidism treated with levothyroxine.&nbsp; The patient is married and is a stay-at-home mother.&nbsp; Blood pressure is 90/60 mm Hg and pulse is 96/min.&nbsp; Pharyngeal examination shows bilateral tonsillar enlargement.&nbsp; Skin examination shows increased pigmentation at the palmar creases and mucous membranes as well as a few patches of vitiligo.&nbsp; Initial laboratory testing shows mild hyponatremia and hyperkalemia with normal renal function.&nbsp; Complete blood count is normal, but differential shows moderate eosinophilia.&nbsp; Follow-up testing confirms a low 8 AM serum cortisol.&nbsp; Which of the following is the most likely cause of this patient&#39;s adrenal insufficiency?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t53662\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Primary adrenal insufficiency</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Autoimmune adrenalitis (most common)</li><li>Infection (eg, tuberculosis)</li><li>Metastatic infiltration</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Fatigue, weakness, anorexia/weight loss</li><li>Nausea, vomiting, abdominal pain</li><li>Salt craving, postural hypotension</li><li>Hyperpigmentation</li><li>Acute adrenal crisis: confusion, hypotension/shock</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Hyponatremia, hyperkalemia, eosinophilia</li><li>Low morning cortisol, high ACTH</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Glucocorticoids (eg, hydrocortisone, prednisone)</li><li>Mineralocorticoids (eg, fludrocortisone)</li></ul></td></tr></tbody></table></div><p>This patient has several features of chronic <strong>primary adrenal insufficiency</strong> (PAI), including weight loss, abdominal pain, and fatigue.&nbsp; <strong>Hyperpigmentation</strong> is a common finding and is due to cosecretion of melanocyte-stimulating hormone with ACTH (both are derived from proopiomelanocortin), which is increased in response to cortisol deficiency.&nbsp; In addition, loss of mineralocorticoid production can cause hypotension, hyponatremia, and <strong>hyperkalemia</strong>.&nbsp; Eosinophilia and hyperplasia of lymphoid tissue (eg, tonsils) are common but nonspecific findings.</p><p><strong>Autoimmune adrenalitis</strong> is responsible for &gt;90% of cases of PAI in developed countries.&nbsp; It is due to autoantibodies against adrenal enzymes that are responsible for corticosteroid synthesis.&nbsp; Autoimmune adrenalitis can occur as an isolated disorder or in association with other autoimmune syndromes (eg, primary hypothyroidism, vitiligo).</p><p><strong>(Choice A)</strong>&nbsp; Bilateral adrenal hemorrhage due to sepsis (eg, <em>Neisseria meningitidis</em>) can lead to PAI; however, this is less common, and the onset of clinical features is typically acute and dramatic.</p><p><strong>(Choice B)</strong>&nbsp; Hyperfunctioning adrenal tumors are a potential cause of hypercortisolism, but not PAI.&nbsp; Bilateral adrenal metastasis can cause PAI but this is a rare occurrence.</p><p><strong>(Choice D)</strong>&nbsp; Exogenous glucocorticoids can suppress pituitary secretion of ACTH and hypothalamic production of corticotropin-releasing hormone, leading to central (secondary) adrenal insufficiency.&nbsp; In contrast to PAI, secretion of melanocyte-stimulating hormone is not increased so patients do not display hyperpigmentation.&nbsp; Also, because <a href=\"27888\">mineralocorticoid production</a> is controlled by the renin-angiotensin system, aldosterone levels are normal and hyperkalemia is not seen with central adrenal insufficiency.</p><p><strong>(Choice E)</strong>&nbsp; PAI in HIV disease can be due to opportunistic infections (eg, cytomegalovirus, atypical mycobacteria, fungal infections) or inhibition of glucocorticoid synthesis by azole antifungal drugs.&nbsp; However, this patient has no apparent opportunistic infections, and her other autoimmune findings make autoimmune adrenalitis more likely.</p><p><strong>(Choice F)</strong>&nbsp; PAI due to tuberculosis (TB) is typically seen with miliary disease and is uncommon in developed countries.&nbsp; It is unlikely that this patient contracted TB and so rapidly developed manifestations of TB-induced PAI following her trip to Thailand 6 months ago.</p><p><strong>Educational objective:</strong><br>Autoimmune adrenalitis is the most common cause of primary adrenal insufficiency (PAI) in developed countries.&nbsp; The key differentiating features of PAI from central adrenal insufficiency are the hyperpigmentation and hyperkalemia seen in PAI.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23445,
            "topic": "Adrenal insufficiency",
            "titleId": 23445,
            "title": "Adrenal insufficiency",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adrenal hemorrhage",
                    "choiceNumber": 1,
                    "correctTaken": 307,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Adrenal tumor",
                    "choiceNumber": 2,
                    "correctTaken": 228,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Autoimmune adrenalitis",
                    "choiceNumber": 3,
                    "correctTaken": 5457,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exogenous glucocorticoid use",
                    "choiceNumber": 4,
                    "correctTaken": 1649,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "HIV infection",
                    "choiceNumber": 5,
                    "correctTaken": 108,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tuberculosis",
                    "choiceNumber": 6,
                    "correctTaken": 1056,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "415,446,true,-1,1*995,1095,true,-1,1*1197,1287,true,-1,1*1447,1535,true,-1,1*2332,2521,true,-1,1*2782,2933,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "491",
                    "mediaDataId": 0,
                    "title": "Adrenal insufficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26760044",
                    "mediaDataId": 0,
                    "title": "Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice Guideline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26760044",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25165474",
                    "mediaDataId": 0,
                    "title": "Tuberculosis of the adrenal gland: a case report and review of the literature of infections of the adrenal gland.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25165474",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 166,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 8805,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 3061,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 2175,
            "questionIndex": 2175,
            "questionText": "<p>A 35-year-old man comes to the office with a year-long history of fatigue and weakness.&nbsp; He has had a significant decrease in appetite and interest in day-to-day activities due to lack of energy.&nbsp; He also reports cold intolerance, a dull constant headache, constipation, erectile dysfunction, and low libido.&nbsp; The patient has no fever, neck swelling, skin rash, head injury, or excessive urination.&nbsp; Temperature is 36.6 C (97.9 F), blood pressure is 98/72 mm Hg, pulse is 50/min, and respirations are 14/min.&nbsp; The skin is dry and pale.&nbsp; Neurologic examination shows delayed deep tendon reflexes.&nbsp; The testes are small and soft on palpation.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>10.2 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>5,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neutrophils</td><td>45%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eosinophils</td><td>10%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lymphocytes</td><td>40%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Monocytes</td><td>5%</td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>132 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>4.0 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>56 mg/dL</td></tr></tbody></table><p>Further evaluation in this patient would most likely show which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31494\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Clinical features of hypopituitarism </strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology </strong></p></td><td><ul><li><strong>Pituitary causes </strong><ul style=\"list-style-type:circle;\"><li>Primary (eg, adenoma) or metastatic mass</li><li>Infiltration (eg, hemochromatosis, lymphocytic hypophysitis)</li><li>Hemorrhage (pituitary apoplexy) or infarction (Sheehan syndrome)</li></ul></li><li><strong>Hypothalamic causes </strong><ul style=\"list-style-type:circle;\"><li>Mass lesions</li><li>Radiation therapy</li><li>Infiltration (sarcoidosis)</li><li>Trauma to skull base</li><li>Infections (tuberculosis meningitis)</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation </strong></p></td><td><ul><li><strong>ACTH deficiency (secondary adrenal insufficiency) </strong><ul style=\"list-style-type:circle;\"><li>Postural hypotension, tachycardia, fatigue, weight loss, hypoglycemia, eosinophilia</li></ul></li><li><strong>Hypothyroidism (central) </strong><ul style=\"list-style-type:circle;\"><li>Fatigue, cold intolerance, constipation, dry skin, bradycardia, slowed deep tendon reflexes</li></ul></li><li><strong>Gonadotropins </strong><ul style=\"list-style-type:circle;\"><li>Women: Amenorrhea, infertility</li><li>Men: Infertility, loss of libido</li></ul></li></ul></td></tr></tbody></table></div><p>This patient&#39;s presentation suggests <strong>panhypopituitarism</strong> with inadequate production of multiple anterior pituitary hormones.&nbsp; Potential features include:</p><ul><li><strong>Central adrenal insufficiency</strong> (<strong>low cortisol</strong> and ACTH) - fatigue, anorexia, hypoglycemia, eosinophilia.&nbsp; Skin may be pale due to decreased production of ACTH and melanocyte-stimulating hormone</li><li><strong>Hypogonadotropic hypogonadism</strong> (low FSH, LH, and testosterone) - low libido, erectile dysfunction, testicular atrophy</li><li><strong>Central hypothyroidism</strong> (low or inappropriately normal TSH, <strong>low free T4</strong>) - cold intolerance, constipation, bradycardia</li></ul><p>Patients may have mild hyponatremia (due to antidiuretic hormone release) and mild hypotension (due to decreased peripheral arterial resistance).&nbsp; Unlike cortisol, adrenal <strong>aldosterone</strong> secretion is regulated primarily by the renin-angiotensin system and is <strong>not affected</strong> in hypopituitarism.&nbsp; In contrast, in primary adrenal insufficiency, aldosterone production is lost, leading to hyperkalemia and severe hypotension, and ACTH production is increased, with associated hyperpigmentation.</p><p>Hypopituitarism is often due to compression by pituitary or extrapituitary tumors and may be associated with mass-effect symptoms (eg, headache, visual field defects).&nbsp; Other causes include infiltrative diseases (eg, sarcoidosis, hemochromatosis), trauma, and vascular insults (apoplexy, Sheehan syndrome).</p><p><strong>Educational objective:</strong><br>Hypopituitarism is characterized by glucocorticoid deficiency, hypogonadism, and hypothyroidism.&nbsp; Typical features include fatigue, cold intolerance, hypoglycemia, anorexia, and low libido.&nbsp; In contrast to primary adrenal insufficiency, aldosterone is normal in central adrenal insufficiency due to hypopituitarism.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2767,
            "topic": "Hypopituitarism",
            "titleId": 2767,
            "title": "Hypopituitarism",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"400\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tNormal\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 1,
                    "correctTaken": 7203,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"400\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 2,
                    "correctTaken": 6807,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"400\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tNormal\n\t\t\t</td>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 3,
                    "correctTaken": 1617,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"400\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tNormal\n\t\t\t</td>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tHigh\n\t\t\t</td>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 4,
                    "correctTaken": 261,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"400\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tNormal\n\t\t\t</td>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tNormal\n\t\t\t</td>\n\t\t\t<td align=\"center\" width=\"33%\">\n\t\t\t\tLow\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 5,
                    "correctTaken": 91,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1012,1099,true,-1,1*1335,1483,true,-1,1*342,399,true,-1,1*96,136,true,-1,1*545,557,true,-1,1*155,197,true,-1,1*329,341,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "616",
                    "mediaDataId": 0,
                    "title": "Pituitary tumors",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25033850",
                    "mediaDataId": 0,
                    "title": "Dynamic pituitary hormones change after traumatic brain injury.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25033850",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24365347",
                    "mediaDataId": 0,
                    "title": "Neurology of the pituitary.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24365347",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 99,
            "othersAvgTimeSpent": 79,
            "notes": null,
            "peopleTaken": 15979,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 45,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"400\"><tbody><tr><td align=\"center\" width=\"33%\"><strong>Free T4</strong></td><td align=\"center\" width=\"33%\"><strong>Serum cortisol</strong></td><td align=\"center\" width=\"33%\"><strong>Aldosterone</strong></td></tr></tbody></table>",
            "standards": null,
            "totalTimeSpentReview": 1342,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 18971,
            "questionIndex": 20452,
            "questionText": "<p>A 50-year-old man comes to the office due to a 4-month history of achy joint pain in the lower back, shoulders, hips, and knees.&nbsp; The pain increases with activity, and he has no morning stiffness.&nbsp; The patient also has excessive sweating, polyuria, and erectile dysfunction.&nbsp; Medical history is unremarkable.&nbsp; The patient has a 25-pack-year smoking history and drinks moderate amounts of alcohol on social occasions.&nbsp; Blood pressure is 150/90 mm Hg, pulse is 80/min, and respirations are 16/min.&nbsp; Examination shows crepitus on passive movement of the knee joints.&nbsp; There is increased interdental spacing and an enlarged tongue, and the remainder of the examination is normal.&nbsp; Plain radiography of the hand reveals widening of the joint spaces, osteophytes, and thickened soft tissues.&nbsp; Laboratory evaluation reveals low testosterone and hyperglycemia.&nbsp; What is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31111\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:.1in;\"><strong>Clinical features of acromegaly</strong></p></td></tr><tr><td style=\"width: 18%;\"><p align=\"center\"><strong>Local tumor effect</strong></p></td><td style=\"width: 82%;\"><p>Headache, visual field defects, cranial nerve defects</p></td></tr><tr><td><p align=\"center\"><strong>Musculoskeletal</strong></p></td><td><p>Gigantism, frontal bossing, malocclusion of jaw, macrognathia, arthritis, carpal tunnel syndrome, enlargement of hands/feet</p></td></tr><tr><td><p align=\"center\"><strong>Skin</strong></p></td><td><p>Skin thickening, hyperhidrosis (odor), skin tags</p></td></tr><tr><td><p align=\"center\"><strong>Cardiovascular</strong></p></td><td><p>Cardiomyopathy, hypertension, heart failure</p></td></tr><tr><td><p align=\"center\"><strong>Respiratory</strong></p></td><td><p>Sleep apnea</p></td></tr><tr><td><p align=\"center\"><strong>Gastrointestinal</strong></p></td><td><p>Colon polyps/cancer, diverticulosis</p></td></tr><tr><td><p align=\"center\"><strong>Endocrine</strong></p></td><td><p>Galactorrhea, hypogonadism, diabetes mellitus, hypertriglyceridemia</p></td></tr><tr><td><p align=\"center\"><strong>Additional features</strong></p></td><td><p>Enlarged tongue, thyroid, salivary glands, liver, spleen, kidney, prostate</p></td></tr></tbody></table></div><p>This patient has characteristic features of <strong>acromegaly</strong>, including arthralgias, jaw widening (increased interdental spaces), and macroglossia.&nbsp; Acromegaly is caused by excessive production of <strong>growth hormone</strong> (GH), usually by a <strong>pituitary somatotroph adenoma</strong>.&nbsp; Enlarging adenomas can also cause decreased secretion of other pituitary hormones (eg, gonadotropins, leading to erectile dysfunction and low testosterone).&nbsp; In addition to causing hyperglycemia (eg, polyuria) and increasing metabolic rate (eg, hyperhidrosis), excess GH directly and indirectly (via release of <a href=\"3944\">insulin-like growth factor-1</a> from the liver) leads to overgrowth of tissues, including bone, cartilage, and visceral organs.</p><p>Joint involvement is common and often involves both axial and appendicular skeletons.&nbsp; GH causes <strong>hyperplasia of articular chondrocytes and synovial hypertrophy</strong>, which may be visible on x-ray as <strong>joint space widening</strong>.&nbsp; In later stages, cartilage degeneration typically occurs, leading to clinical and radiographic findings resembling osteoarthritis.&nbsp; Spinal involvement may lead to kyphoscoliosis.&nbsp; Treatment (eg, transsphenoidal surgery) can minimize arthropathy in the hypertrophic stages but will not reverse degenerative changes.</p><p><strong>(Choice B)</strong>&nbsp; Macroglossia is a characteristic manifestation of amyloid light-chain amyloidosis in plasma cell disorders.&nbsp; Patients may have polyarticular arthritis with widening of the joint spaces and thickening of soft tissues.&nbsp; However, hyperhidrosis and dental malocclusion are more typical of acromegaly.</p><p><strong>(Choice C)</strong>&nbsp; Hereditary hemochromatosis&ndash;associated arthropathy most commonly presents as degenerative arthritis involving the second and third metacarpophalangeal joints.&nbsp; <a href=\"24857\">Periarticular osteophytes</a> may be seen on x-ray, but joint spaces are narrowed; close inspection may reveal deposition of calcium pyrophosphate dihydrate in articular cartilage (<a href=\"118\">chondrocalcinosis</a>).&nbsp; Cranial abnormalities are atypical.</p><p><strong>(Choice D)</strong>&nbsp; Paget disease of bone is characterized by excessive, disordered bone formation; affected bone weakens, leading to bowing, fracture, and arthritis of adjacent joints.&nbsp; However, findings are focal and asymmetric; x-rays reveal <a href=\"39755\">mixed lytic-sclerotic lesions</a> and thickening of cortical and trabecular bone.&nbsp; Visceral enlargement (enlarged tongue) and hyperhidrosis are not typical.</p><p><strong>(Choice E)</strong>&nbsp; Hypertrophic osteoarthropathy is a paraneoplastic syndrome of pulmonary malignancy, primarily adenocarcinoma.&nbsp; It is characterized by bone and soft tissue enlargement in the distal extremities.&nbsp; Manifestations include clubbing, arthropathy, periostosis of long bones, and joint effusions; cranial abnormalities are not common.</p><p><strong>Educational objective:</strong><br>Joint involvement in acromegaly is common and often involves the axial and appendicular skeletons.&nbsp; Excessive growth hormone causes hyperplasia of articular chondrocytes and synovial hypertrophy, which may be visible on x-ray as joint space widening. In later stages, cartilage degeneration may lead to clinical and radiographic findings resembling osteoarthritis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2661,
            "topic": "Acromegaly",
            "titleId": 2661,
            "title": "Acromegaly",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acromegaly",
                    "choiceNumber": 1,
                    "correctTaken": 3469,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Amyloidosis",
                    "choiceNumber": 2,
                    "correctTaken": 228,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemochromatosis",
                    "choiceNumber": 3,
                    "correctTaken": 578,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Paget disease of bone",
                    "choiceNumber": 4,
                    "correctTaken": 201,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Paraneoplastic syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 475,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "805,1050,true,-1,1*1728,1862,true,-1,1*280,297,true,-1,1*319,328,true,-1,1*400,411,true,-1,1*429,464,true,-1,1*475,501,true,-1,1*1075,1154,true,-1,1*1680,1725,true,-1,1*2100,2171,true,-1,1*1875,1887,true,-1,1*2031,2090,true,-1,1*2183,2342,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "753",
                    "mediaDataId": 0,
                    "title": "Growth hormone disorders: Excess (gigantism, acromegaly) and deficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 91,
            "othersAvgTimeSpent": 90,
            "notes": null,
            "peopleTaken": 5067,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2463,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 16419,
            "questionIndex": 17863,
            "questionText": "<p>A 31-year-old woman comes to the office due to worsening fatigue and abdominal pain for the last month since the birth of a child.&nbsp; She had an emergency cesarean delivery complicated by significant hemorrhage that required transfusion of multiple units of blood.&nbsp; The patient reports that she has been unable to breastfeed and has switched to formula to feed her infant.&nbsp; She also reports occasional dizziness when standing.&nbsp; Temperature is 36.1 C (97 F), blood pressure is 80/62 mm Hg, and pulse is 96/min.&nbsp; The skin is dry, and the abdomen is nontender to palpation.&nbsp; The patient has sparse axillary and pubic hair.&nbsp; The remainder of the examination is unremarkable.&nbsp; Which of the following laboratory findings would likely be seen in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31624\"><table class=\"table-default-style\" style=\"width:100%\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Primary versus secondary adrenal insufficiency</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Primary</strong></p></td><td><p align=\"center\"><strong>Secondary</strong></p></td></tr><tr><td><p align=\"center\"><strong>Mechanism</strong></p></td><td><ul><li align=\"center\">Destruction of bilateral adrenal cortex</li></ul></td><td><ul><li align=\"center\">Disruption of hypothalamic-pituitary axis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Possible etiologies</strong></p></td><td><ul><li>Autoimmune adrenalitis</li><li>Infection, malignancy</li></ul></td><td><ul><li>Chronic glucocorticoid therapy</li><li>Infiltrative disease</li><li>Ischemia of anterior pituitary gland</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cortisol</strong></p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">&#8595;</p></td></tr><tr><td><p align=\"center\"><strong>Aldosterone</strong></p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">Normal</p></td></tr><tr><td><p align=\"center\"><strong>ACTH</strong></p></td><td><p align=\"center\">&#8593;</p></td><td><p align=\"center\">&#8595;</p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>More severe symptoms</li><li>Hypovolemia</li><li>Hyperkalemia, hyponatremia</li><li>Hyperpigmentation</li></ul></td><td><ul><li>Less severe symptoms</li><li>Euvolemia</li><li>Minimal electrolyte disturbance</li><li>No hyperpigmentation</li></ul></td></tr></tbody></table></div><p>This patient has <a href=\"4245\">Sheehan syndrome</a>, which is caused by <strong>anterior pituitary infarction</strong> in the setting of postpartum hemorrhage.&nbsp; The anterior pituitary gland blood supply operates through a low-pressure portal system, making it susceptible to ischemic injury with reduced perfusion.&nbsp; In contrast, the direct arterial supply of the posterior pituitary gland renders it, and its secreted hormones (<a href=\"58862\">antidiuretic hormone [ADH] and oxytocin</a>), more resilient to hypotension.</p><p>As in this patient, manifestations related to loss of multiple anterior pituitary hormones include lactation failure (loss of prolactin), dry skin and fatigue (decreased TSH), and decreased body hair (central hypogonadism from loss of FSH and LH), in addition to central/secondary <strong>adrenal insufficiency (AI)</strong> (due to decreased ACTH).</p><p>AI is characterized by <strong>cortisol deficiency</strong>; it presents with gastrointestinal symptoms (eg, abdominal pain, nausea, anorexia) and loss of vascular tone (eg, orthostatic hypotension).&nbsp; In addition, because cortisol acts as an <a href=\"1578\">inhibitor of ADH</a>, the decreased cortisol in AI often leads to the syndrome of inappropriate antidiuretic hormone release with hyponatremia.&nbsp; Although these features occur in both primary and central (ie, pituitary/secondary, hypothalamic/tertiary) AI, further manifestations differ based on the site of the hormone deficiency:</p><ul><li><p>Primary AI (eg, Addison disease) results from destruction of the <a href=\"27032\">adrenal cortex</a>.&nbsp; ACTH is increased, and patients develop hyperpigmentation (cosecretion of melanocyte-stimulating hormone with ACTH).&nbsp; Aldosterone deficiency leads to hyperkalemia, salt wasting, volume contraction, and hypotension <strong>(Choice B)</strong>.</p></li><li><p><strong>Central AI</strong> (eg, <strong>Sheehan syndrome</strong>) results from disease of the pituitary or hypothalamus, leading to a <strong>deficiency in ACTH</strong>; skin hyperpigmentation does not occur.&nbsp; Because the adrenal cortex remains intact, aldosterone synthesis (regulated by the <a href=\"18382\">renin-angiotensin-aldosterone system</a>) is unaffected and the <strong>potassium is normal</strong>.&nbsp; Hypotension can occur but is typically mild.</p></li></ul><p><strong>(Choice C)</strong>&nbsp; This patient has Sheehan syndrome, resulting in secondary AI and low ACTH.&nbsp; Primary AI causes elevated ACTH and hyponatremia, but the potassium is typically elevated.</p><p><strong>(Choice D)</strong>&nbsp; Hyperaldosteronism (Conn syndrome) results in elevated serum sodium and low potassium.&nbsp; ACTH is normal.</p><p><strong>(Choice E)</strong>&nbsp; Although secondary AI results in low ACTH, the serum potassium would be normal due to the continued effects of aldosterone.</p><p><strong>Educational objective:</strong><br>Adrenal insufficiency (AI) results in gastrointestinal symptoms and loss of vascular tone (eg, orthostatic hypotension); hyponatremia is common due to the syndrome of inappropriate antidiuretic hormone.&nbsp; Unlike patients with primary AI (eg, Addison disease), patients with central (secondary or tertiary) AI (eg, Sheehan syndrome) do not develop hyperkalemia or skin hyperpigmentation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23445,
            "topic": "Adrenal insufficiency",
            "titleId": 23445,
            "title": "Adrenal insufficiency",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:400px\">\n\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t\t<td style=\"vertical-align:middle;width:33%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;width:33%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;\">\n\t\t\t\tnormal\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 1,
                    "correctTaken": 3260,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:400px\">\n\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t\t<td style=\"vertical-align:middle;width:33%\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;width:33%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 2,
                    "correctTaken": 860,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:400px\">\n\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t\t<td style=\"vertical-align:middle;width:33%\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;width:33%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;\">\n\t\t\t\tnormal\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 3,
                    "correctTaken": 163,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:400px\">\n\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t\t<td style=\"vertical-align:middle;width:33%\">\n\t\t\t\tnormal\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;width:33%\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 4,
                    "correctTaken": 97,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:400px\">\n\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t\t<td style=\"vertical-align:middle;width:33%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;width:33%\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 5,
                    "correctTaken": 633,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "502,543,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "491",
                    "mediaDataId": 0,
                    "title": "Adrenal insufficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 57,
            "othersAvgTimeSpent": 92,
            "notes": null,
            "peopleTaken": 5013,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:400px\"><tbody style=\"text-align:center\"><tr><td style=\"vertical-align:middle;width:33%\"><strong>ACTH</strong></td><td style=\"vertical-align:middle;width:33%\"><strong>Serum sodium</strong></td><td style=\"vertical-align:middle;\"><strong>Serum potassium</strong></td></tr></tbody></table>",
            "standards": null,
            "totalTimeSpentReview": 1617,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 2174,
            "questionIndex": 2174,
            "questionText": "<p>A 35-year-old man comes to the office after a year of weakness, fatigue, and weight loss.&nbsp; He has experienced reduced appetite and intermittent diarrhea.&nbsp; The patient had no improvement after several sessions with a clinical psychologist, who suggested evaluation for a physiological cause of his symptoms.&nbsp; His medical history is unremarkable, and he takes no regularly scheduled medications.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Family history is notable for hypothyroidism (sister).&nbsp; Temperature is 37.2 C (99 F), blood pressure is 106/66 mm Hg, pulse is 94/min, and respirations are 14/min.&nbsp; On physical examination, the patient does not appear to be in acute distress.&nbsp; His neck shows no thyromegaly or lymphadenopathy.&nbsp; Cardiopulmonary examination is normal, and the abdomen is soft with normal bowel sounds and no organomegaly.&nbsp; Motor strength and deep tendon reflexes are normal and symmetric.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"400\"><tbody><tr><td>Hemoglobin</td><td>12.3 g/dL</td></tr><tr><td>Leukocytes</td><td>4,700/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Sodium</td><td>130 mEq/L</td></tr><tr><td>Potassium</td><td>5.5 mEq/L</td></tr><tr><td>8 AM cortisol</td><td>7.2 &micro;g/dL (normal: 5-23 &micro;g/dL)</td></tr><tr><td>TSH</td><td>2.5 mIU/L</td></tr></tbody></table></blockquote><p>Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"4649\" src=\"https://www.uworld.com/media/L2455.png\" ></p><p>This patient has chronic weakness, weight loss, hyponatremia, and hyperkalemia associated with a low-normal cortisol level.&nbsp; This is a typical presentation of <strong>primary adrenal insufficiency</strong> (PAI), also known as Addison disease.&nbsp; PAI can be due to autoimmune adrenalitis, infections (eg, tuberculosis), malignancy, or adrenal hemorrhage.&nbsp; The initial symptoms are nonspecific and include <strong>fatigue</strong>, weakness, and <strong>weight loss</strong>.&nbsp; <strong>Gastrointestinal symptoms</strong> occur in most patients.&nbsp; Aldosterone deficiency causes <strong>volume depletion</strong>, which can manifest as hypotension or syncope.&nbsp; Skin signs can include hyperpigmentation or vitiligo.&nbsp; Almost all patients have <strong>hyponatremia</strong> due to salt wasting, volume depletion, and increased antidiuretic hormone release.&nbsp; Most also have hyperkalemia due to aldosterone deficiency.</p><p>The initial evaluation should include an <strong>8 AM serum cortisol</strong> and <strong>plasma ACTH</strong>.</p><ul><li>A low cortisol level (&lt;5 &micro;g/dL) with high ACTH confirms PAI, and a low cortisol level with low ACTH suggests central (pituitary [secondary] or hypothalamic [tertiary]) adrenal insufficiency.&nbsp;</li><li>A high or high-normal cortisol level (&gt;15 &micro;g/dL) essentially rules out PAI.&nbsp;</li><li>Some patients with manifestations strongly suggestive of PAI may have low-normal cortisol levels (5-15 &micro;g/dL) that fall within the normal range, as seen here.&nbsp;</li></ul><p>Because of this, and because the ACTH assay can take several days, an <strong>ACTH stimulation test</strong> (cosyntropin test) is usually performed concurrently to rapidly confirm the diagnosis.&nbsp; Cosyntropin is a synthetic ACTH analog.</p><ul><li>Infusion of a 250-&micro;g bolus of cosyntropin normally triggers a rapid increase in serum cortisol.&nbsp;</li><li>In contrast, patients with PAI will not have a significant rise.&nbsp;</li><li>In addition, most patients with central adrenal insufficiency have a blunted (minimal or suboptimal) response due to adrenal atrophy from chronically low ACTH.&nbsp;</li><li>If results are indeterminate, further pituitary function testing can be considered.</li></ul><p><strong>(Choice A)</strong>&nbsp; Urinary cortisol levels are decreased in severe PAI, but sensitivity is too low for use in the initial diagnosis.&nbsp; Urinary 24-hour cortisol is one of the first line tests in Cushing syndrome (eg, facial plethora, striae, hypertension at a young age).</p><p><strong>(Choice C)</strong>&nbsp; Cortisol is synthesized in response to hypoglycemia.&nbsp; In the insulin hypoglycemia test, insulin is given to induce hypoglycemia, and cortisol levels are measured.&nbsp; However, this test is technically cumbersome and can be hazardous in some patients.</p><p><strong>(Choice D)</strong>&nbsp; Intravenous hydrocortisone is given for adrenal crisis (ie, abdominal pain, fever, hemodynamic instability).&nbsp; This patient has chronic, stable symptoms, and the diagnosis should be confirmed prior to treatment.</p><p><strong>(Choice E)</strong>&nbsp; Dexamethasone suppresses release of ACTH from the pituitary, which subsequently reduces adrenal cortisol production.&nbsp; The dexamethasone suppression tests are used to evaluate hypercortisolism (eg, Cushing) but are not used in PAI.</p><p><strong>Educational objective:</strong><br>The evaluation of adrenal insufficiency should include an 8 AM serum cortisol and plasma ACTH.&nbsp; In addition, an ACTH stimulation test (cosyntropin test) can identify patients with primary adrenal insufficiency (and most patients with central adrenal insufficiency) and should be performed in the initial evaluation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23445,
            "topic": "Adrenal insufficiency",
            "titleId": 23445,
            "title": "Adrenal insufficiency",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "24-hour urine free cortisol",
                    "choiceNumber": 1,
                    "correctTaken": 3751,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "ACTH stimulation test",
                    "choiceNumber": 2,
                    "correctTaken": 9730,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insulin-induced hypoglycemia test",
                    "choiceNumber": 3,
                    "correctTaken": 952,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous hydrocortisone",
                    "choiceNumber": 4,
                    "correctTaken": 1174,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low-dose overnight dexamethasone suppression test",
                    "choiceNumber": 5,
                    "correctTaken": 2841,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "129,155,true,-1,1*1184,1563,true,-1,1*1727,1887,true,-1,1*1888,1970,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "491",
                    "mediaDataId": 0,
                    "title": "Adrenal insufficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26760044",
                    "mediaDataId": 0,
                    "title": "Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26760044",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 138,
            "othersAvgTimeSpent": 105,
            "notes": null,
            "peopleTaken": 18448,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1323,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 2592,
            "questionIndex": 2592,
            "questionText": "<p>A 31-year-old woman comes to the office due to a 6.8-kg (15-lb) weight gain over the last few months.&nbsp; She has been unable to lose weight despite rigorous dieting and regular exercise.&nbsp; The patient also has experienced weakness and cannot lift weights that she was able to lift before the onset of her symptoms.&nbsp; Her menstrual periods have been irregular for the last few months, and she has had increasing anxiety and insomnia for which she has started seeing a clinical psychologist.&nbsp; Medical history is unremarkable.&nbsp; She drinks wine only on rare occasions and quit smoking 7 years ago after a 5-pack-year history.&nbsp; On examination, blood pressure is 160/100 mm Hg and pulse is 88/min and regular.&nbsp; Neurologic examination shows proximal muscle weakness.&nbsp; Dark terminal hair is present on the lower abdomen.&nbsp; Fasting laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"275\"><tbody><tr><td>Glucose</td><td>130 mg/dL</td></tr><tr><td>Sodium</td><td>142 mEq/L</td></tr><tr><td>Potassium</td><td>3.6 mEq/L</td></tr><tr><td>Chloride</td><td>98 mEq/L</td></tr><tr><td>Bicarbonate</td><td>28 mEq/L</td></tr><tr><td>Calcium</td><td>9.2 mg/dL</td></tr><tr><td>TSH</td><td>2.2 mIU/L</td></tr></tbody></table></blockquote><p>Which of the following is the most appropriate next step in evaluating this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t39756\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Features of Cushing syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical manifestations</strong></p></td><td><ul><li><strong>Central obesity</strong></li><li>Skin atrophy &amp; wide, purplish <strong>striae</strong></li><li>Proximal muscle weakness</li><li>Hypertension</li><li><strong>Glucose intolerance</strong></li><li>Skin hyperpigmentation (if due to ACTH excess)</li><li>Depression, anxiety</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>24-hr urinary cortisol excretion</li><li>Late-night salivary cortisol assay</li><li>Low-dose dexamethasone suppression test</li></ul></td></tr></tbody></table></div></p><p>This patient has weight gain, psychiatric symptoms, hirsutism, hypertension, and hyperglycemia.&nbsp; This constellation of findings is consistent with hypercortisolism (<strong>Cushing syndrome</strong>).&nbsp; This condition is most commonly due to exogenous administration of glucocorticoids, but can also be due to an ACTH-producing pituitary tumor (Cushing disease), ectopic ACTH production (eg, small cell lung cancer), or primary adrenal disease.</p><p>The initial step in the evaluation is to confirm <strong>hypercortisolism</strong> with a late-night <strong>salivary cortisol</strong> assay, 24-hour <strong>urine free cortisol</strong> measurement, and/or overnight <strong>low-dose dexamethasone suppression test</strong>.&nbsp; Two of these first-line tests should be abnormal to establish the diagnosis.&nbsp; If hypercortisolism is confirmed, ACTH levels are measured to differentiate ACTH-dependent (ie, Cushing disease, ectopic ACTH) from ACTH-independent (eg, adrenal adenoma) causes <strong>(Choice C)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Early-morning cortisol levels will be low or low-normal in patients with primary adrenal insufficiency.&nbsp; However, there is considerable overlap in cortisol levels in normal subjects and those with Cushing syndrome, and this test has low utility in the evaluation of hypercortisolism.</p><p><strong>(Choice D)</strong>&nbsp; The ratio of plasma aldosterone to plasma renin activity is useful to evaluate primary hyperaldosteronism, which typically presents with hypertension and hypokalemia.&nbsp; This patient&#39;s hyperglycemia and psychiatric and menstrual symptoms are more consistent with hypercortisolism.</p><p><strong>(Choice E)</strong>&nbsp; Hyperandrogenism can be seen in Cushing syndrome due to ACTH-induced adrenal androgen production or co-secretion of cortisol and testosterone by an adrenal tumor.&nbsp; Testosterone levels may be useful in evaluating hirsutism, but would not explain this patient&#39;s constellation of findings consistent with Cushing syndrome.</p><p><strong>Educational objective:</strong><br>The initial step in the evaluation of Cushing syndrome is to confirm hypercortisolism with a late-night salivary cortisol assay, 24-hour urine free cortisol measurement, and/or overnight low-dose dexamethasone test.&nbsp; If hypercortisolism is confirmed, ACTH levels are measured to differentiate ACTH-dependent from ACTH-independent causes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11847,
            "topic": "Cushing syndrome",
            "titleId": 11847,
            "title": "Cushing syndrome",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "2",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Early-morning cortisol level",
                    "choiceNumber": 1,
                    "correctTaken": 5750,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Overnight low-dose dexamethasone suppression test",
                    "choiceNumber": 2,
                    "correctTaken": 4473,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum ACTH level",
                    "choiceNumber": 3,
                    "correctTaken": 2560,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum aldosterone to plasma renin activity ratio",
                    "choiceNumber": 4,
                    "correctTaken": 623,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum testosterone level",
                    "choiceNumber": 5,
                    "correctTaken": 1027,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "566,807,true,-1,1*1016,1272,true,-1,1*1410,1580,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "627",
                    "mediaDataId": 0,
                    "title": "Cushing syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18334580",
                    "mediaDataId": 0,
                    "title": "The diagnosis of Cushing syndrome: an Endocrine Society Practice Guideline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18334580",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 158,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 14433,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 31,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 910,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 17771,
            "questionIndex": 19231,
            "questionText": "<p>A 24-year-old woman comes to the office due to episodic sweating, palpitation, and tremor for the past 3 weeks.&nbsp; The symptoms typically occur after she skips meals and are relieved by eating carbohydrate-containing foods.&nbsp; The patient has had no abdominal pain, weight change, or excessive urination.&nbsp; Three months ago, she was diagnosed with diabetes mellitus, and treatment with insulin degludec was started.&nbsp; She refuses to monitor glucose levels at home.&nbsp; Medical history is notable for chronic pancreatitis resulting from adult-onset cystic fibrosis; the patient has no other organ involvement from this disease.&nbsp; Her only other medication is oral lipase for pancreatic exocrine insufficiency.&nbsp; Examination shows no abnormalities.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Laboratory results show a hemoglobin A1c of 7.5% and serum creatinine of 0.75 mg/dL.&nbsp; Which of the following is the primary contributor to this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"2507\" src=\"https://www.uworld.com/media/L24201.jpg\" ></p><p>Abnormalities of the cystic fibrosis transmembrane conductance regulator (<em>CFTR</em>) gene cause formation of viscous mucus, which can lead to obstruction of the pancreatic duct with inflammation and fibrosis of the surrounding gland.&nbsp; In addition to exocrine pancreatic insufficiency, <strong>destruction of the insulin-secreting beta cells</strong> in the pancreatic islets can develop, resulting in <strong>pancreatogenic diabetes</strong>.&nbsp; In such cases, exogenous insulin is required.&nbsp; Pancreatogenic diabetes is also common in patients with pancreatectomy or chronic pancreatitis of other causes (eg, alcohol).</p><p>Patients with pancreatogenic diabetes typically also lose <strong>glucagon-secreting alpha cells</strong>.&nbsp; Because glucagon is the primary counterregulatory hormone to insulin, these patients are at risk for <strong>insulin-induced hypoglycemia</strong>, which may be rapid and severe.&nbsp; Loss of alpha cell reserve is also seen in patients with long-standing type 1 (idiopathic) diabetes.</p><p>This patient is likely experiencing recurrent hypoglycemia due to unopposed insulin analogue therapy.&nbsp; Management requires a conservative insulin regimen, and she should be advised that careful monitoring of home glucose is necessary.&nbsp; In addition, she should be issued an emergency glucagon kit for use in severe hypoglycemia.</p><p><strong>(Choice A)</strong>&nbsp; Insulin degludec is an insulin analogue that forms polymers at the injection site, causing delayed uptake from the site and a prolonged duration of action.&nbsp; The insulin is cleared primarily by the kidneys; this patient has normal renal function and clearance is likely normal.</p><p><strong>(Choices B and D)</strong>&nbsp; Malabsorption in patients with cystic fibrosis primarily affects fats and proteins, not carbohydrates.&nbsp; At least 24-48 hours of fasting is typically required to deplete hepatic glycogen stores, and this patient has no other indication of reduced carbohydrate reserve.&nbsp; In patients with intact counterregulatory systems (ie, glucagon, epinephrine), as glycogen stores are depleted, hepatic glucose production continues via gluconeogenesis.&nbsp; However, this effect is inadequate in this patient due to loss of glucagon.</p><p><strong>(Choice E)</strong>&nbsp; Excessive circulating insulin can cause hypoglycemia and leads to down-regulation, not upregulation, of insulin receptor expression.</p><p><strong>Educational objective:</strong><br>Chronic pancreatitis or pancreatic resection can cause loss of insulin-producing beta cells, leading to pancreatogenic diabetes; exogenous insulin is required.&nbsp; Patients typically also lose glucagon-secreting alpha cells and are at risk for rapid and severe hypoglycemia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2740,
            "topic": "Hypoglycemia",
            "titleId": 2740,
            "title": "Hypoglycemia",
            "topicAttributeId": 330638,
            "topicAttribute": "Normal structure and function of endocrine glands",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreased clearance of insulin",
                    "choiceNumber": 1,
                    "correctTaken": 2294,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Depleted hepatic glycogen stores",
                    "choiceNumber": 2,
                    "correctTaken": 3256,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucagon deficiency",
                    "choiceNumber": 3,
                    "correctTaken": 8084,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Malabsorption of nutrients",
                    "choiceNumber": 4,
                    "correctTaken": 1082,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Upregulation of insulin receptors in the peripheral tissues",
                    "choiceNumber": 5,
                    "correctTaken": 3674,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "483,609,true,-1,1*1214,1292,true,-1,1*1305,1460,true,-1,1*1704,2116,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "411",
                    "mediaDataId": 0,
                    "title": "Pancreatitis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 95,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 18390,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 44,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1479,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 3899,
            "questionIndex": 3899,
            "questionText": "<p><u><strong>Patient Information</strong></u><br><strong>Age:</strong> 53 years<br><strong>Gender:</strong> F, self-identified<br><strong>Race/Ethnicity:</strong> unspecified<br><strong>Site of Care:</strong> office</p><p><u><strong>History</strong></u><br><strong>Reason for Visit/Chief Concern:</strong> &#x22;I&#39;ve been peeing a lot recently.&#x22;<br><strong>History of Present Illness:</strong><br>&#8226; increased urinary frequency for the past 4 weeks<br>&#8226; no burning with urination, urgency, or difficulty initiating urination<br>&#8226; wakes up several times at night to urinate<br>&#8226; frequent dry mouth sensation; drinks fluids almost every hour to alleviate thirst<br><strong>Past Medical History:</strong><br>&#8226; hypertension<br><strong>Medications:</strong><br>&#8226; amlodipine<br><strong>Allergies:</strong><br>&#8226; no known drug allergies<br><strong>Family History:</strong><br>&#8226; sister with diabetes mellitus at a young age<br><strong>Psychosocial History:</strong><br>&#8226; account executive<br>&#8226; 1 or 2 beers on weekends<br>&#8226; does not smoke</p><p><u><strong>Physical Examination</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"Text-align:center;\"><tbody><tr><td><strong>Temp</strong></td><td><strong>Pulse</strong></td><td><strong>Resp</strong></td><td><strong>BP</strong></td><td><strong>O<font size=\"2\"><sub>2</sub></font> Sat</strong></td><td><strong>Ht</strong></td><td><strong>Wt</strong></td><td><strong>BMI</strong></td></tr><tr><td>37.1 C<br>(98.8 F)</td><td style=\"vertical-align:top;\">85/min</td><td style=\"vertical-align:top;\">16/min</td><td>120/76<br>mm Hg</td><td>99%<br>on RA</td><td>163 cm<br>(5 ft 4 in)</td><td>84 kg<br>(185 lb)</td><td style=\"vertical-align:top;\">32 kg/m<font size=\"2\"><sup>2</sup></font></td></tr></tbody></table>&nbsp;<p>&#8226; Appearance: awake and alert<br>&#8226; Pulmonary: clear lung fields<br>&#8226; Cardiac: regular rhythm; S<font size=\"2\"><sub>1</sub></font> and S<font size=\"2\"><sub>2</sub></font><br>&#8226; Abdominal: soft and nontender<br>&#8226; Neurologic: no abnormalities; fully oriented</p><p><u><strong>Diagnostic Studies</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Blood glucose</td><td style=\"vertical-align:middle;\">93 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Serum sodium</td><td style=\"vertical-align:middle;\">150 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Serum potassium</td><td style=\"vertical-align:middle;\">4.1 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Bicarbonate</td><td style=\"vertical-align:middle;\">24 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">26 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Serum creatinine</td><td style=\"vertical-align:middle;\">1.1 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Serum uric acid</td><td style=\"vertical-align:middle;\">9.1 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Serum osmolality</td><td style=\"vertical-align:middle;\">314 mOsm/kg</td></tr><tr><td style=\"vertical-align:middle;\">Urine osmolality</td><td style=\"vertical-align:middle;\">124 mOsm/kg</td></tr></tbody></table><p><u><strong>Question:</strong></u> Which of the following is most consistent with this patient&#39;s findings?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t80553\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"4\"><p align=\"center\"><strong>ADH/AVP-related causes of polyuria &amp; polydipsia</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Primary polydipsia</strong></p></td><td><p align=\"center\"><strong>AVP deficiency<br />(central DI)</strong></p></td><td><p align=\"center\"><strong>AVP resistance<br />(nephrogenic DI)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Defect</strong></p></td><td><ul><li>&uarr; Water intake</li></ul></td><td><ul><li>&darr; ADH release from pituitary gland</li></ul></td><td><ul><li>Renal ADH resistance (normal or &uarr; ADH)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Antipsychotic use</li><li>Anxiety, psychiatric condition</li></ul></td><td><ul><li>Idiopathic</li><li>Trauma</li><li>Pituitary surgery</li><li>Ischemic encephalopathy</li></ul></td><td><ul><li>Long-term lithium use</li><li>Hypercalcemia</li><li>Hereditary (<em>AVPR2</em> mutation)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Low (or normal) serum Na</li></ul></td><td><ul><li>High-normal or elevated serum Na*</li></ul></td><td><ul><li>Normal or mildly elevated serum Na*</li></ul></td></tr><tr><td colspan=\"4\"><p>*Na is elevated if thirst mechanism is impaired (eg, hypothalamic involvement).</p><p><strong>ADH</strong> = antidiuretic hormone; <strong>AVP</strong> = arginine vasopressin; <strong>DI</strong> = diabetes insipidus.</p></td></tr></tbody></table></div><p>Patients with polyuria and polydipsia should be assessed for <strong>antidiuretic hormone (ADH)</strong> (also known as <strong>arginine vasopressin [AVP]) deficiency</strong> and <strong>resistance</strong> (formerly called central and nephrogenic diabetes insipidus [DI], respectively).&nbsp; Normally, elevated serum osmolality triggers ADH release, leading to <a href=\"45725\">increased collecting duct permeability to free water</a>, water reabsorption, and production of highly concentrated urine (eg, urine osmolality &gt;800 mOsm/kg).&nbsp; However, patients with ADH deficiency (AVP-D) or resistance (AVP-R) have decreased water reabsorption and persistently <strong>low urine osmolality</strong> (&lt;300 mOsm/kg) despite <strong>high serum osmolality</strong> (&gt;300 mOsm/kg).</p><p>Two main categories are seen:</p><ul><li><p><strong>AVP-D (central DI):</strong>&nbsp; associated with <strong>decreased ADH</strong> secretion from the pituitary gland (eg, trauma, hypoxia, malignancy [eg, lung])</p></li><li><p><strong>AVP-R (nephrogenic DI):</strong>&nbsp; associated with <strong>normal or elevated ADH levels</strong> with varying degrees of renal <strong>ADH resistance</strong>; can be caused by hereditary conditions (eg, ADH receptor gene mutations), significant electrolyte disturbances (eg, severe hypercalcemia), medications (eg, lithium), chronic kidney disease</p></li></ul><p>In AVP-D, serum <strong>sodium</strong> is usually slightly <strong>elevated</strong> or high-normal, which serves to stimulate thirst and continued water intake needed to compensate for urinary water losses.&nbsp; Uric acid may be slightly elevated if mild dehydration is present; more severe hypernatremia can result if the thirst mechanism is impaired (eg, hypothalamic lesion).&nbsp; Patients with AVP-R typically have an intact thirst mechanism that is sufficient to maintain normal or high-normal sodium levels.</p><p><strong>(Choice B)</strong>&nbsp; Osmotic diuresis (eg, glucose, mannitol, urea) can cause polyuria with a high serum osmolality; it is unlikely given this patient&#39;s normal serum glucose level.</p><p><strong>(Choice C)</strong>&nbsp; Thiazide diuretics (eg, hydrochlorothiazide) can lead to frequent urination and hyperuricemia but would cause mild electrolyte abnormalities, including hyponatremia and hypokalemia, findings not seen in this patient.&nbsp; They also classically cause mild hypercalcemia (vs severe hypercalcemia, sometimes associated with AVP-R).</p><p><strong>(Choice D)</strong>&nbsp; Primary polydipsia (formerly psychogenic polydipsia) manifests with polyuria and dilute urine but is due to excessive water intake.&nbsp; Patients have hyponatremia and low serum osmolality.</p><p><strong>(Choice E)</strong>&nbsp; Renal tubular acidosis usually presents with normal anion gap metabolic acidosis.&nbsp; Serum bicarbonate is low, and significant hypernatremia and dilute urine are not typical.</p><p><strong>(Choice F)</strong>&nbsp; Syndrome of inappropriate ADH leads to relatively concentrated urine with urine osmolality greater than serum osmolality along with hyponatremia (excess renal water reabsorption).&nbsp; Polyuria is uncommon.</p><p><strong>Educational objective:</strong><br>Antidiuretic hormone (also known as arginine vasopressin) deficiency or resistance is characterized by polyuria, polydipsia, and persistently dilute urine (eg, low urine osmolality) despite elevated serum osmolality.&nbsp; Hypernatremia may be present.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 18034,
            "topic": "Diabetes insipidus",
            "titleId": 18034,
            "title": "Diabetes insipidus",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Diabetes insipidus",
                    "choiceNumber": 1,
                    "correctTaken": 4027,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucose diuresis",
                    "choiceNumber": 2,
                    "correctTaken": 89,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydrochlorothiazide adverse effect",
                    "choiceNumber": 3,
                    "correctTaken": 155,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary polydipsia",
                    "choiceNumber": 4,
                    "correctTaken": 365,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal tubular acidosis",
                    "choiceNumber": 5,
                    "correctTaken": 135,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Syndrome of inappropriate antidiuretic hormone",
                    "choiceNumber": 6,
                    "correctTaken": 276,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2329,2376,true,-1,1*1820,1843,true,-1,1*2086,2186,true,-1,1*1844,2017,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "494",
                    "mediaDataId": 0,
                    "title": "Arginine vasopressin deficiency and resistance (diabetes insipidus)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "34718110",
                    "mediaDataId": 0,
                    "title": "Diabetes insipidus.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/34718110",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 64,
            "othersAvgTimeSpent": 120,
            "notes": null,
            "peopleTaken": 5047,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 797,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 4305,
            "questionIndex": 4305,
            "questionText": "<p>A 29-year-old woman comes to the emergency department due to worsening generalized weakness and lightheadedness, causing her difficulty ambulating.&nbsp; The patient has had fatigue, nausea, diffuse abdominal pain, and a 10-kg (22-lb) weight loss over the past 3 months.&nbsp; She has a history of hypothyroidism and takes levothyroxine.&nbsp; The patient works as a flight attendant.&nbsp; Temperature is 37.4 C (99.3 F), blood pressure is 80/50 mm Hg, and pulse is 110/min.&nbsp; Orthostatic changes are present.&nbsp; BMI is 19 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows dry and pigmented buccal mucous membranes.&nbsp; Lungs are clear to auscultation and heart sounds are normal.&nbsp; The abdomen is soft with mild generalized tenderness.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">11 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">240,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">7,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neutrophils</td><td style=\"vertical-align:middle;\">60%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eosinophils</td><td style=\"vertical-align:middle;\">10%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lymphocytes</td><td style=\"vertical-align:middle;\">30%</td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td style=\"vertical-align:middle;\">30 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">1.2 mg/dL</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s current condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t53662\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Primary adrenal insufficiency</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Autoimmune adrenalitis (most common)</li><li>Infection (eg, tuberculosis)</li><li>Metastatic infiltration</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Fatigue, weakness, anorexia/weight loss</li><li>Nausea, vomiting, abdominal pain</li><li>Salt craving, postural hypotension</li><li>Hyperpigmentation</li><li>Acute adrenal crisis: confusion, hypotension/shock</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Hyponatremia, hyperkalemia, eosinophilia</li><li>Low morning cortisol, high ACTH</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Glucocorticoids (eg, hydrocortisone, prednisone)</li><li>Mineralocorticoids (eg, fludrocortisone)</li></ul></td></tr></tbody></table></div><p>This patient likely has <strong>primary adrenal insufficiency</strong> (PAI) (also known as Addison disease), which most commonly results from an <strong>autoimmune response</strong> against the bilateral adrenal cortex.&nbsp; It often occurs in conjunction with other autoimmune disease (eg, primary hypothyroidism, vitiligo).</p><p>The clinical manifestations of PAI result from a deficiency of hormone production in all 3 layers of the <a href=\"27888\">adrenal cortex</a>.&nbsp; Reduced mineralocorticoid (mainly aldosterone) production leads to renal sodium wasting with consequent hypovolemia (and weight loss), hypotension, and <strong>orthostasis</strong>.&nbsp; Reduced glucocorticoid (eg, cortisol) production causes fatigue and contributes to hypotension.&nbsp; There is also decreased negative feedback on ACTH, which leads to high levels of both ACTH and its precursor, proopiomelanocortin (POMC); this causes <strong>hyperpigmentation</strong> of the skin and mucous membranes due to increased levels of melanocyte-stimulating hormone, which is also derived from POMC.&nbsp; A peripheral <strong>eosinophilia</strong> is common, likely due to reduced migration of eosinophils from the bloodstream into the tissues in the setting of low cortisol.&nbsp; For unclear reasons, abdominal pain/tenderness and <strong>normocytic anemia</strong> are often present as well.</p><p>Reduced production of adrenal androgens (eg, dehydroepiandrosterone) can lead to decreased libido and secondary sexual characteristics (eg, pubic hair); these effects are typically only seen in women because testicular androgen production continues in men.</p><p><strong>(Choice B)</strong>&nbsp; Anorexia nervosa can present with weight loss and amenorrhea; however, it would not explain hyperpigmented mucous membranes and requires a BMI &#8804;18.5 kg/m<font size=\"2\"><sup>2</sup></font> for diagnosis.</p><p><strong>(Choice C)</strong>&nbsp; Diuretic overuse can lead to hypovolemia, hypotension, and orthostatic symptoms; however, it would not explain this patient&#39;s hyperpigmented mucous membranes, peripheral eosinophilia, and abdominal pain.</p><p><strong>(Choice D)</strong>&nbsp; Small cell lung cancer can cause weight loss and sometimes presents with ectopic production of ACTH; however, this leads to hypercortisolism (eg, weight gain, hypertension) rather than adrenal insufficiency.</p><p><strong>(Choice E)</strong>&nbsp; Peripheral eosinophilia is common with parasitic infection (eg, strongyloidiasis); however, parasitic infection is less likely in the absence of fever and would not explain hyperpigmented mucous membranes.</p><p><strong>(Choice F)</strong>&nbsp; Viral gastroenteritis can cause fatigue, weight loss, and gastrointestinal distress, but the symptoms typically resolve on their own within about a week.&nbsp; The several-month duration of this patient&#39;s symptoms, combined with hyperpigmented mucous membranes, makes PAI more likely.</p><p><strong>Educational objective:</strong><br>Primary adrenal insufficiency most commonly results from an autoimmune response against the bilateral adrenal cortex and often occurs in conjunction with other autoimmune disease (eg, primary hypothyroidism, vitiligo).&nbsp; Clinical manifestations result from deficiency of mineralocorticoids, glucocorticoids, and androgens and include fatigue, weight loss, hypotension, and hyperpigmentation of the skin and mucous membranes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23445,
            "topic": "Adrenal insufficiency",
            "titleId": 23445,
            "title": "Adrenal insufficiency",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Autoimmune inflammation",
                    "choiceNumber": 1,
                    "correctTaken": 6333,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Eating disorder",
                    "choiceNumber": 2,
                    "correctTaken": 2253,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Excess diuretic use",
                    "choiceNumber": 3,
                    "correctTaken": 2435,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Occult malignancy",
                    "choiceNumber": 4,
                    "correctTaken": 1378,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parasitic infection",
                    "choiceNumber": 5,
                    "correctTaken": 3383,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Viral infection",
                    "choiceNumber": 6,
                    "correctTaken": 192,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "69,105,true,-1,1*734,835,true,-1,1*1517,1668,true,-1,1*1720,1765,true,-1,1*1766,2022,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "491",
                    "mediaDataId": 0,
                    "title": "Adrenal insufficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 51,
            "othersAvgTimeSpent": 87,
            "notes": null,
            "peopleTaken": 15974,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 40,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 779,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 4325,
            "questionIndex": 4325,
            "questionText": "<p>A 66-year-old man comes to the office with nausea, loss of appetite, fatigue, and marked weakness.&nbsp; Medical history is significant for hypertension treated with amlodipine.&nbsp; The patient also has polymyalgia rheumatica, for which he was prescribed daily prednisone 12 months ago, but he stopped taking it 7 days ago because he was unhappy with the associated weight gain.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 100/70 mm Hg without orthostatic changes, pulse is 100/min, and respirations are 18/min.&nbsp; The patient&#39;s face is round and plethoric, and there is excess supraclavicular fat deposition.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Serum sodium</td><td style=\"vertical-align:middle;\">131 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Serum potassium</td><td style=\"vertical-align:middle;\">4.3 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Chloride</td><td style=\"vertical-align:middle;\">96 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Bicarbonate</td><td style=\"vertical-align:middle;\">24 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">10 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Serum creatinine</td><td style=\"vertical-align:middle;\">0.9 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Calcium</td><td style=\"vertical-align:middle;\">9.6 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Blood glucose</td><td style=\"vertical-align:middle;\">71 mg/dL</td></tr></tbody></table><p>Chest x-ray is unremarkable.&nbsp; Which of the following biochemical abnormalities is most likely to be present in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31624\"><table class=\"table-default-style\" style=\"width:100%\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Primary versus secondary adrenal insufficiency</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Primary</strong></p></td><td><p align=\"center\"><strong>Secondary</strong></p></td></tr><tr><td><p align=\"center\"><strong>Mechanism</strong></p></td><td><ul><li align=\"center\">Destruction of bilateral adrenal cortex</li></ul></td><td><ul><li align=\"center\">Disruption of hypothalamic-pituitary axis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Possible etiologies</strong></p></td><td><ul><li>Autoimmune adrenalitis</li><li>Infection, malignancy</li></ul></td><td><ul><li>Chronic glucocorticoid therapy</li><li>Infiltrative disease</li><li>Ischemia of anterior pituitary gland</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cortisol</strong></p></td><td><p align=\"center\">&darr;</p></td><td><p align=\"center\">&darr;</p></td></tr><tr><td><p align=\"center\"><strong>Aldosterone</strong></p></td><td><p align=\"center\">&darr;</p></td><td><p align=\"center\">Normal</p></td></tr><tr><td><p align=\"center\"><strong>ACTH</strong></p></td><td><p align=\"center\">&uarr;</p></td><td><p align=\"center\">&darr;</p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>More severe symptoms</li><li>Hypovolemia</li><li>Hyperkalemia, hyponatremia</li><li>Hyperpigmentation</li></ul></td><td><ul><li>Less severe symptoms</li><li>Euvolemia</li><li>Minimal electrolyte disturbance</li><li>No hyperpigmentation</li></ul></td></tr></tbody></table></div><p>This patient, who has nausea, weakness, and fatigue following abrupt discontinuation of chronic glucocorticoid therapy, most likely has <strong>secondary (central) adrenal insufficiency</strong> (AI), which results from disruption of the <a href=\"1578\">hypothalamic-pituitary axis</a> (HPA).&nbsp; Chronic use of exogenous glucocorticoids (eg, prednisone) suppresses the secretion of both corticotropin-releasing hormone from the hypothalamus and ACTH from the anterior pituitary gland.&nbsp; On abrupt discontinuation of exogenous glucocorticoids, the pituitary gland may be unable to increase ACTH secretion to meet metabolic demands for up to <strong>6-12 months</strong>, resulting in secondary AI.</p><p>Any patient who receives chronic glucocorticoids for &#8805;3 weeks is at risk for developing secondary AI, with the risk increasing in those who have had a longer treatment duration and those who have <strong>cushingoid features</strong> (eg, facial plethora, supraclavicular fat pad).&nbsp; The diagnosis of secondary AI is confirmed by the measurement of <strong>low</strong> levels of both <strong>morning cortisol</strong> and <strong>ACTH</strong>.&nbsp; Because aldosterone secretion from the <a href=\"27888\">adrenal cortex</a> is mediated primarily by angiotensin II rather than ACTH, aldosterone levels are normal in secondary AI.&nbsp; Mild hyponatremia may be present because cortisol deficiency can increase antidiuretic hormone (ADH) secretion, but otherwise, electrolyte abnormalities in secondary AI are typically minimal.</p><p><strong>(Choices A, B, and D)</strong>&nbsp; Primary AI results from the destruction of all 3 layers of the bilateral adrenal cortex (eg, autoimmune adrenalitis).&nbsp; There are low levels of both cortisol and aldosterone, and ACTH levels are increased due to the absence of cortisol-induced negative feedback on the HPA.&nbsp; The low aldosterone levels cause hyperkalemia and hypovolemia, with hypovolemia inducing a more prominent increase in ADH secretion and more pronounced hyponatremia than occurs in secondary AI.&nbsp; In addition, the increased ACTH levels cause hyperpigmentation via increased levels of the precursor of ACTH, proopiomelanocortin.</p><p><strong>(Choice E)</strong>&nbsp; Increased ACTH and cortisol levels can be seen physiologically in response to stress or pathologically in ACTH-dependent Cushing syndrome (ie, Cushing disease, ectopic ACTH production).</p><p><strong>Educational objective:</strong><br>Chronic use of exogenous glucocorticoids can cause secondary (central) adrenal insufficiency (AI) due to disruption of the hypothalamic-pituitary axis.&nbsp; Laboratory studies show low ACTH and cortisol levels and a normal aldosterone level.&nbsp; In contrast, patients with primary AI have elevated ACTH, low aldosterone and cortisol, and significant electrolyte abnormalities (eg, hyperkalemia, hyponatremia).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2767,
            "topic": "Hypopituitarism",
            "titleId": 2767,
            "title": "Hypopituitarism",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreased ACTH, decreased aldosterone, and decreased cortisol levels",
                    "choiceNumber": 1,
                    "correctTaken": 3678,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased ACTH and decreased aldosterone levels",
                    "choiceNumber": 2,
                    "correctTaken": 1283,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased ACTH and decreased cortisol levels",
                    "choiceNumber": 3,
                    "correctTaken": 6387,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased ACTH and decreased cortisol levels",
                    "choiceNumber": 4,
                    "correctTaken": 3219,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased ACTH and increased cortisol levels",
                    "choiceNumber": 5,
                    "correctTaken": 1446,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1205,1306,true,-1,1*2616,2754,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "491",
                    "mediaDataId": 0,
                    "title": "Adrenal insufficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19474430",
                    "mediaDataId": 0,
                    "title": "Predisposing factors for adrenal insufficiency.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19474430",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 78,
            "othersAvgTimeSpent": 79,
            "notes": null,
            "peopleTaken": 16013,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 40,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 799,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 10352,
            "questionIndex": 11270,
            "questionText": "<p>A 32-year-old woman comes to the office due to lightheadedness.&nbsp; She had an uncomplicated vaginal delivery 6 weeks ago with minimal blood loss.&nbsp; The patient had mild fatigue and backache during the last trimester of pregnancy, but the fatigue has worsened since the delivery.&nbsp; She has also been having intermittent generalized abdominal pain, loss of appetite, and weakness.&nbsp; She says her skin is tanning even though she has spent only minimal time outdoors.&nbsp; Yesterday, the patient felt like she was &#x22;going to pass out&#x22; and experienced several episodes of lightheadedness accompanied by nausea and abdominal discomfort.&nbsp; She has no chest pain, shortness of breath, or bleeding.&nbsp; The patient has a history of hypothyroidism and takes levothyroxine.&nbsp; Her temperature is 36.1 C (97 F), blood pressure is 110/60 mm Hg supine and 85/45 mm Hg standing, and pulse is 104/min.&nbsp; Skin shows generalized hyperpigmentation.&nbsp; Lungs are clear, and her heart rate is tachycardic but regular with no gallops or murmurs.&nbsp; Abdominal examination shows mild, diffuse tenderness without guarding and normal bowel sounds.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"250\"><tbody><tr><td style=\"width:60%\">Hematocrit</td><td>32%</td></tr><tr><td>Leukocytes</td><td>9,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Sodium</td><td>131 mEq/L</td></tr><tr><td>Potassium</td><td>5.6 mEq/L</td></tr><tr><td>Bicarbonate</td><td>18 mEq/L</td></tr><tr><td>Creatinine</td><td>1.4 mg/dL</td></tr><tr><td>TSH</td><td>4.6 &micro;U/mL</td></tr></tbody></table></blockquote><p>Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t31624\"><table class=\"table-default-style\" style=\"width:100%\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Primary versus secondary adrenal insufficiency</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Primary</strong></p></td><td><p align=\"center\"><strong>Secondary</strong></p></td></tr><tr><td><p align=\"center\"><strong>Mechanism</strong></p></td><td><ul><li align=\"center\">Destruction of bilateral adrenal cortex</li></ul></td><td><ul><li align=\"center\">Disruption of hypothalamic-pituitary axis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Possible etiologies</strong></p></td><td><ul><li>Autoimmune adrenalitis</li><li>Infection, malignancy</li></ul></td><td><ul><li>Chronic glucocorticoid therapy</li><li>Infiltrative disease</li><li>Ischemia of anterior pituitary gland</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cortisol</strong></p></td><td><p align=\"center\">&darr;</p></td><td><p align=\"center\">&darr;</p></td></tr><tr><td><p align=\"center\"><strong>Aldosterone</strong></p></td><td><p align=\"center\">&darr;</p></td><td><p align=\"center\">Normal</p></td></tr><tr><td><p align=\"center\"><strong>ACTH</strong></p></td><td><p align=\"center\">&uarr;</p></td><td><p align=\"center\">&darr;</p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>More severe symptoms</li><li>Hypovolemia</li><li>Hyperkalemia, hyponatremia</li><li>Hyperpigmentation</li></ul></td><td><ul><li>Less severe symptoms</li><li>Euvolemia</li><li>Minimal electrolyte disturbance</li><li>No hyperpigmentation</li></ul></td></tr></tbody></table></div></p><p>This patient has several symptoms consistent with <strong>adrenal insufficiency (AI)</strong>, including weakness, abdominal pain, loss of appetite, and mild hyponatremia.&nbsp; She also has postural hypotension and hyperkalemia, which further raise suspicion for AI.&nbsp; Common in the postpartum period, AI can be due to adrenal (primary AI) or pituitary (secondary AI) disease.</p><p>Patients with <strong>primary AI</strong> have loss of glucocorticoid, mineralocorticoid, and adrenal androgen secretion.&nbsp; Symptoms are often severe, and patients may develop significant hypotension, hyperkalemia, and hyperchloremic acidosis.&nbsp; Primary AI is also frequently associated with hyperpigmentation due to increased pituitary secretion of ACTH and melanocyte-stimulating hormone.&nbsp; Autoimmune adrenalitis is the most common etiology for primary adrenal insufficiency and involves both humoral and cell-mediated immune destruction of the adrenal cortex.&nbsp; Up to half of the patients with autoimmune adrenalitis have other autoimmune disorders, which may also flare up in the postpartum period.</p><p>In contrast to primary AI, patients with <strong>secondary AI</strong> have only glucocorticoid and adrenal androgen deficiency with preservation of mineralocorticoid production (regulated primarily by the renin-angiotensin system, not the pituitary).&nbsp; Therefore, hyperkalemia, significant hypotension, and hyperchloremic acidosis are not seen.&nbsp; Lymphocytic hypophysitis (lymphocytic infiltration of the pituitary gland) and Sheehan syndrome (pituitary infarction due to hemorrhage/hypotension during labor) are common causes of postpartum secondary AI.&nbsp; This patient has hyperpigmentation and features of mineralocorticoid deficiency suggesting primary rather than secondary AI <strong>(Choices C and D)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Undertreated hypothyroidism can cause hypotension and fatigue, but this patient&#39;s electrolyte abnormalities and hyperpigmentation are more consistent with primary AI.</p><p><strong>(Choice E)</strong>&nbsp; Cardiomyopathy in the postpartum/peripartum period presents with systolic heart failure (ie, shortness of breath, edema).</p><p><strong>(Choice F)</strong>&nbsp; Postpartum endometritis occurs during the first 10 days after delivery, most commonly in patients with prolonged rupture of membranes or cesarian delivery.&nbsp; Typical features include fever, lower abdominal pain, and foul-smelling vaginal discharge.</p><p><strong>Educational objective:</strong><br>Postpartum adrenal insufficiency (AI) may be due to adrenal (primary AI) or pituitary (secondary AI) disease.&nbsp; Hyperpigmentation and signs of mineralocorticoid deficiency suggest primary rather than secondary AI.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23445,
            "topic": "Adrenal insufficiency",
            "titleId": 23445,
            "title": "Adrenal insufficiency",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Autoimmune adrenalitis",
                    "choiceNumber": 1,
                    "correctTaken": 76177,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inadequate dose of levothyroxine",
                    "choiceNumber": 2,
                    "correctTaken": 2936,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lymphocytic hypophysitis",
                    "choiceNumber": 3,
                    "correctTaken": 2750,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pituitary infarction",
                    "choiceNumber": 4,
                    "correctTaken": 24861,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postpartum cardiomyopathy",
                    "choiceNumber": 5,
                    "correctTaken": 608,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postpartum endometritis",
                    "choiceNumber": 6,
                    "correctTaken": 227,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1123,1146,true,-1,1*1295,1604,true,-1,1*1933,2144,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "491",
                    "mediaDataId": 0,
                    "title": "Adrenal insufficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24503135",
                    "mediaDataId": 0,
                    "title": "Adrenal insufficiency.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24503135",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 117,
            "othersAvgTimeSpent": 86,
            "notes": null,
            "peopleTaken": 107559,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 508,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 3230,
            "questionIndex": 3230,
            "questionText": "<p>A 27-year-old man comes to the physician for follow-up of hypertension.&nbsp; He feels healthy and has no complaints.&nbsp; Two weeks ago, he was found to have high blood pressure during an emergency department visit for a sports injury.&nbsp; The patient has a strong family history of hypertension and stroke.&nbsp; His blood pressure is 155/97 mm Hg and pulse is 78/min.&nbsp; Physical examination and basic laboratory workup are unremarkable.&nbsp; He is instructed to follow a low-salt diet and started on low-dose (12.5 mg daily) hydrochlorothiazide.&nbsp; Two weeks later, the patient comes to the emergency department complaining of muscle cramps, weakness, and palpitations.&nbsp; His blood pressure is 150/93 mm Hg and pulse is 82/min.&nbsp; Mucous membranes are moist.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"300\"><tbody><tr><td>Potassium</td><td>2.5 mEq/L</td></tr><tr><td>Glucose</td><td>78 mg/dL</td></tr><tr><td>Serum creatinine</td><td>1.0 mg/dL</td></tr></tbody></table></blockquote><p>Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img id=\"7091\"  src=\"https://www.uworld.com/media/L14820.jpg\" draggable=\"false\" ></p><p>This younger hypertensive patient with significant family history raises suspicion for a secondary cause of hypertension.&nbsp; The easily induced hypokalemia after starting a thiazide diuretic suggests primary hyperaldosteronism.&nbsp; Patients with mild primary hyperaldosteronism may not have spontaneous hypokalemia, but they are prone to developing diuretic-induced hypokalemia.&nbsp; Other findings include metabolic alkalosis and mild hypernatremia (143-147 mEq/L).&nbsp; The best screening test is early-morning plasma aldosterone concentration (PAC) to plasma renin activity (PRA) ratio.&nbsp; A PAC/PRA ratio &gt;20 with plasma aldosterone &gt;15 ng/dL suggests primary hyperaldosteronism.</p><p><strong>(Choice A)</strong>&nbsp; Computed tomography angiography of the abdomen is a screening test for renovascular hypertension due to renal artery stenosis or fibromuscular dysplasia.&nbsp; These conditions cause secondary hyperaldosteronism.&nbsp; A PAC/PRA ratio &lt;10 will be present in these patients.&nbsp; Computed tomography angiogram is not required in this patient at this time.</p><p><strong>(Choice B)</strong>&nbsp; Dexamethasone suppression test can diagnose Cushing&#39;s syndrome.&nbsp; Patients typically develop findings such as central obesity, purple striae, proximal muscle wasting, glucose intolerance, and hypertension.&nbsp; This patient&#39;s normal glucose makes this unlikely.</p><p><strong>(Choice D)</strong>&nbsp; Thiazide diuretics can cause hypokalemia.&nbsp; However, low-dose thiazide is usually not associated with the degree of hypokalemia seen in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Urine potassium excretion by collecting 24-hour urine has been used to document inappropriate potassium excretion.&nbsp; A 24-hour urinary potassium level &gt;30 mEq in the presence of hypokalemia suggests hyperaldosteronism.&nbsp; However, this test is no longer commonly used.</p><p><strong>Educational objective:</strong><br>Patients with mild primary hyperaldosteronism may not have spontaneous hypokalemia, but they are prone to developing diuretic-induced hypokalemia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 10292,
            "topic": "Hyperaldosteronism",
            "titleId": 10292,
            "title": "Hyperaldosteronism",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Computed tomography angiography of the abdomen",
                    "choiceNumber": 1,
                    "correctTaken": 4202,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dexamethasone suppression test",
                    "choiceNumber": 2,
                    "correctTaken": 2647,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma renin activity and aldosterone concentration",
                    "choiceNumber": 3,
                    "correctTaken": 83621,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum thiazide level",
                    "choiceNumber": 4,
                    "correctTaken": 28131,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urine potassium excretion by 24-hour collection",
                    "choiceNumber": 5,
                    "correctTaken": 5695,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "490,700,true,-1,1*921,978,true,-1,1*1611,1712,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "493",
                    "mediaDataId": 0,
                    "title": "Adrenal gland anatomy and physiology",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 74,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 124296,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2008,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 17107,
            "questionIndex": 18558,
            "questionText": "<p>A 32-year-old primigravida at 16 weeks gestation comes to the office due to urinary frequency and increased thirst.&nbsp; Although she limits fluids before bed, she still urinates 6-8 times a night.&nbsp; The patient previously had intermittent urinary frequency, but symptoms have worsened since she became pregnant.&nbsp; Family history is significant for type 2 diabetes mellitus in her mother and father.&nbsp; Vital signs are within normal limits.&nbsp; Examination shows no abnormalities.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td style=\"vertical-align:middle;\">140 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td style=\"vertical-align:middle;\">14 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">0.8 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td style=\"vertical-align:middle;\">9 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td style=\"vertical-align:middle;\">100 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Urinalysis</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Specific gravity</td><td style=\"vertical-align:middle;\">1.001</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Protein</td><td style=\"vertical-align:middle;\">none</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocyte esterase</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Nitrites</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Bacteria</td><td style=\"vertical-align:middle;\">none</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;White blood cells</td><td style=\"vertical-align:middle;\">1-2/hpf</td></tr></tbody></table><p>A 24-hour urine collection shows a urine output of 5.5 L after an intake of 2 L.&nbsp; What is the most likely cause of this patient&#39;s urinary frequency?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"31378\" src=\"https://www.uworld.com/media/L57009.png\" ></p><p>This pregnant patient with polydipsia and nocturia has <strong>polyuria&nbsp;</strong>(eg, 24-hr urinary output &gt;3 L), and her urinalysis reveals <strong>low specific gravity</strong> (&lt;1.006), indicating <strong>dilute urine</strong>&nbsp;(water diuresis).&nbsp; Polyuria and dilute urine in the setting of normal serum sodium and fluid intake (2 L) suggest <strong>diabetes insipidus (DI)</strong>.</p><p>DI is characterized by an inability to concentrate urine and is due to an insufficiency of, or renal resistance to,&nbsp;<strong>antidiuretic hormone</strong> (ADH, or vasopressin), which normally increases renal water reabsorption in the collecting ducts.&nbsp; DI can remain undiagnosed because the body often compensates for water losses with a demand for increased fluid intake (eg, increased thirst).&nbsp; However, during <strong>pregnancy</strong>, placentally produced enzymes (eg, vasopressinase) increase ADH breakdown and can worsen symptoms, thereby <strong>unmasking undiagnosed DI</strong>.&nbsp; Some women develop transient DI of pregnancy due to an exaggerated response to vasopressinase.&nbsp; This phenomenon may resolve with delivery but recur in subsequent pregnancies.</p><p>In this patient, a more complete workup (eg, challenge with desmopressin, an ADH analogue) is required to confirm the precise etiology of DI (ie, central DI due to insufficient ADH levels vs nephrogenic DI due to renal resistance to ADH).</p><p><strong>(Choices B and D)</strong>&nbsp; Polyuria occurs in gestational diabetes mellitus and urea-related osmotic diuresis.&nbsp; However, polyuria in both settings results from osmotic diuresis (eg, excretion of excess glucose due to hyperglycemia or of urea following kidney injury resolution).&nbsp; Therefore, a high specific gravity, indicating concentrated urine, would be expected.&nbsp; This patient&#39;s low urine specific gravity, normoglycemia, and absence of kidney injury make osmotic diuresis unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Increased urinary frequency is common in pregnancy due to physiologic changes and expanded blood volume.&nbsp; However, normal pregnancy changes are not associated with overt polyuria.&nbsp; This patient&#39;s excessive urinary output (despite normal fluid intake) and low urine specific gravity suggest an underlying disorder.</p><p><strong>(Choice E)</strong>&nbsp; Urinary tract infection can manifest with urinary frequency and urgency but does not cause pathologically increased urinary output (eg, polyuria).&nbsp; Furthermore, this patient&#39;s urinalysis result (absent bacteriuria, normal nitrite, normal leukocyte esterase) make infection unlikely.</p><p><strong>Educational objective:</strong><br>Diabetes insipidus (DI) is characterized by polyuria (eg, 24-hr urinary output &gt;3 L) and excretion of an inappropriately dilute urine with low specific gravity despite normal serum sodium concentration and fluid intake.&nbsp; During pregnancy, preexisting mild DI symptoms can worsen due to increased turnover of antidiuretic hormone.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 18034,
            "topic": "Diabetes insipidus",
            "titleId": 18034,
            "title": "Diabetes insipidus",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Diabetes insipidus",
                    "choiceNumber": 1,
                    "correctTaken": 9589,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gestational diabetes mellitus",
                    "choiceNumber": 2,
                    "correctTaken": 979,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal pregnancy changes",
                    "choiceNumber": 3,
                    "correctTaken": 5702,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Osmotic diuresis due to urea",
                    "choiceNumber": 4,
                    "correctTaken": 403,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urinary tract infection",
                    "choiceNumber": 5,
                    "correctTaken": 112,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "155,184,true,-1,1*230,349,true,-1,1*738,889,true,-1,1*1477,1574,true,-1,1*1899,1975,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "494",
                    "mediaDataId": 0,
                    "title": "Arginine vasopressin deficiency and resistance (diabetes insipidus)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 90,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 16785,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1300,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 2173,
            "questionIndex": 2173,
            "questionText": "<p>A 38-year-old woman comes to the office due to muscle weakness that has progressively worsened over the past 6 months.&nbsp; She has difficulty climbing stairs and combing her hair and is unable to walk even short distances without rest.&nbsp; There is no associated muscle pain.&nbsp; The patient has hypothyroidism that was diagnosed a year ago when she started gaining weight; she has been taking levothyroxine since then.&nbsp; Four months ago, she developed acute back pain.&nbsp; X-ray at that time revealed demineralization of the vertebral bones.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 155/100 mm Hg, pulse is 76/min, and respirations are 15/min.&nbsp; BMI is 32 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination is notable for facial hirsutism and mild proximal muscle weakness in the extremities.&nbsp; The muscles are not tender on palpation, and no fasciculations are noted.&nbsp; Deep tendon reflexes and sensory examination findings are normal.&nbsp; TSH level is normal.&nbsp; Which of the following is most likely responsible for this patient&#39;s muscle weakness?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T35184\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"6\"><p align=\"center\"><strong>Differential diagnosis of myopathy</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Weakness</strong></p></td><td><p align=\"center\"><strong>Pain &amp; tenderness</strong></p></td><td><p align=\"center\"><strong>ESR</strong></p></td><td><p align=\"center\"><strong>Creatine kinase</strong></p></td><td><p align=\"center\"><strong>Other features</strong></p></td></tr><tr><td><p align=\"center\"><strong>Glucocorticoid-induced myopathy</strong></p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">No</p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">Normal</p></td><td><ul><li>Prominent atrophy</li><li>Lower extremities most affected</li></ul></td></tr><tr><td><p align=\"center\"><strong>Polymyalgia rheumatica</strong></p></td><td><p align=\"center\">No</p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">&#8593;</p></td><td><p align=\"center\">Normal</p></td><td><ul><li>Stiffness of shoulders &amp; hips with restricted motion</li><li>Often coexists with GCA</li><li>Rapid improvement with glucocorticoids</li></ul></td></tr><tr><td><p align=\"center\"><strong>Polymyositis &amp; dermatomyositis</strong></p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">Uncommon</p></td><td><p align=\"center\">Normal or &#8593;</p></td><td><p align=\"center\">&#8593;</p></td><td><ul><li>Multisystem involvement (arthritis, rash, ILD)</li><li>&#8593; Malignancy risk</li></ul></td></tr><tr><td><p align=\"center\"><strong>Statin-induced myopathy</strong></p></td><td><p align=\"center\">Variable</p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">Normal or &#8593;</p></td><td><ul><li>Additive risk with fibrates</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hypothyroid myopathy</strong></p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">Yes</p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">&#8593;</p></td><td><ul><li>Delayed DTRs; myoedema</li><li>Hypothyroid symptoms &amp; abnormal thyroid test results</li></ul></td></tr><tr><td colspan=\"6\"><p><strong>DTR</strong> = deep tendon reflex; <strong>ESR</strong> = erythrocyte sedimentation rate; <strong>GCA</strong> = giant cell arteritis; <strong>ILD</strong> = interstitial lung disease.</p></td></tr></tbody></table></div><p>This patient has <strong>muscle weakness</strong> associated with weight gain, bone demineralization, hypertension, and <strong>hirsutism</strong>, a combination of symptoms and signs consistent with hypercortisolism, or <strong>Cushing syndrome</strong>.&nbsp; Although Cushing syndrome most commonly results from exogenous glucocorticoid use (eg, dexamethasone, prednisone), it can also be caused by <strong>endogenous cortisol</strong> secretion, including:</p><ul><li><p>ACTH-producing pituitary tumor (Cushing disease)</p></li><li><p>Ectopic ACTH production (eg, small cell lung cancer)</p></li><li><p>Primary adrenal disease (eg, adenoma)</p></li></ul><p>This patient requires further laboratory workup to determine the etiology.</p><p>Regardless of etiology, myopathy in Cushing syndrome (ie, <strong>glucocorticoid-induced myopathy</strong>) primarily manifests as painless<strong> weakness</strong> of <strong>proximal muscles</strong> that may interfere with daily activities.&nbsp; It results from the direct <strong>catabolic effects</strong> of cortisol on skeletal muscle that lead to <strong>muscle atrophy</strong>.&nbsp; Possible mechanisms include inhibition of Akt-1 (an antiapoptotic signaling molecule) and interference with insulin-like growth factor 1 signaling.&nbsp; Glucocorticoids also decrease myocyte differentiation and protein synthesis.</p><p>Because the myopathy mostly results from breakdown and impaired regeneration of muscle rather than direct damage to myocytes, it is classically <strong>painless</strong>, and serum <strong>creatine kinase</strong> (an enzyme released from damaged skeletal muscle) is typically <strong>normal</strong> in glucocorticoid-induced myopathy.&nbsp; Erythrocyte sedimentation rate is also normal due to a lack of inflammation.</p><p><strong>(Choice A)</strong>&nbsp; Mitochondrial dysfunction causes muscle weakness due to decreased ATP production but generally involves multiple organ systems and manifestations (eg, seizures, vision disturbances, dysphagia).&nbsp; Isolated myopathy can occur but usually presents during childhood or adolescence with decreased exercise tolerance, muscle weakness, and myalgias.</p><p><strong>(Choices B and D)</strong>&nbsp; Muscle weakness caused by motor neuron disease (eg, amyotrophic lateral sclerosis) is accompanied by features of upper motor neuron (hyperreflexia, spasticity) and/or lower motor neuron (atrophy, fasciculations) dysfunction.&nbsp; Inflammatory myopathies sometimes present with myalgias and muscle tenderness, but painless weakness is more typical.&nbsp; Neither of these types of disorder would explain this patient&#39;s hypertension, hirsutism, or bone demineralization.</p><p><strong>(Choice E)</strong>&nbsp; Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired inflammatory disorder characterized by demyelination of the peripheral nerves and nerve roots.&nbsp; CIDP presents with progressive, symmetric muscle weakness and is usually associated with distal sensory loss and diminished deep tendon reflexes.</p><p><strong>Educational objective:</strong><br>Myopathy in Cushing syndrome (ie, glucocorticoid-induced myopathy) is characterized by progressive, painless muscle weakness mostly involving the proximal muscles.&nbsp; It results from the direct catabolic effects of cortisol on skeletal muscle that lead to muscle atrophy.&nbsp; Creatine kinase and erythrocyte sedimentation rate are typically normal.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11847,
            "topic": "Cushing syndrome",
            "titleId": 11847,
            "title": "Cushing syndrome",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Mitochondrial dysfunction",
                    "choiceNumber": 1,
                    "correctTaken": 1449,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Motor neuron disease",
                    "choiceNumber": 2,
                    "correctTaken": 1533,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Muscle atrophy",
                    "choiceNumber": 3,
                    "correctTaken": 7357,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Muscle inflammation",
                    "choiceNumber": 4,
                    "correctTaken": 4621,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Peripheral nerve demyelination",
                    "choiceNumber": 5,
                    "correctTaken": 859,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1551,1964,true,-1,1*2492,2533,true,-1,1*2576,2681,true,-1,1*199,230,true,-1,1*444,490,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "627",
                    "mediaDataId": 0,
                    "title": "Cushing syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18296633",
                    "mediaDataId": 0,
                    "title": "Glucocorticoids differentially regulate degradation of MyoD and Id1 by N-terminal ubiquitination to promote muscle protein catabolism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18296633",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 136,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 15819,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1838,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 4419,
            "questionIndex": 4419,
            "questionText": "<p>A 34-year-old woman comes to the office due to a 6-month history of easy bruising with minimal or no trauma.&nbsp; She also has had difficulty climbing stairs due to muscle weakness and frequent nocturnal muscle cramps.&nbsp; The patient has experienced a 7-kg (15-lb) weight gain despite following a restricted-calorie vegan diet.&nbsp; Her medical history is notable for an uncomplicated root canal procedure 6 months ago but is otherwise unremarkable.&nbsp; She takes no prescription or over-the-counter medications.&nbsp; The patient is not currently sexually active and has never been pregnant.&nbsp; Her last menstrual period was 3 months ago.&nbsp; There is no family history of bleeding disorders.&nbsp; Her blood pressure is 146/94 mm Hg and pulse is 78/min.&nbsp; BMI is 29 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Examination shows facial plethora with dark terminal hair on her upper lip and chin.&nbsp; There is inflammatory acne on her face and back, extensive tinea versicolor on the trunk, and scattered bruises over the extremities.&nbsp; Fasting laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"350\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>14 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>160,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>9,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neutrophils</td><td>80%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eosinophils</td><td>0%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lymphocytes</td><td>17%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Monocytes</td><td>2%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basophils</td><td>1%</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>140 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>3.6 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Chloride</td><td>100 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td>28 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>0.8 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td>9 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>122 mg/dL</td></tr></tbody></table></blockquote><p>Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p><img id=\"4734\"  src=\"https://www.uworld.com/media/L29332.jpg\"  draggable=\"false\" ></p><p>This patient has several features suggesting <strong>Cushing syndrome</strong> (hypercortisolism).&nbsp; Weight gain, proximal muscle weakness, and hypertension are common presenting findings.&nbsp; Patients can experience easy <strong>bruisability</strong>, dermal atrophy, and wide purple striae due to the catabolic effects of cortisol on connective tissue; however, platelet function and coagulation proteins are normal.&nbsp; Dermatologic signs may include <strong>hyperpigmentation</strong> (in ACTH-dependent Cushing syndrome) and increased incidence of cutaneous fungal infections (eg, tinea versicolor, onychomycosis).&nbsp; Women can have features of <strong>hyperandrogenism</strong> (eg, menstrual irregularities, acne, hirsutism) due to co-secretion of adrenal androgens with cortisol.</p><p>Hyperglycemia is common (due to peripheral insulin resistance and hypercortisolism-induced gluconeogenesis).&nbsp; Hypokalemia and alkalosis may be present (due to the partial mineralocorticoid effects of cortisol) if cortisol levels are very high.&nbsp; Once there is laboratory confirmation of <strong>hypercortisolism</strong> (eg, late-night salivary cortisol assay, 24-hour urine free cortisol measurement, overnight low-dose dexamethasone suppression test), <strong>ACTH levels</strong> are measured to differentiate ACTH-dependent (eg, ACTH-secreting pituitary tumor, ectopic ACTH) from ACTH-independent (eg, adrenal adenoma) causes.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"2310\">Cutaneous small-vessel vasculitis</a> can be triggered by infections, medications, inflammatory conditions, or malignancy.&nbsp; It presents with nonblanching violaceous petechiae that can coalesce into palpable purpura.&nbsp; Weight gain, hyperglycemia, and hyperandrogenic symptoms would not be common.</p><p><strong>(Choice C)</strong>&nbsp; Polycystic ovary syndrome shares a number of features with Cushing syndrome, including obesity, irregular menstrual periods, and hyperandrogenism.&nbsp; However, skin atrophy, muscle weakness, and bruisability are not characteristic.</p><p><strong>(Choices D, E, and F)</strong>&nbsp; Vitamin C deficiency causes microvascular bleeding due to impaired synthesis of collagen.&nbsp; Vitamin K deficiency also causes bleeding, due to reduced levels of coagulation factors II, VII, IX, and X.&nbsp; Von Willebrand disease is an autosomal dominant disorder characterized by impaired platelet function and excessive bleeding.&nbsp; However, none of these conditions would explain this patient&#39;s weight gain, muscle weakness, hyperandrogenism, hyperglycemia, and metabolic alkalosis.&nbsp; In addition, vitamin C or K deficiencies are not common in vegans.</p><p><strong>Educational objective:</strong><br>Cushing syndrome is characterized by weight gain, muscle weakness, and hypertension.&nbsp; Patients can experience easy bruisability, dermal atrophy, and striae due to the catabolic effects of cortisol on connective tissue.&nbsp; Women can have features of hyperandrogenism due to co-secretion of adrenal androgens with cortisol.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11847,
            "topic": "Cushing syndrome",
            "titleId": 11847,
            "title": "Cushing syndrome",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cushing syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 1016,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cutaneous small vessel vasculitis",
                    "choiceNumber": 2,
                    "correctTaken": 21,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polycystic ovary syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 370,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin C deficiency",
                    "choiceNumber": 4,
                    "correctTaken": 43,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin K deficiency",
                    "choiceNumber": 5,
                    "correctTaken": 31,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Von Willebrand disease",
                    "choiceNumber": 6,
                    "correctTaken": 3,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "203,412,true,-1,1*594,742,true,-1,1*1489,1563,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "627",
                    "mediaDataId": 0,
                    "title": "Cushing syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20821267",
                    "mediaDataId": 0,
                    "title": "The diagnosis of Cushing&#39;s syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20821267",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 56,
            "othersAvgTimeSpent": 133,
            "notes": null,
            "peopleTaken": 1484,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 882,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 4721,
            "questionIndex": 4721,
            "questionText": "<p>A 66-year-old woman is brought to the emergency department due to agitation, restlessness, and poor sleep.&nbsp; Over the past 3 months, she has had headaches and generalized weakness.&nbsp; She has gained 6.3 kg (13.9 lb) without a change in diet.&nbsp; The patient&#39;s medical history is unremarkable, and she takes no medications.&nbsp; She has smoked a pack of cigarettes daily for the past 50 years but does not use recreational drugs or alcohol.&nbsp; Blood pressure is 160/110 mm Hg and pulse is 90/min.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Sodium</td><td style=\"vertical-align:middle;\">140 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Potassium</td><td style=\"vertical-align:middle;\">3.2 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Chloride</td><td style=\"vertical-align:middle;\">102 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Bicarbonate</td><td style=\"vertical-align:middle;\">28 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">12 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">0.9 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Glucose</td><td style=\"vertical-align:middle;\">205 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Calcium</td><td style=\"vertical-align:middle;\">9.4 mg/dL</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s hypertension?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T35223\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:.5in;\"><strong>Secondary causes of hypertension</strong></p></td></tr><tr><td><p align=\"center\"><strong>Condition</strong></p></td><td><p align=\"center\"><strong>Clinical clues/features</strong></p></td></tr><tr><td><p align=\"center\"><strong>Renal parenchymal disease</strong></p></td><td><ul><li>Elevated creatinine level</li><li>Abnormal urinalysis (proteinuria, red blood cell casts)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Renovascular disease</strong></p></td><td><ul><li>Recurrent flash pulmonary edema</li><li>Elevated creatinine level (particularly with ACE inhibitor use)</li><li>Abdominal bruit</li></ul></td></tr><tr><td><p align=\"center\"><strong>Primary hyperaldosteronism</strong></p></td><td><ul><li>Hypokalemia (spontaneous or thiazide induced)</li><li>Metabolic alkalosis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Obstructive sleep apnea</strong></p></td><td><ul><li>Daytime somnolence</li><li>Increased neck circumference</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pheochromocytoma</strong></p></td><td><ul><li>Paroxysmal hypertension &amp; tachycardia</li><li>Headaches, palpitations, diaphoresis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cushing syndrome</strong></p></td><td><ul><li>Cushingoid body habitus &amp; proximal muscle atrophy</li><li>Hyperglycemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Thyroid disease</strong></p></td><td><ul><li>Hyperthyroidism: anxiety, heat intolerance, weight loss, tachycardia</li><li>Hypothyroidism: fatigue, cold intolerance, weight gain, bradycardia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Primary hyperparathyroidism</strong></p></td><td><ul><li>Mild hypercalcemia &plusmn; symptoms (eg, constipation)</li><li>Kidney stones</li></ul></td></tr><tr><td><p align=\"center\"><strong>Coarctation of the aorta</strong></p></td><td><ul><li>Upper extremity hypertension with brachial-femoral pulse delay (common)</li><li>Lateralizing hypertension (less common)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s <strong>hypertension</strong>, neuropsychiatric disturbances (eg, agitation, restlessness), <strong>hyperglycemia</strong>, and weight gain suggest hypercortisolism (<strong>Cushing syndrome</strong>).&nbsp; Other potential&nbsp;<a href=\"4734\">manifestations</a>&nbsp;include proximal muscle weakness, central adiposity with enlargement of the supraclavicular and dorsal neck fat pads, abdominal striae, facial rounding, and ecchymosis.&nbsp; Most cases of Cushing syndrome are due to exogenous glucocorticoid intake, ectopic ACTH production (eg, small cell lung cancer), or ACTH-producing pituitary adenomas (Cushing disease).&nbsp; Primary adrenal hypercortisolism (eg, adrenal adenoma) is less common.&nbsp; Associated <strong>hypokalemia</strong>, most often seen with ectopic ACTH-producing tumors, suggests severe hypercortisolism because very high levels of cortisol, a glucocorticoid, can overwhelm enzymatic inactivation and activate mineralocorticoid receptors, leading to hypokalemic metabolic alkalosis.</p><p>Initial testing for suspected hypercortisolism can include a 24-hour assay for <strong>urine free cortisol</strong>, a late-night salivary cortisol measurement, or a low-dose dexamethasone suppression test.&nbsp; Once hypercortisolism is established, an <strong>ACTH level</strong> can determine whether it is ACTH-dependent (Cushing disease, ectopic ACTH production) or ACTH-independent (adrenal disease,&nbsp;exogenous glucocorticoid intake).&nbsp; Patients with an elevated ACTH should have a high-dose <strong>dexamethasone suppression test</strong> to determine whether ACTH production is pituitary (dexamethasone suppresses cortisol) or ectopic (dexamethasone does not suppress cortisol).</p><p><strong>(Choices B and F)</strong>&nbsp; Renovascular hypertension&mdash;which can be due to fibromuscular dysplasia (younger patients) or renal artery stenosis (older patients, particularly smokers)&mdash;is a common cause of secondary hypertension.&nbsp; Associated findings may include flash pulmonary edema and elevated creatinine, but weight gain and hyperglycemia are not seen.</p><p><strong>(Choice C)</strong>&nbsp; Hypothyroidism can cause hypertension associated with weight gain and hyperglycemia.&nbsp; However, typical neuropsychiatric symptoms include fatigue and depression rather than agitation and restlessness; hypokalemia is not a common effect.</p><p><strong>(Choice D)</strong>&nbsp; Pheochromocytoma is a catecholamine-producing adrenal medullary tumor that causes hypertension, headaches, neuropsychiatric symptoms (eg, anxiety, restlessness), and hyperglycemia.&nbsp; However, diaphoresis is typically present, and weight gain and hypokalemic metabolic alkalosis are not typical.</p><p><strong>(Choice E)</strong>&nbsp; Aldosterone activates mineralocorticoid receptors but not glucocorticoid receptors (even at high levels).&nbsp; Therefore, primary hyperaldosteronism (ie, Conn syndrome) would cause hypertension and hypokalemia (mineralocorticoid activity),&nbsp;but features of hypercortisolism (eg, hyperglycemia, restlessness, significant weight gain) would not be expected.</p><p><strong>Educational objective:</strong><br>Cushing syndrome (ie, hypercortisolism) is characterized by hypertension, neuropsychiatric disturbances, hyperglycemia, and weight gain.&nbsp; Very high cortisol levels can activate mineralocorticoid receptors, leading to hypokalemic metabolic alkalosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11847,
            "topic": "Cushing syndrome",
            "titleId": 11847,
            "title": "Cushing syndrome",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cushing syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 10193,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fibromuscular dysplasia",
                    "choiceNumber": 2,
                    "correctTaken": 277,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothyroidism",
                    "choiceNumber": 3,
                    "correctTaken": 999,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pheochromocytoma",
                    "choiceNumber": 4,
                    "correctTaken": 1341,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary hyperaldosteronism",
                    "choiceNumber": 5,
                    "correctTaken": 2499,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal artery stenosis",
                    "choiceNumber": 6,
                    "correctTaken": 598,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "3027,3042,true,-1,1*3511,3861,true,-1,1*1422,1680,true,-1,1*2371,2599,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "627",
                    "mediaDataId": 0,
                    "title": "Cushing syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 95,
            "othersAvgTimeSpent": 79,
            "notes": null,
            "peopleTaken": 15907,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 837,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 3832,
            "questionIndex": 3832,
            "questionText": "<p>A 50-year-old man comes to the physician complaining of 2 months of muscle cramps.&nbsp; He also complains of weakness and fatigue.&nbsp; He has a 20-pack-year smoking history but does not drink alcohol.&nbsp; The patient&#39;s past medical and family histories are noncontributory.&nbsp; His temperature is 36.7 C (98 F), blood pressure is 150/96 mm Hg, and pulse is 78/min.&nbsp; His body mass index is 28 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The rest of the examination is within normal limits.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"300\"><tbody><tr><td>Plasma sodium</td><td>147 mEq/L</td></tr><tr><td>Potassium</td><td>2.6 mEq/L</td></tr><tr><td>Serum creatinine</td><td>0.8 mg/dL</td></tr></tbody></table></blockquote><p>Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img id=\"7159\"  src=\"https://www.uworld.com/media/L8891.png\" draggable=\"false\" ></p><p>Primary hyperaldosteronism should be suspected in any hypertensive patient presenting with hypokalemia.&nbsp; Patients with mild primary hyperaldosteronism may not have spontaneous hypokalemia, but they are prone to develop <strong>diuretic-induced hypokalemia</strong>.&nbsp; Severe hypokalemia can cause muscle cramps/weakness.&nbsp; Other findings include <strong>metabolic alkalosis</strong> and <strong>mild hypernatremia</strong> (143-147 mEq/L).&nbsp; Patients usually <strong>do not have peripheral edema</strong> due to spontaneous diuresis (aldosterone escape).</p><p>The best screening test is early-morning plasma aldosterone concentration (PAC) to plasma renin activity (PRA) ratio.&nbsp; However, drugs that significantly alter the PAC/PRA ratio (eg, spironolactone, eplerenone, amiloride, triamterene) should be withdrawn for 4 weeks before testing.&nbsp; A <strong>PAC/PRA ratio &gt;20</strong> with plasma aldosterone &gt;15 ng/dL suggests primary hyperaldosteronism and requires further confirmatory adrenal suppression testing.&nbsp; Adrenal suppression testing usually involves salt loading and documenting inability to suppress serum aldosterone.&nbsp; Patients with positive adrenal suppression testing should then undergo adrenal imaging, usually by computed tomography (CT) scan <strong>(Choice C)</strong>.</p><p>Hyperaldosteronism is most commonly due to bilateral adrenal hyperplasia (50%-60%) or aldosterone-producing adrenal adenoma (40%-50%).&nbsp; If CT scan does not reveal a discrete unilateral mass, adrenal vein sampling is recommended to differentiate between hyperplasia and adenoma.&nbsp; Surgery is preferred for adenoma, and medical therapy is preferred for hyperplasia.</p><p><strong>(Choice A)</strong>&nbsp; Chest CT scan can diagnose a lung cancer, which can sometimes be associated with syndrome of inappropriate antidiuretic hormone or Lambert-Eaton syndrome.&nbsp; Lambert-Eaton syndrome usually presents with progressively worsening proximal muscle weakness, fatigue, ptosis, and autonomic dysfunction (eg, dry mouth).&nbsp; Syndrome of inappropriate antidiuretic hormone causes hyponatremia instead of hypernatremia.</p><p><strong>(Choice B)</strong>&nbsp; Dexamethasone suppression test can diagnose Cushing&#39;s syndrome.&nbsp; Patients typically develop findings such as central obesity, purple striae, proximal muscle wasting, glucose intolerance, and hypertension.</p><p><strong>(Choice D)</strong>&nbsp; Measurement of 24-hour urinary potassium excretion was used previously to document inappropriate potassium excretion.&nbsp; A 24-hour urinary potassium level &gt;30 mEq in the presence of hypokalemia suggests hyperaldosteronism.&nbsp; However, this test is no longer commonly used.</p><p><strong>(Choice E)</strong>&nbsp; Plasma free metanephrines would be elevated in pheochromocytoma, a secondary cause of hypertension.&nbsp; Patients usually develop hypertension and the classic triad of episodic headache, sweating, and palpitations with tachycardia.&nbsp; However, pheochromocytoma does not usually cause the degree of hypokalemia seen in this patient.</p><p><strong>Educational objective:</strong><br>The ratio of plasma aldosterone concentration to plasma renin activity is the preferred initial screening test for primary hyperaldosteronism.&nbsp; Adrenal suppression testing can confirm the diagnosis, and positive tests require further adrenal imaging.&nbsp; Adrenal venous sampling is the most sensitive test for differentiating adrenal adenoma and bilateral adrenal hyperplasia in patients without discrete unilateral adrenal mass on imaging.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 10292,
            "topic": "Hyperaldosteronism",
            "titleId": 10292,
            "title": "Hyperaldosteronism",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chest computed tomography scan",
                    "choiceNumber": 1,
                    "correctTaken": 11632,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dexamethasone suppression testing",
                    "choiceNumber": 2,
                    "correctTaken": 7757,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Imaging of adrenals by computed tomography scan",
                    "choiceNumber": 3,
                    "correctTaken": 4189,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Measurement of 24-hour urinary potassium excretion",
                    "choiceNumber": 4,
                    "correctTaken": 3269,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma free metanephrines",
                    "choiceNumber": 5,
                    "correctTaken": 898,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma renin activity and aldosterone concentration",
                    "choiceNumber": 6,
                    "correctTaken": 96159,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "635,1198,true,-1,1*1345,1572,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "493",
                    "mediaDataId": 0,
                    "title": "Adrenal gland anatomy and physiology",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 62,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 123904,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1077,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 15534,
            "questionIndex": 16966,
            "questionText": "<p>A 65-year-old woman comes to the office for follow-up.&nbsp; Two months ago, the patient was found to have low bone mineral density on screening dual-energy x-ray absorptiometry.&nbsp; Her serum calcium and vitamin D levels were within normal limits, and weekly alendronate therapy was prescribed.&nbsp; After starting the bisphosphonate, the patient has had burning epigastric discomfort and nausea, which are controlled with daily over-the-counter antacids.&nbsp; She also has heart failure, for which she takes furosemide.&nbsp; The patient consumes a balanced diet and performs weight-bearing exercises regularly.&nbsp; Blood pressure is 110/66 mm Hg and pulse is 88/min.&nbsp; Physical examination is normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Sodium</td><td style=\"vertical-align:middle;\">143 mEq/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Potassium</td><td style=\"vertical-align:middle;\">3.9 mEq/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Bicarbonate</td><td style=\"vertical-align:middle;\">34 mEq/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Creatinine</td><td style=\"vertical-align:middle;\">1.7 mg/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Calcium</td><td style=\"vertical-align:middle;\">12.1 mg/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Phosphorus</td><td style=\"vertical-align:middle;\">1.2 mg/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Magnesium</td><td style=\"vertical-align:middle;\">1.1 mg/dL</td></tr></tbody></table><p>Serum creatinine was 0.8 mg/dL 2 months ago.&nbsp; Which of the following is the most likely cause of this patient&#39;s hypercalcemia?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t52312\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Milk-alkali syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Excessive intake of <strong>calcium &amp; absorbable alkali</strong></li><li>Renal vasoconstriction &amp; decreased GFR</li><li>Renal loss of sodium &amp; water, reabsorption of bicarbonate</li></ul></td></tr><tr><td><p align=\"center\"><strong>Symptoms</strong></p></td><td><ul><li>Nausea, vomiting, constipation</li><li>Polyuria, polydipsia</li><li>Neuropsychiatric symptoms</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br />findings</strong></p></td><td><ul><li>Hypercalcemia</li><li>Metabolic alkalosis</li><li>Acute kidney injury</li><li>Suppressed PTH</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Discontinuation of causative agent</li><li>Isotonic saline followed by furosemide</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>GFR</strong> = glomerular filtration rate; <strong>PTH</strong> = parathyroid hormone.</p></td></tr></tbody></table></div><p>This patient has <strong>acute kidney injury</strong> associated with <strong>hypercalcemia</strong> and <strong>metabolic alkalosis</strong> (ie, increased serum bicarbonate).&nbsp; In light of her recent use of over-the-counter antacids for bisphosphonate-induced pill esophagitis, this most likely represents <strong>milk-alkali syndrome</strong>.&nbsp; Milk-alkali syndrome is due to excessive intake of calcium and absorbable alkali, usually in the form of <strong>calcium carbonate antacids</strong>.</p><p>Hypercalcemia in milk-alkali syndrome causes renal vasoconstriction and decreased glomerular blood flow.&nbsp; In addition, inhibition of the Na-K-2Cl cotransporter (due to activation of calcium-sensing receptors in the thick ascending loop) and impaired activity of antidiuretic hormone lead to the loss of sodium and free water.&nbsp; This results in hypovolemia (eg, acute kidney injury) as well as increased reabsorption of bicarbonate (eg, metabolic alkalosis), which is augmented by the increased intake of alkali.&nbsp; Risk factors include chronic kidney disease and concurrent use of thiazide (eg, hydrochlorothiazide) diuretics (which promote volume depletion and calcium retention), ACE inhibitors, or nonsteroidal anti-inflammatory drugs (which decrease glomerular filtration).</p><p>Evaluation of milk-alkali syndrome should include measurement of serum <strong>parathyroid hormone</strong> (PTH), which would be expected to be suppressed.&nbsp; Additional findings can include <strong>hypophosphatemia</strong> due to intestinal binding of phosphate by calcium carbonate, and <strong>hypomagnesemia</strong> due to decreased renal reabsorption of magnesium.</p><p><strong>(Choice A)</strong>&nbsp; Bisphosphonate-induced osteonecrosis is rare in patients on low-dose bisphosphonates for osteoporosis and is typically associated with local pain (eg, in the mandible) and exposed bone.&nbsp; Bisphosphonates generally cause hypocalcemia, not hypercalcemia.</p><p><strong>(Choices C and D)</strong>&nbsp; Primary hyperparathyroidism can cause hypercalcemia and increased renal production of 1,25-dihydroxyvitamin D.&nbsp; However, it does not cause alkalosis, and when renal insufficiency occurs, it is usually associated with more severe hypercalcemia.</p><p><strong>(Choice E)</strong>&nbsp; Overdiuresis with loop diuretics (eg, furosemide) can also cause acute kidney injury with contraction alkalosis and hypomagnesemia.&nbsp; However, loop diuretics decrease (not increase) serum calcium levels by promoting renal calcium excretion.</p><p><strong>Educational objective:</strong><br>Milk-alkali syndrome is characterized by hypercalcemia, acute kidney injury, and metabolic alkalosis.&nbsp; It is caused by excessive intake of calcium and absorbable alkali, usually in the form of calcium carbonate taken for heartburn or osteoporosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 28677,
            "topic": "Milk alkali syndrome",
            "titleId": 28677,
            "title": "Milk alkali syndrome",
            "topicAttributeId": 330638,
            "topicAttribute": "Normal structure and function of endocrine glands",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bisphosphonate-induced osteonecrosis",
                    "choiceNumber": 1,
                    "correctTaken": 342,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Excessive calcium carbonate intake",
                    "choiceNumber": 2,
                    "correctTaken": 2029,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased release of parathyroid hormone",
                    "choiceNumber": 3,
                    "correctTaken": 1835,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased renal activation of vitamin D",
                    "choiceNumber": 4,
                    "correctTaken": 251,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal tubular effect of loop diuretic",
                    "choiceNumber": 5,
                    "correctTaken": 525,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "433,471,true,-1,1*945,1325,true,-1,1*1537,1718,true,-1,1*1859,2039,true,-1,1*2579,2709,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "468",
                    "mediaDataId": 0,
                    "title": "Calcium disorders",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24288027",
                    "mediaDataId": 0,
                    "title": "Calcium-alkali syndrome in the modern era.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24288027",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 90,
            "othersAvgTimeSpent": 121,
            "notes": null,
            "peopleTaken": 5055,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 40,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1677,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 3100,
            "questionIndex": 3100,
            "questionText": "<p>A 46-year-old man comes to the office due to bilateral ankle and facial swelling, especially prominent in the periorbital area.&nbsp; He has no shortness of breath, fever, or changes in urine color.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; He has no significant medical history and takes no medications.&nbsp; His temperature is 37.1 C (99 F), blood pressure is 130/70 mm Hg, pulse is 78/min, and respirations are 14/min.&nbsp; Examination shows bilateral 1+ pitting ankle edema.&nbsp; Auscultation shows clear lungs, normal heart sounds, and no murmurs.&nbsp; Dipstick urinalysis is positive for protein.&nbsp; A 24-hour urine collection shows proteinuria of 4.6 g/day.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"300\"><tbody><tr><td>Total serum calcium</td><td>7.5 mg/dL</td></tr><tr><td>Albumin</td><td>2.2 g/dL</td></tr><tr><td>Phosphorus</td><td>3.5 mg/dL</td></tr><tr><td>Magnesium</td><td>2.2 mg/dL</td></tr><tr><td>Creatinine</td><td>0.8 mg/dL</td></tr></tbody></table></blockquote><p>Which of the following is the most likely cause of this patient&#39;s low serum calcium level?</p>",
            "questionHeader": "",
            "explanationText": "<p>Approximately 40%-45% of total blood calcium is bound to albumin and other plasma proteins, the remainder is transported in the blood as ionized calcium (40%-55%) or complexed with phosphate and other anions (5%-15%).&nbsp; As a result, patients with hypoalbuminemia may have a significant deficit in total blood calcium.&nbsp; However, the ionized plasma calcium (physiologically active form) is hormonally regulated and remains stable.</p><p>Assessing the clinical significance of hypocalcemia detected in a common serum metabolic panel requires <strong>correction</strong> for the serum albumin concentration.&nbsp; The serum calcium concentration decreases by <strong>0.8 mg/dL for every 1 g/dL decrease in serum albumin</strong>;&nbsp;the corrected calcium level can be calculated using the following formula:</p><p align=\"center\">Corrected calcium = (measured total calcium) + 0.8 &times; (4.0 g/dL &#8722; serum albumin in g/dL)</p><p>This patient with nephrotic syndrome (heavy proteinuria, hypoalbuminemia, edema) has a corrected calcium of 8.94 mg/dL ([7.5 mg/dL] + 0.8 &times; [4 g/dL &#8722; 2.2 g/dL]).&nbsp; The hypocalcemia is most likely due to hypoalbuminemia (from nephrotic-range proteinuria) and is not clinically significant.&nbsp; Direct measurement of <strong>ionized calcium</strong> is performed in many clinical laboratories, but it requires special handling and may not be readily available.</p><p><strong>(Choices A and B)</strong>&nbsp; Vitamin D is formed in the skin or absorbed from the intestine.&nbsp; It is then hydroxylated in the liver (25-hydroxylation) to produce physiologically inert 25-hydroxyvitamin D (25[OH]D).&nbsp; The second step (1-alpha-hydroxylation) occurs in the kidney to form the physiologically active form of vitamin D (1,25[OH]<font size=\"2\"><sub>2</sub></font>D), which plays an active role in calcium and phosphorus absorption from the small intestine.&nbsp; Patients with chronic renal failure are unable to form 1,25(OH)<font size=\"2\"><sub>2</sub></font>D, leading to hypocalcemia secondary to decreased intestinal absorption.&nbsp; However, this patient&#39;s normal creatinine level makes this unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Hypoparathyroidism can cause hypocalcemia, and is most commonly due to autoimmune destruction of the parathyroid gland or surgery (parathyroidectomy, thyroid, or radical head/neck surgery for cancer).&nbsp; In addition to hypocalcemia, these patients would be expected to have decreased parathyroid hormone (PTH) levels and elevated serum phosphorus.&nbsp; This patient&#39;s normal serum phosphorus makes this unlikely.</p><p><strong>(Choice E)</strong>&nbsp; Pseudohypoparathyroidism is a rare disorder characterized by PTH resistance in target organs (kidney, bone).&nbsp; These patients have hypocalcemia, elevated phosphorus, and high PTH levels.</p><p><strong>Educational objective:</strong><br>Patients with hypoalbuminemia can have decreased total serum calcium.&nbsp; However, ionized calcium (physiologically active form) is hormonally regulated and remains stable.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2731,
            "topic": "Hypocalcemia",
            "titleId": 2731,
            "title": "Hypocalcemia",
            "topicAttributeId": 330638,
            "topicAttribute": "Normal structure and function of endocrine glands",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreased 1-alpha-hydroxylation of 25-OH vitamin D",
                    "choiceNumber": 1,
                    "correctTaken": 25180,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased 25-hydroxylation of vitamin D",
                    "choiceNumber": 2,
                    "correctTaken": 7516,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased levels of parathyroid hormone",
                    "choiceNumber": 3,
                    "correctTaken": 3399,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased serum albumin",
                    "choiceNumber": 4,
                    "correctTaken": 82744,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal levels of parathyroid hormone with impaired action at target organs",
                    "choiceNumber": 5,
                    "correctTaken": 4288,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "359,457,true,-1,1*655,710,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "468",
                    "mediaDataId": 0,
                    "title": "Calcium disorders",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "4758544",
                    "mediaDataId": 0,
                    "title": "Interpretation of serum calcium in patients with abnormal serum proteins.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/4758544",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 63,
            "othersAvgTimeSpent": 88,
            "notes": null,
            "peopleTaken": 123127,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 529,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 2497,
            "questionIndex": 2497,
            "questionText": "<p>A 23-year-old woman comes to the office with a month of milky discharge from both nipples.&nbsp; The patient&#39;s menstrual cycles have also been erratic for the past 3 months, and her libido is poor.&nbsp; She has mild breast tenderness but does not report any other symptoms.&nbsp; The patient says she had a &#x22;nervous breakdown&#x22; a year ago, felt depressed, and did not leave the house for almost 2 months.&nbsp; She thought a neighbor was plotting to burn down her house, so she sat up many nights at the door watching for unusual activity.&nbsp; The patient was eventually treated and remains on medication.&nbsp; She has a family history of breast cancer, bipolar disorder, and Graves disease.&nbsp; She occasionally drinks alcohol, and smokes a half-pack of cigarettes per day.&nbsp; Laboratory studies show a prolactin level of 70 ng/mL (normal, 3-30 ng/mL) and a TSH of 3.0 &micro;U/mL.&nbsp; Urine pregnancy test is negative.&nbsp; Which of the following is most likely responsible for this patient&#39;s current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s history of paranoia, social isolation, and disorganized behavior are suggestive of psychosis, and she is likely being treated with an <strong>antipsychotic medication</strong>.&nbsp; Antipsychotic medications cause dopamine blockade and because dopamine is a prolactin-inhibiting factor, the <strong>blockade of dopamine</strong> in the tuberoinfundibular pathway can lead to <strong>hyperprolactinemia</strong> and symptoms such as <strong>gynecomastia, galactorrhea, menstrual dysfunction</strong>, and <strong>decreased libido</strong>.</p><p><strong>Risperidone</strong> is a commonly used, second-generation antipsychotic that is known to have a <strong>high frequency</strong> of <strong>prolactin elevation</strong> and is likely responsible for this patient&#39;s symptoms.</p><p><strong>(Choice A)</strong>&nbsp; The antipsychotic aripiprazole is both an antagonist as well as a partial agonist of dopamine D2 receptors.&nbsp; Due to its partial agonism of dopamine, it is less likely to cause hyperprolactinemia.</p><p><strong>(Choice B)</strong>&nbsp; Galactocele is a benign milk collection in lactating women, usually due to a blocked duct.&nbsp; This patient&#39;s pregnancy test was negative, and there is no indication that she is breastfeeding.</p><p><strong>(Choice C)</strong>&nbsp; Hypothyroidism can predispose to hyperprolactinemia but typically presents with other complaints such as lethargy, dry skin, or cold intolerance, which this patient does not have.&nbsp; In addition, this woman&#39;s TSH is within normal range.</p><p><strong>(Choice D)</strong>&nbsp; Polycystic ovary syndrome (PCOS) is associated with increased androgen levels resulting in acne, hirsutism, and menstrual irregularities.&nbsp; It can occasionally cause an elevation in prolactin levels.&nbsp; This patient does not report symptoms of hyperandrogenism typical of PCOS.</p><p><strong>(Choice E)</strong>&nbsp; Prolactinomas are benign pituitary tumors that typically cause headaches and visual disturbances, which this woman does not have.&nbsp; They can cause very high prolactin levels (&gt;200 ng/mL), whereas medication-related hyperprolactinemia is typically 25-100 ng/mL with levels seldom above 200 ng/mL.</p><p><strong>(Choice G)</strong>&nbsp; Valproate is an anticonvulsant used to treat bipolar disorder and seizures.&nbsp; It does not cause galactorrhea but is associated with adverse effects such as blood dyscrasias and liver toxicity.</p><p><strong>Educational objective:</strong><br>Antipsychotic medications can cause hyperprolactinemia secondary to their dopamine blockade effect.&nbsp; Risperidone has a high frequency of prolactin elevation.&nbsp; In comparison to antipsychotics, prolactinomas are capable of producing very high levels of prolactin (&gt;200 ng/mL).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11896,
            "topic": "Hyperprolactinemia",
            "titleId": 11896,
            "title": "Hyperprolactinemia",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Aripiprazole",
                    "choiceNumber": 1,
                    "correctTaken": 1560,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Galactocele",
                    "choiceNumber": 2,
                    "correctTaken": 28,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothyroidism",
                    "choiceNumber": 3,
                    "correctTaken": 120,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polycystic ovary syndrome",
                    "choiceNumber": 4,
                    "correctTaken": 45,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prolactinoma",
                    "choiceNumber": 5,
                    "correctTaken": 1773,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Risperidone",
                    "choiceNumber": 6,
                    "correctTaken": 18157,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Valproate",
                    "choiceNumber": 7,
                    "correctTaken": 296,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1629,1926,true,-1,1*688,795,true,-1,1*495,674,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "610",
                    "mediaDataId": 0,
                    "title": "Antipsychotics",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19702492",
                    "mediaDataId": 0,
                    "title": "Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19702492",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18477617",
                    "mediaDataId": 0,
                    "title": "Prolactin and dopamine: what is the connection? A review article.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18477617",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 42,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 21979,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1133,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 17103,
            "questionIndex": 18554,
            "questionText": "<p>An 8-year-old boy is brought to the office due to a 2-month history of excessive urination.&nbsp; He has been drinking large amounts of water and has been irritable and restless.&nbsp; The patient takes no medications and has had normal growth with achievement of all expected developmental milestones.&nbsp; Vital signs are normal.&nbsp; Physical examination, including neurologic examination, is normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Sodium</td><td style=\"vertical-align:middle;\">142 mEq/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Potassium</td><td style=\"vertical-align:middle;\">4.2 mEq/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Chloride</td><td style=\"vertical-align:middle;\">100 mEq/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Bicarbonate</td><td style=\"vertical-align:middle;\">24 mEq/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">30 mg/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Creatinine</td><td style=\"vertical-align:middle;\">1.0 mg/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Calcium</td><td style=\"vertical-align:middle;\">9.2 mg/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Glucose</td><td style=\"vertical-align:middle;\">100 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Urinalysis</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Specific gravity</td><td style=\"vertical-align:middle;\">1.001</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Protein</td><td style=\"vertical-align:middle;\">none</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Blood</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Glucose</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Ketones</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Nitrites</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Bacteria</td><td style=\"vertical-align:middle;\">none</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">White blood cells</td><td style=\"vertical-align:middle;\">1-2/hpf</td></tr></tbody></table><p>Urine osmolality is 120 mOsm/kg, and urine output over 24 hours is 3.7 L.&nbsp; Which of the following is the most appropriate next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"75452\" src=\"https://www.uworld.com/media/highresdefault/L107388.png\"  ></p><p>Extracellular fluid balance is regulated by <strong>arginine vasopressin</strong> (AVP), also known as antidiuretic hormone.&nbsp; AVP is secreted from the hypothalamus and posterior pituitary in response to rising plasma osmolality; it stimulates <a href=\"2821\">renal water reabsorption</a>, resulting in concentrated urine.&nbsp; Patients with <strong>AVP deficiency</strong> (AVP-D) (formerly central diabetes insipidus) or <strong>AVP resistance</strong> (AVP-R) (formerly nephrogenic diabetes insipidus) have <strong>impaired urinary concentrating ability</strong> and produce inappropriately dilute urine.</p><p>This patient has <strong>polyuria</strong> with <strong>dilute urine</strong> (urine osmolality &lt;300 mOsm/kg, specific gravity &lt;1.006), suggesting an AVP disorder.&nbsp; However, his <strong>serum sodium</strong> level is normal, which is common when a patient is able to drink sufficient water to replace renal losses.&nbsp; In such cases, <a href=\"75453\">water deprivation testing</a> can distinguish between an AVP disorder and primary polydipsia.&nbsp; Water is restricted until serum osmolality is &gt;295 mOsm/kg and serum sodium is &gt;145 mEq/L, which normally would trigger maximal AVP secretion.&nbsp; Urine osmolality is then reassessed:</p><ul><li>An appropriate rise in urinary concentration (eg, to &gt;600 mOsm/kg) indicates primary polydipsia.</li></ul><ul><li>Persistently dilute urine confirms an AVP disorder; if urine also remains dilute following administration of desmopressin (an AVP analogue), then AVP-R (which in children is most commonly due to hereditary disorders) is likely.</li></ul><p>The water deprivation test is performed in the hospital (ie, supervised) in older children and should not be used in very young children due to the risk of severe hypernatremia.</p><p><strong>(Choice A)</strong>&nbsp; Chest x-ray can detect lung malignancy, which may cause the syndrome of inappropriate antidiuretic hormone secretion, a condition characterized by impaired water excretion, hyponatremia, and concentrated urine.</p><p><strong>(Choice B)</strong>&nbsp; A low fractional excretion of sodium (eg, &lt;1%) may suggest decreased kidney perfusion (eg, dehydration) but does not assess urinary concentrating capacity or narrow the diagnosis.</p><p><strong>(Choices C and E)</strong>&nbsp; Once an AVP disorder is confirmed, MRI (to visualize the hypothalamus and pituitary gland in AVP-D) or ultrasonography (to visualize the kidneys in AVP-R) may be appropriate.&nbsp; However, water deprivation testing is needed first in this patient.</p><p><strong>(Choice D)</strong>&nbsp; Diabetes mellitus (occasionally assessed with an oral glucose tolerance test) can cause polyuria and polydipsia but is typically associated with osmotic diuresis (ie, from glucosuria) and concentrated (not dilute) urine.</p><p><strong>Educational objective:</strong><br>Patients with polyuria and dilute urine who have normal serum sodium require water deprivation testing to distinguish primary polydipsia from an arginine vasopressin (AVP) disorder.&nbsp; Persistently dilute urine following water deprivation (ie, serum osmolality &gt;295 mEq/L and serum sodium &gt;145 mEq/L) suggests an AVP disorder.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 18034,
            "topic": "Diabetes insipidus",
            "titleId": 18034,
            "title": "Diabetes insipidus",
            "topicAttributeId": 330612,
            "topicAttribute": "Hypothalamus and pituitary disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chest x-ray",
                    "choiceNumber": 1,
                    "correctTaken": 12,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fractional excretion of sodium",
                    "choiceNumber": 2,
                    "correctTaken": 452,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the brain",
                    "choiceNumber": 3,
                    "correctTaken": 167,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oral glucose tolerance test",
                    "choiceNumber": 4,
                    "correctTaken": 207,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ultrasonography of the kidneys",
                    "choiceNumber": 5,
                    "correctTaken": 87,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Water deprivation test",
                    "choiceNumber": 6,
                    "correctTaken": 4435,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "916,1098,true,-1,1*1518,1601,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "494",
                    "mediaDataId": 0,
                    "title": "Arginine vasopressin deficiency and resistance (diabetes insipidus)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33713498",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of diabetes insipidus for the internist: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33713498",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 99,
            "othersAvgTimeSpent": 92,
            "notes": null,
            "peopleTaken": 5360,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1196,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 16006,
            "questionIndex": 17445,
            "questionText": "<p>A 34-year-old woman comes to the office after a recent hospitalization.&nbsp; Over the past several months, the patient has had worsening weakness, anorexia, nausea, and abdominal discomfort.&nbsp; Two weeks ago, she had a syncopal episode; evaluation found a low serum cortisol level and subnormal response to ACTH stimulation.&nbsp; The patient was treated in the hospital and was discharged on oral hydrocortisone therapy.&nbsp; Since discharge, she has had intermittent episodes of light-headedness and nausea but reports improvement in other symptoms.&nbsp; Her husband adds that the patient consumes excessive amounts of salty foods.&nbsp; Temperature is 36.9 C (98.4 F), blood pressure is 108/66 mm Hg supine and 98/60 mm Hg upright, and pulse is 88/min supine and 102/min upright.&nbsp; Physical examination reveals hyperpigmentation of the oral mucosa and palmar creases.&nbsp; Cardiopulmonary and abdominal examination shows no abnormalities.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">12.8 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">205,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">7,800/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td style=\"vertical-align:middle;\">130 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td style=\"vertical-align:middle;\">5.5 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">0.8 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td style=\"vertical-align:middle;\">110 mg/dL</td></tr></tbody></table><p>Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t53662\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Primary adrenal insufficiency</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Autoimmune adrenalitis (most common)</li><li>Infection (eg, tuberculosis)</li><li>Metastatic infiltration</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Fatigue, weakness, anorexia/weight loss</li><li>Nausea, vomiting, abdominal pain</li><li>Salt craving, postural hypotension</li><li>Hyperpigmentation</li><li>Acute adrenal crisis: confusion, hypotension/shock</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Hyponatremia, hyperkalemia, eosinophilia</li><li>Low morning cortisol, high ACTH</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Glucocorticoids (eg, hydrocortisone, prednisone)</li><li>Mineralocorticoids (eg, fludrocortisone)</li></ul></td></tr></tbody></table></div><p>This patient likely has <strong>primary adrenal insufficiency (PAI)</strong>&nbsp;given her low serum cortisol level, abnormal ACTH stimulation test, and hyperpigmentation (increased melanocyte-stimulating hormone, which, along with ACTH,&nbsp;is derived from proopiomelanocortin).&nbsp; The resultant&nbsp;<strong>loss of both glucocorticoid and mineralocorticoid </strong>production from the <a href=\"27888\">adrenal glands</a>&nbsp;leads to&nbsp;<strong>hypotension, orthostatic syncope</strong>, hyponatremia (salt craving), and hyperkalemia.</p><p>The patient received appropriate initial treatment with <strong>hydrocortisone</strong>, which has <strong>glucocorticoid </strong>and mild mineralocorticoid activity.&nbsp; However, most patients who have PAI and are treated with hydrocortisone alone may continue to have signs of mineralocorticoid deficiency, including hyponatremia, hyperkalemia, and orthostatic hypotension.&nbsp; <strong>Fludrocortisone</strong> is a <strong>synthetic mineralocorticoid</strong> analog that can be given in small doses with hydrocortisone to replace mineralocorticoid activity.&nbsp; In contrast, patients with central (ie, hypothalamic, pituitary) adrenal insufficiency usually have adequate mineralocorticoid activity (aldosterone secretion is regulated by the renin-angiotensin system) and are treated with glucocorticoids alone.</p><p><strong>(Choice B)</strong>&nbsp; Midodrine is an alpha-adrenergic agonist used to treat orthostatic hypotension.&nbsp; It may improve this patient&#39;s orthostatic symptoms but would not correct the other features of mineralocorticoid deficiency (eg, hyperkalemia).</p><p><strong>(Choice C)</strong>&nbsp; Switching to dexamethasone would not correct this patient&#39;s mineralocorticoid deficiency because this medication has only glucocorticoid and no mineralocorticoid activity.&nbsp; Furthermore, hydrocortisone is generally preferred over dexamethasone for PAI because it has a shorter duration of action and can be given in divided doses to better mimic the circadian rhythm of endogenous cortisol secretion.</p><p><strong>(Choice D)</strong>&nbsp; Although hydrocortisone has both glucocorticoid and mineralocorticoid properties, increasing the dose to get more mineralocorticoid activity is likely to result in toxicity from excessive glucocorticoid exposure (eg, weight gain, hyperglycemia, bone loss).</p><p><strong>(Choice E)</strong>&nbsp; Glucocorticoids in PAI are given in the lowest dose necessary to correct the clinical features of deficiency, although some experts measure morning ACTH to confirm that the dose is not excessive.&nbsp; However, ACTH stimulation testing is primarily used in diagnosis of adrenal insufficiency, and the diagnosis in this patient is already established.</p><p><strong>Educational objective:</strong><br>Patients with primary adrenal insufficiency have glucocorticoid and mineralocorticoid deficiency.&nbsp; Most patients require replacement of both glucocorticoid (eg, hydrocortisone) and mineralocorticoid (eg, fludrocortisone) activity.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23445,
            "topic": "Adrenal insufficiency",
            "titleId": 23445,
            "title": "Adrenal insufficiency",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "1",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Add fludrocortisone",
                    "choiceNumber": 1,
                    "correctTaken": 9590,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Add midodrine",
                    "choiceNumber": 2,
                    "correctTaken": 1046,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Change therapy to dexamethasone",
                    "choiceNumber": 3,
                    "correctTaken": 1969,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increase hydrocortisone dose",
                    "choiceNumber": 4,
                    "correctTaken": 1911,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform repeat ACTH stimulation testing",
                    "choiceNumber": 5,
                    "correctTaken": 1544,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1743,1821,true,-1,1*1979,2379,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "491",
                    "mediaDataId": 0,
                    "title": "Adrenal insufficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26760044",
                    "mediaDataId": 0,
                    "title": "Diagnosis and treatment of&#160;primary adrenal insufficiency: an&#160;Endocrine&#160;Society&#160;clinical practice guideline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26760044",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25098712",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of adrenal insufficiency.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25098712",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 104,
            "othersAvgTimeSpent": 83,
            "notes": null,
            "peopleTaken": 16060,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 827,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 15710,
            "questionIndex": 17146,
            "questionText": "<p>A 68-year-old woman comes to the emergency department due to severe generalized weakness and dizziness.&nbsp; She has not fallen or lost consciousness.&nbsp; The patient reports no chest pain, dyspnea, cough, or diarrhea; however, she has had worsening fatigue, nausea, and anorexia for the past 3 weeks.&nbsp; The patient has a history of breast cancer treated with surgery and chemotherapy 5 years ago but was found to have a vertebral metastatic lesion during evaluation of back pain a month ago.&nbsp; Radiation therapy and systemic chemotherapy are planned, but she has not received treatment yet.&nbsp; The patient has no other medical conditions, and the only prescribed medication is opioid analgesic as needed.&nbsp; Temperature is 37.5 C (99.5 F), blood pressure is 108/66 mm Hg, and pulse is 102/min.&nbsp; Orthostatic changes are present and oral mucosa are dry.&nbsp; The lungs are clear on auscultation and heart sounds are normal.&nbsp; The abdomen is soft with mild generalized tenderness, and no lower extremity edema is present.&nbsp; There is focal tenderness of the mid thoracic vertebrae with no focal neurologic deficit.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">12.8 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">280,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">8,200/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neutrophils</td><td style=\"vertical-align:middle;\">60%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eosinophils</td><td style=\"vertical-align:middle;\">8%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lymphocytes</td><td style=\"vertical-align:middle;\">30%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Monocytes</td><td style=\"vertical-align:middle;\">2%</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td style=\"vertical-align:middle;\">130 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td style=\"vertical-align:middle;\">5.1 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td style=\"vertical-align:middle;\">28 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">1.2 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td style=\"vertical-align:middle;\">9.2 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td style=\"vertical-align:middle;\">70 mg/dL</td></tr></tbody></table><p>In addition to intravenous fluids, which of the following is the most appropriate management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t53662\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Primary adrenal insufficiency</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Autoimmune adrenalitis (most common)</li><li>Infection (eg, tuberculosis)</li><li>Metastatic infiltration</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Fatigue, weakness, anorexia/weight loss</li><li>Nausea, vomiting, abdominal pain</li><li>Salt craving, postural hypotension</li><li>Hyperpigmentation</li><li>Acute adrenal crisis: confusion, hypotension/shock</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Hyponatremia, hyperkalemia, eosinophilia</li><li>Low morning cortisol, high ACTH</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Glucocorticoids (eg, hydrocortisone, prednisone)</li><li>Mineralocorticoids (eg, fludrocortisone)</li></ul></td></tr></tbody></table></div><p>This patient has evidence of <strong>primary adrenal insufficiency</strong> (AI), likely due to metastatic breast cancer.&nbsp; The adrenal glands are a common site of <strong>metastatic cancer</strong> spread, especially for primary tumors of the lung, breast, kidney, and skin (ie, melanoma).&nbsp; With extensive involvement of the bilateral adrenal glands, primary AI can occur, with manifestations reflecting <a href=\"27888\">adrenocortical</a> destruction:</p><ul><li><p>Reduced aldosterone production causes renal sodium wasting and potassium retention, leading to hypovolemia, <strong>hypotension/orthostasis</strong>, and <strong>hyperkalemia</strong>.&nbsp; The hypovolemia provides nonosmotic stimulus for antidiuretic hormone (ADH) secretion, with consequent water retention and <strong>hyponatremia</strong>.</p></li><li><p>Reduced cortisol production contributes to hypotension (cortisol helps enhance vascular tone), causes <strong>constitutional symptoms</strong> (eg, fatigue, anorexia), can trigger <strong>hypoglycemia</strong>, and may lead to eosinophilia (by reducing eosinophil migration into the tissues).&nbsp; Because cortisol normally inhibits ADH secretion, the reduced cortisol levels also contribute to hyponatremia.</p></li></ul><p>Although low morning cortisol levels can suggest AI, the <strong>diagnosis</strong> is made by <strong>cosyntropin stimulation testing</strong>.&nbsp; Cosyntropin is a synthetic form of ACTH; absence of the expected increase in cortisol levels following cosyntropin administration reflects adrenocortical destruction.&nbsp; The test is usually performed in the morning, when cortisol responses in healthy individuals are normally the most pronounced.&nbsp; Measuring basal ACTH (before cosyntropin injection) can help differentiate primary AI (high basal ACTH) from AI due to hypothalamic-pituitary deficiency (low basal ACTH).</p><p><strong>(Choice A)</strong>&nbsp; Appetite stimulants (eg, megestrol) and nutritional supplements may be helpful for malignancy-related anorexia.&nbsp; However, this patient&#39;s electrolyte abnormalities are consistent with primary AI, which is likely causing much of her anorexia.</p><p><strong>(Choice B)</strong>&nbsp; Blood cultures and empiric antibiotics may be appropriate for suspected vertebral osteomyelitis, which can cause fatigue and focal vertebral tenderness.&nbsp; However, fever and leukocytosis would be expected, and this patient&#39;s vertebral tenderness is most likely due to known vertebral metastatic disease.</p><p><strong>(Choice D)</strong>&nbsp; Overtreatment with opioid pain medications (eg, oxycodone) may cause confusion and malaise; however, it would not explain this patient&#39;s laboratory findings.</p><p><strong>(Choice E)</strong>&nbsp; Percutaneous gastrostomy tube placement is indicated in patients with severe dysphagia or those who are unable to maintain adequate nutrition with oral intake alone.&nbsp; It would not be appropriate in this patient as her anorexia may improve with treatment of primary AI.</p><p><strong>Educational objective:</strong><br>The adrenal glands are a common site of metastatic cancer spread, and extensive metastatic involvement can lead to primary adrenal insufficiency (PAI).&nbsp; Clinical manifestations of PAI include hypotension/orthostasis, hyponatremia, hyperkalemia, and hypoglycemia.&nbsp; Diagnosis is made by cosyntropin stimulation testing.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23445,
            "topic": "Adrenal insufficiency",
            "titleId": 23445,
            "title": "Adrenal insufficiency",
            "topicAttributeId": 330552,
            "topicAttribute": "Adrenal disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Appetite stimulant and nutritional supplements",
                    "choiceNumber": 1,
                    "correctTaken": 4240,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Blood culture and empiric antibiotics",
                    "choiceNumber": 2,
                    "correctTaken": 827,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cosyntropin stimulation testing",
                    "choiceNumber": 3,
                    "correctTaken": 4376,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinuation of opioid analgesics",
                    "choiceNumber": 4,
                    "correctTaken": 1086,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Percutaneous gastrostomy tube placement",
                    "choiceNumber": 5,
                    "correctTaken": 341,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "652,802,true,-1,1*2015,2185,true,-1,1*2198,2232,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "491",
                    "mediaDataId": 0,
                    "title": "Adrenal insufficiency",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 84,
            "othersAvgTimeSpent": 98,
            "notes": null,
            "peopleTaken": 10870,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 40,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 792,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}